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1. Introduction 
1.1. Acid stress adaptation 
The interplay between humans and microbes for human health is highly important and was 
first described over 100 years ago by Pasteur (Schottelius, 1902). The human surfaces and the 
gastrointestinal tract (GI) are inhabited by approximately 1014 mutualistic microbial cells – 
ten times more cells than the human body consists of (Hooper & Gordon, 2001; Savage, 
1977). One gram (wet weight) of the human colon contains about 1011 prokaryotes (Whitman 
et al., 1998). While the gut represents an ideal milieu for bacteria as it is enriched by dietary 
compounds, bacteria in return help their hosts to digest polysaccharides and provide them 
with essential vitamins (Conly et al., 1994; Savage, 1986). As babies are born without any 
germs, their gut is colonized immediately after birth by first mainly facultative and later on 
mainly obligate anaerobic bacteria to develop a normal healthy digestive tract (Hooper, 2004; 
Savage, 1977). In fact, exceeding hygiene standards in early childhood can be linked to 
inflammatory bowel disease (IBD), represented by Crohn´s disease and ulcerative colitis, 
resulting in intolerance against normal gut inhabitants (Gent et al., 1994). The main 
colonizers consist largely of two phyla, Bacteroidetes and Firmicutes (Bäckhed et al., 2005; 
Eckburg et al., 2005), but also include members of the family Enterobacteriaceae. 
Enterobacteria can be harmless, as it is the case with most types of Escherichia coli, but they 
also harbor pathogens such as Salmonella typhimurium, enteropathogenic (EPEC) or 
enterohemorrhagic E. coli (EHEC), which disturb the normal gut flora and cause severe 
intestinal diseases (Stecher & Hardt, 2008).  
While colonizing the gut, bacteria are exposed to substantial changes in the pH range. The 
stomach contains hydrochloric acid (HCl) and thereby reaches extreme low pH values of 1.5 – 
2.5 (Smith, 2003). Furthermore, weak organic acids such as propionic and acetic acids, which 
are produced during the bacterial fermentation process, lead to additional acidic stress. These 
weak acids, protonated and uncharged at low pH, can freely diffuse through the cytoplasmic 
membrane of the bacteria and easily dissociate in the neutral cytoplasm. This leads to 
decreased internal pH, destabilized inactive macromolecules, and the destruction of the proton 
motive force (PMF) (Bearson et al., 1997; Foster, 2004; Slonczewski et al., 1981; Zilberstein 
1. Introduction 
 
2 
 
et al., 1984). Consequently, bacteria are unable to keep up their proton gradient, which is 
crucial for ATP formation and cell metabolism. To survive these extreme stress conditions, 
neutrophil enterobacteria have evolved several passive and active strategies to protect their 
internal homeostasis (Fig. 1). Passive survival mechanisms include the impermeability of the 
cytoplasmic membrane for charged ions such as protons and the buffering capacity of the 
cytoplasm by polyamines, proteins and nucleic acids (Slonczewski & Foster, 1996). By 
contrast, proton pumps actively export protons out of the cell by consumption of ATP. To 
avoid further proton influx, other charged ions like potassium are imported by K+-transporters 
such as Trk or Kup (Bakker & Mangerich, 1981; Rhoads et al., 1976). Moreover, acidic pH 
can activate transcription regulators like Fur and PhoP, leading to the synthesis of diverse acid 
shock proteins (ASPs). These ASPs also contribute to the retention of the internal pH 
homestasis (Bearson et al., 1997). 
 
Figure 1: Stress adaptation in E. coli. To survive the acidic environment of the gastrointestinal tract, 
enterobacteria have evolved several different strategies: Passive mechanisms include the 
impermeability of the cytoplasmic membrane for charged ions and the buffering capacity of the 
cytoplasm. Proton pumps and potassium transporters belong to the active constitutive mechanisms. 
Furthermore, the degradative amino acid decarboxylase systems Gad, Adi and Cad are induced by acid 
stress and glutamate, arginine and lysine, respectively. Their endproducts, gamma aminobutyric acid 
(GABA), agmatine or cadaverine, are exported out of the cell, thus increasing the external pH. In 
addition, regulators such as Fur, PhoP and RpoS induce the expression of specific acid shock proteins 
(ASPs). In the periplasma, chaperones such as HdeA and HdeB protect the proteins from damage. 
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Additionally, Acid Resistance systems (AR) contribute to the survival of E. coli at a pH of 2 
for at least two hours (Foster, 2004; Gorden & Small, 1993). There are five different systems 
known to help bacteria respond to many different acid stress conditions. In the glucose 
repressed AR1 system, which is also known as the oxidative system (Bearson et al., 1997), 
the sigma factor σS encoded by the gene rpoS and the cAMP receptor protein CRP regulate 
the expression of several ASPs. The mechanism is still unclear, but AR1 helps cells which 
were grown to stationary phase in pH 5.5 buffered Lysogeny Broth (LB) medium survive the 
shift to pH 2.5 buffered minimal medium (Foster, 2004). The systems AR2, AR3 and AR4, 
also called the Gad (AR2), Adi (AR3) or Cad (AR4) system, require all the activity of an 
enzyme to decarboxylate the amino acids (aa) glutamate, arginine or lysine, respectively. 
Within this enzymatic reaction catalyzed by the decarboxylases GadA/GadB, AdiA or CadA, 
CO2 is produced and a cellular proton is consumed, thus contributing to an increase of the 
internal pH. The resulting basic polyamines gamma aminobutyric acid (GABA), agmatine or 
cadaverine are exported out of the cell by the amino acid/polyamine antiporters GadC, AdiC 
or CadB, leading to an increase of the extracellular pH (Foster, 2004). AR2, the best known of 
the AR systems, and AR3 can be partially induced by σS and enable cell survival at stationary 
phase and pH values as low as 2.5 by maintaining an internal pH of 4.2 and 4.7, respectively 
(Richard & Foster, 2004). By contrast, the pH optimum of the AR4 lysine decarboxylase is 
higher and lies at pH 5.7 (Sabo et al., 1974). Furthermore, AR3 is only active under anaerobic 
conditions, while AR4 favors microaerobic conditions. In some E. coli strains, but not in K12 
strains, the AR5 system exists. This system contains SpeF, an ornithine decarboxylase, and 
PotE, an ornithine-putrescine antiporter. Like AR4, it functions only under moderately acidic 
conditions (Applebaum et al., 1977; Zhao & Houry, 2010). 
As periplasmic proteins also need acid stress protection, E. coli expresses acid inducible 
chaperones such as HdeA and HdeB, which act in the periplasm by protecting proteins from 
damage and degradation (Gajiwala & Burley, 2000).  
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1.2. The Cad system 
As mentioned above, E. coli possesses the lysine dependent decarboxylase system AR4: the 
Cad system (Fig. 2). Its main components are the lysine decarboxylase CadA, the 
lysine/cadaverine antiporter CadB and the regulator of the cadBA operon – CadC (Auger et 
al., 1989; Meng & Bennett, 1992a; Meng & Bennett, 1992b; Sabo et al., 1974; Watson et al., 
1992).  
1.2.1. CadA, CadB and CadC 
In E. coli, two different types of amino acid decarboxylases exist: Constitutively expressed 
biosynthetic decarboxylases important for polyamine synthesis (Goldemberg, 1980; Tabor & 
Tabor, 1985) and inducible biodegradative decarboxylases like CadA (Gale, 1946). The 
activity of the cytoplasmic CadA reaches its maximal level when incubated in rich medium 
containing lysine with low oxygen levels and acidic pH (Sabo et al., 1974). The enzyme 
catalyzes the decarboxylation of lysine to cadaverine while consuming a proton and releasing 
CO2. It has a relative size of 81 kDa (715 aa) and forms decamers consisting of five dimers 
(Kanjee et al., 2011; Meng & Bennett, 1992a; Sabo et al., 1974). Two CadA decamers and up 
to five hexamers of the AAA+-ATPase RavA (ATPases associated with various cellular 
activities) can build a cage-like complex, which does not influence CadA activity, but 
stimulates the ATPase activity of RavA (Snider et al., 2006). Furthermore, an interaction with 
the small alarmone ppGpp blocks CadA activity (Kanjee et al., 2011). Since ppGpp responds 
to amino acid starvation in the cell, it presumably inhibits the lysine decarboxylase to prevent 
further lysine consumption. 
Following lysine decarboxylation, the end product cadaverine is exported by the 
lysine/cadaverine antiporter CadB (Meng & Bennett, 1992b). CadB is an inner membrane 
protein with a relative size of 47 kDa (444 aa) and contains 12 transmembrane helices (Meng 
& Bennett, 1992a). Furthermore, it shows similarity to the ornithine/putrescine antiporter 
PotE (Soksawatmaekhin et al., 2004). The exported polyamine cadaverine not only 
contributes to the increase of the extracellular pH, but also inhibits the activity of the porines 
OmpC and OmpF, thus decreasing of proton influx (Samartzidou & Delcour, 1999; 
Samartzidou et al., 2003). 
The genes cadC, cadB and cadA are clustered on the E. coli chromosome, while cadB and 
cadA are organized in an operon containing the same promoter (Auger et al., 1989; Meng & 
Bennett, 1992a; Watson et al., 1992). The transcriptional regulator CadC activates cadBA 
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expression under low pH conditions and in the presence of lysine (Neely et al., 1994). CadC 
is anchored in the inner membrane and has a relative molecular mass of 58 kDa (512 aa) (Dell 
et al., 1994; Watson et al., 1992). It consists of three different domains: the cytoplasmic N-
terminal domain (aa 1 - 158), the transmembrane domain (aa 159 - 187) and the periplasmic 
C-terminal domain (aa 188 - 512) (Dell et al., 1994). CadC belongs to the ToxR-like 
transcriptional activators, as approximately 100 amino acids of the NH2-terminus show high 
similarity to the COOH-termini of other ToxR-like regulators such as ToxR and Tcp of Vibrio 
cholera, PsaE of Yersinia pseudotuberculosis and WmpR of Pseudoalteromonas tunicata 
(Egan et al., 2002; Hase & Mekalanos, 1998; Miller et al., 1987; Watson et al., 1992; Yang & 
Isberg, 1997). Like ToxR, CadC is not part of a two-component-system consisting of a kinase 
and a response regulator, but rather acts as one-component system with DNA-binding at its 
NH2-terminus (Miller et al., 1987; Ulrich et al., 2005; Watson et al., 1992).  
1.2.2. Regulation of the Cad system 
Several different mechanisms exist to regulate the expression of the cad genes cadA and cadB 
(Fig. 2). Mutations in the periplasmic domain of CadC revealed that CadC acts as the pH 
sensor of the system (Dell et al., 1994; Haneburger et al., 2011). In addition, two periplasmic 
cysteine residues (Cys208 and Cys272) can build a disulfide bridge at neutral pH, which is 
reduced at low pH. Therefore, cysteines seem to play a functional role in the pH sensing of 
CadC, too (Tetsch et al., 2011). Detection of the two CadC binding sites Cad1 (-144 to -112 
bp) and Cad2 (-89 to -59 bp) in the cadBA promoter (Pcad or PcadBA), crosslinking-studies and 
the crystallization of the periplasmic domain led to speculations that CadC binds to the 
promoter as an oligomer (Eichinger et al., 2011; Küper & Jung, 2005). Furthermore, PcadBA 
harbors five binding sites for the small histone-like protein H-NS (Küper & Jung, 2005), and 
also the promoter of CadC is regulated by H-NS (Krin et al., 2010). H-NS binding causes 
altered DNA topology and transcriptional repression at neutral pH and aerobic conditions 
(Cortassa & Aon, 1993; Reams et al., 1997; Shi et al., 1993). Anaerobiosis leads to ten times 
higher CadA activities as aerobiosis (Sabo et al., 1974). In the absence of lysine, the Cad 
system is inhibited by LysP (Popkin & Maas, 1980; Tabor et al., 1980) - a lysine permease 
with an average size of 54 kDa (489 aa) consisting of 12 transmembrane domains (Steffes et 
al., 1992). In the absence of lysine, LysP presumably interacts directly with CadC via its 
transmembrane domain preventing CadC activation (Tetsch et al., 2008). In the presence of 
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exogenous lysine, lysine is transported into the cell by LysP leading to reduced interaction 
with CadC and to cadBA expression at acidic pH (Tetsch et al., 2008).  
 
 
 
Figure 2: The Cad system of E. coli. At neutral pH and in the absence of lysine (in red), the lysine 
permease LysP inhibits the regulator CadC. Additionally, H-NS prevents cadBA expression. A 
decrease of the external pH, together with the presence of lysine, leads to a release of CadC and lysine 
transport into the cell by LysP. CadC can bind to the PcadBA promoter, thereby starting the production 
of the lysine decarboxylase CadA and the antiporter CadB. CadA decarboxylases lysine while 
consuming a proton and producing CO2 and cadaverine.  
 
 
Lysine transport is stimulated at low pH and under anaerobic conditions (Steffes et al., 1992). 
Moreover, the expression of lysP itself is repressed by the incoming lysine and the LysR-type 
transcriptional regulator ArgP (Neely & Olson, 1996; Ruiz et al., 2011). Interestingly, without 
lysine ArgP acts as a transcription activator of lysP (Ruiz et al., 2011). Another regulatory 
principle to restrict cadBA expression is represented by the negative feedback inhibition of the 
decarboxylase products cadaverine and CO2 (Neely et al., 1994; Takayama et al., 1994). 
Recent studies on the cadaverine inhibition mechanism revealed that the periplasmic domain 
of CadC binds cadaverine resulting in reduced activity (Haneburger et al., 2012; Tetsch et al., 
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2008). In addition to these findings, the deletion of the gene yjeK resulted in a CadA negative 
phenotype (Kraxenberger, 2006). YjeK in concert with YjeA has been reported to post-
translationally modify the translation elongation factor EF-P (Bailly & de Crecy-Lagard, 
2010).  
1.3. Steps in translation 
Ribosomes translate mRNAs into the corresponding amino acid sequences of proteins (Liljas, 
2009). They consist of several rRNAs and ribosomal proteins and make up the 70S complex 
with the two subunits 30S and 50S in bacteria. In the process of protein synthesis, t-RNA 
synthetases are needed to ligate amino acids to the 3´CCA-end of their accordant transfer 
RNAs (tRNAs) (Schimmel, 1987). After the transport of the resulting aminoacyl-tRNAs to 
the ribosome, a plethora of initiation, elongation and termination factors are recruited to run 
the protein synthesis. To start translation, the 30S ribosome interacts with the mRNA at its 
Shine Dalgarno sequence upstream of the start codon AUG [reviewed in (Schmeing & 
Ramakrishnan, 2009)]. The initiation factors IF-1, IF-2 and IF-3 help the initiator tRNA N-
formyl-Met-tRNA (fMet-tRNAi) to localize at the P (peptidyl)-site of the 30S ribosome under 
GTP consumption by combining the anticodon binding site of the tRNA with the AUG codon 
on the mRNA (Fig. 3A). Subsequently, the initiation factors are released and the stable 70S 
complex is built. With the help of elongation factor EF-Tu and GTP consumption, the second 
amino acid is placed at the A (aminoacyl)-site of the ribosome followed by the formation of 
the first peptide bond. This step is catalyzed by the peptidyl transferase center of the 
ribosomal 50S subunit (Fig. 3B). The elongation factor EF-G is then needed to translocate the 
fMet-tRNAi to the ribosomal E (exiting)-site and the second amino acid to the ribosomal P-
site followed by a release of the fMet-tRNA (Fig. 3C, D). Finally, the termination factors RF-
1, RF-2 and RF-3 are important to recognize the stop codon on the mRNA, to release the 
newly built peptide chain and to dissociate the subunits of the ribosome. In vitro experiments 
have revealed that the factors mentioned above are not sufficient for proper translation and 
that additional proteins are needed (Aoki et al., 2008; Ganoza et al., 1985). One of these 
proteins was assumed to play a significant role in translation initiation: elongation factor EF-P 
(Glick & Ganoza, 1975). 
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Figure 3: Translation initiation and elongation [reviewed in (Schmeing & Ramakrishnan, 2009)]. 
A) The initiation factors IF-1, IF-2 and IF-3 help the initiator tRNA N-formyl-Met-tRNA 
(orange) bind with its anticodon binding site to the start codon AUG, which is localized at the P 
(peptidyl)-site of the 30S ribosome. After the release of the initiation factors, the 70S complex is 
formed. 
B) The second aminoacyl-tRNA (purple) is placed to the A (aminoacyl)-site of the ribosome 
by the help of the elongation factor EF-TU. In a peptidyltransferase reaction, the amino acids are 
linked.  
C) The elongation factor EF-G helps the deacetylated initiator tRNA (orange) to translocate to 
the E (exit)-site. The second aminoacyl-tRNA (purple) moves to the P-site. The third aminoacyl-tRNA 
is shown in yellow. 
D) The initiator tRNA (orange) is released from the E-site, and the next aminoacyl-tRNA 
(yellow) can occupy the A-site. The amino acids are linked by the peptidyltransferase activity of the 
ribosome. The following aminoacyl-tRNA is shown in blue.  
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1.4. The elongation factor EF-P 
EF-P has been extensively investigated for more than 30 years (Glick & Ganoza, 1975). The 
protein has a size of 20.5 kDa (187 aa) and is highly conserved in all bacteria (Aoki et al., 
1991; Kyrpides & Woese, 1998). As EF-P was suggested to be essential for cell viability, 
mainly in vitro studies have been performed (Aoki et al., 1997a; Aoki et al., 1997b; Ganoza 
& Aoki, 2000; Glick et al., 1979). However, subsequent studies described the generation and 
analysis of efp mutants in various bacterial strains (Baba et al., 2006; Kearns et al., 2004; 
Peng et al., 2001; Zou et al., 2011). The characterization of these mutants revealed the 
importance of EF-P for swarming and sporulation in Bacillus subtilis (Kearns et al., 2004) as 
well as for virulence and stress response in Agrobacterium tumefaciens and Salmonella 
enterica (Peng et al., 2001; Zou et al., 2011). Although EF-P is known to have a stimulatory 
effect on peptide bond formation between the ribosome-bound initiator transfer RNA fMet-
tRNAi and the tRNA analogue puromycin (Aoki et al., 1991; Glick & Ganoza, 1975), the 
protein is not an essential component of in vitro translation systems (Shimizu et al., 2001). In 
E. coli, one EF-P copy per ten ribosomes can be found, which resembles the copy number of 
other initiation factors (An et al., 1980; Cole et al., 1987). However, the detection of EF-P in 
monosome as well as in polysome fractions led to suggestions that EF-P not only promotes 
formation of the first peptide bond, but also plays a role during translation elongation (Aoki et 
al., 2008).  
Archaea and eukaryotes possess the orthologous variants aIF-5A and eIF-5A, which share 
84% and 64% sequence identity, respectively (Bartig et al., 1992; Cooper et al., 1983). In 
mammalian cells, the genes encoding eIF-5A1 and its isoform eIF-5A2 are oncogenes 
(Clement et al., 2003). Furthermore, eIF5a is suggested to play a role in HIV protein Rev 
mediated transport of mRNAs out of the nucleus, mRNA decay and cell cycle progress 
(Bevec et al., 1996; Park et al., 1997; Ruhl et al., 1993; Zuk & Jacobson, 1998) as well as in 
diabetes and malaria (Kaiser, 2012).  
eIF5A is unique as it is the only protein known to be post-translationally modified at a 
conserved lysine residue by hypusine [Nε-(4-amino-2-hydroxybutyl)-lysine] (Cooper et al., 
1983), an amino acid derived from lysine and spermidine in two enzymatic steps via the 
deoxyhypusine synthase (DHS) and deoxyhypusine hydroxylase (DOHH) (Abbruzzese et al., 
1986; Murphey & Gerner, 1987; Wolff et al., 1995). The activity of eIF5A highly depends on 
this hypusine modification (Park, 2006; Park et al., 2010; Sasaki et al., 1996). In bacteria, the 
enzymes DHS and DOHH are missing, and no hypusine has ever been detected. Instead, an 
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alternative modification has been reported for EF-P (Aoki et al., 2008; Bailly & de Crecy-
Lagard, 2010; Navarre et al., 2010; Peil et al., 2012) (Fig. 4). 
 
 
 
Figure 4: The EF-P modification pathway. YjeK converts (S)-α-lysine into (R)-β-lysine, which is 
then transferred to the K34 of E. coli EF-P by YjeA and hydroxylated by YfcM. Lysylated EF-P gains 
an additional mass of 128 Da, hydroxylated EF-P of 144 Da. 
 
 
The two genes yjeA and yjeK are often organized in one cluster in bacterial genomes, which 
has led to the finding that YjeK and YjeA are involved in EF-P modification (Bailly & de 
Crecy-Lagard, 2010; Yanagisawa et al., 2010). In a first step, the iron sulfur protein YjeK acts 
as a 2,3-lysine aminomutase (LAM) while catalyzing the isomerisation of (S)-α-lysine to (R)-
β-lysine (Behshad et al., 2006). The (R)-β-lysine is then activated and transferred to the 
conserved lysine residue 34 (K34) of EF-P by YjeA resulting in a modified and thus active 
EF-P (Gilreath et al., 2011; Roy et al., 2011). YjeA (also known as PoxA or GenX) is a 
homolog to the class II lysyl-tRNA-synthetase LysRS. In E. coli, YjeA shows 32% identity 
and 50% homology to the COOH-terminus of LysRS containing the catalytic core important 
for lysine binding, but it lacks the NH2-terminus of LysRS with the anticodon binding site 
important for tRNA binding (Ambrogelly et al., 2010; Navarre et al., 2010). Therefore, it has 
been suggested that YjeA has a function differing from the aminoacylation of tRNAs (Bailly 
& de Crecy-Lagard, 2010). Drawing on mass spectrometry (MS) analysis for modified EF-P 
(Aoki et al., 2008), Peil et al. have reported recently that K34 of EF-P is additionally 
hydroxylated by the O2 dependent hydroxylase YfcM (Peil et al., 2012) (Fig. 4). However, a 
deletion of yfcM leads to a wildtype like phenotype in Salmonella enterica, which indicates 
that the hydroxylation plays a minor role in vivo (Bullwinkle et al., 2013). 
Crystal structures of bacterial EF-P reveal a three-domain (I-III) architecture resembling the 
L-shape of tRNAs (Blaha et al., 2009; Hanawa-Suetsugu et al., 2004; Yanagisawa et al., 
2010). It has been assumed that modified EF-P interacts with the 3´CCA-end of tRNAs bound 
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to the P-site of the ribosome (P-tRNAs) and stimulates peptide bond formation through 
stabilization and positioning of the acceptor end of the P-tRNAs (Blaha et al., 2009). In 
addition, several further functions of EF-P have been suggested, including the stimulation of 
the first peptide bond (Glick et al., 1979), the coupling of the ribosomal 30S and 50S subunits 
(Aoki et al., 1991), the enhancement of polylysine synthesis (Glick & Ganoza, 1976), the 
change of the conformation of the ribosomal active site (Ganoza & Aoki, 2000) and the 
inhibition of tRNAs to bind to the A-site before ribosomal proofreading (Aoki et al., 2008). 
As the overall protein synthesis is diminished by only 30% in yeast cells, it has been assumed 
that eIF5A does not play a general role in the translational machinery, but rather has 
importance only for a small subset of mRNAs (Kang & Hershey, 1994). For example, the 
translation of the porin KdgM is dependent on EF-P in Salmonella, thus a deletion of efp 
results in increased membrane permeability and in various phenotypes like attenuated 
virulence in the bacterium (Zou et al., 2011). Although plenty suggestions have been made for 
the action mode of EF-P, in vivo data are still missing. 
1.5. Scope of the thesis 
In this study, the relevance of elongation factor P and its modifying proteins YjeK and YjeA 
in regard to the Cad system is analyzed in more detail. To this end, yjeA/yjeK and efp mutants 
are characterized by determining their lysine decarboxylase phenotype, their capability for 
cadBA expression under non- and inducing conditions and their ability to interact with each 
other and other components of the Cad system. 
Additionally it is examined, which of the Cad proteins is dependent on EF-P mediated 
translation. As no direct EF-P - target has ever been identified before in E. coli, the finding of 
the first target can greatly improve the understanding of the function of EF-P.  
Furthermore it is investigated, if EF-P recognizes a special signal sequence. With the signal 
sequence in hand, further targets can be identified. As the physiological role of EF-P is still 
unclear, the signal sequence can provide first insights into the mode of action of EF-P in vivo. 
To confirm the importance of EF-P for the translation of target proteins, in vitro translation 
assays are performed by Dr. Daniel Wilson and Dr. Agata Starosta (Gene Center, LMU 
Munich).  
Finally, the effect of a hfq deletion on cadBA transcription and on expression of CadC, YjeA, 
YjeK and EF-P is investigated in more detail. 
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2. Materials and Methods 
2.1. Materials 
Following materials were used in this study: 
 
Table 1: Materials and their manufacturers used in this study. 
Material Manufacturer 
[γ-32P] ATP Perkin Elmer (Rodgau)  
5-Bromo-4-Chloro-3-Indoxyl Phosphate (BCIP) AppliChem (Darmstadt) 
Acrylamide Protogel Biozym Diagnostik (Hessisch Oldendorf) 
Agarose Serva (Heidelberg) 
Alkaline Phosphatase New England Biolabs (Frankfurt) 
Conjugated anti-Mouse IgG GE Healthcare (Braunschweig)  
Ammonium Persulfate (APS) National Diagnostics (Atlanta)  
Ampicillin (sodium salt) Roth (Karlsruhe)  
Anti-Rabbit IgG GE Healthcare(Braunschweig) 
Calf Intestinal Phosphatase (CIP) New England Biolabs (Frankfurt) 
Carbenicillin (disodium salt) Roth (Karlsruhe) 
Chloramphenicol Sigma (Deisenhofen)  
Chloroform Roth (Karlsruhe) 
Diethylpyrocarbonate (DEPC) Roth (Karlsruhe) 
 
DNA oligonucleotides  
 
Sigma (Deisenhofen)  
Invitrogen (Karlsruhe)  
Eurofins MWG Operon (Ebersberg)  
DNase I Sigma (Deisenhofen) 
DNA standard (2-Log DNA-Ladder) New England Biolabs (Frankfurt)  
DNeasy 96 blood and tissue kit Qiagen (Hilden)  
dNTPs (deoxynucleotide triphosphates) Invitrogen (Karlsruhe)  
Glycerol Roth (Karlsruhe) 
Hi Yield PCR Clean-Up & Gel-Extraction Kit Süd-Laborbedarf (Gauting)  
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Hi Yield Plasmid Mini Kit Süd-Laborbedarf (Gauting)  
Hybond-P protein transfer membrane GE Healthcare (Braunschweig)  
Isopropyl-D-thiogalactopyranoside (IPTG)  PeqLab (Erlangen) 
Kanamycin (sulfate)  Roth (Karlsruhe)  
L-(+) - Arabinose Roth (Karlsruhe) 
L-Lysine Sigma (Deisenhofen)  
Nitro Blue Tetrazolium (NBT) Biomol (Hamburg) 
Ni-NTA agarose Qiagen (Hilden)  
Ni-NTA magnetic agarose beads Qiagen (Hilden)  
Nitrocellulose membrane GE Healthcare (Braunschweig) 
Page Ruler Prestained Protein Ladder Plus Fermentas (St. Leon-Rot) 
Penta-His anti-Mouse-IgG Qiagen (Hilden)  
Phenol-Chloroform Roth (Karlsruhe) 
Phenol/Chloroform/Isoamylalcohol (25/24/1) Roth (Karlsruhe) 
Phenylmethylsulfonyl fluoride (PMSF) Sigma (Deisenhofen)  
Phusion DNA Polymerase Finnzyme (Espoo, Finnland)  
Pyridoxal Phosphate (PLP) Fluka (Neu-Ulm) 
Quick & Easy E. coli Gene Deletion Kit Gene Bridges (Heidelberg)  
Restriction Nuclease New England Biolabs (Frankfurt) 
Bovine Serum Albumin (BSA) AppliChem (Darmstadt)  
Spermidine Fluka (Neu-Ulm)  
T4 DNA Ligase New England Biolabs (Frankfurt)  
Taq-DNA Polymerase Peqlab (Erlangen) 
Thermoscript Reverse Transcriptase Invitrogen (Karlsruhe) 
Trinitrobenzenesulfonic acid (TNBS) Sigma (Deisenhofen) 
Triton X-100 Calbiochem (La Jolla, Kalifornien)  
Tween 20 GE Healthcare (Braunschweig)  
 
 
All materials not listed here were purchased from the manufacturers Bayer (Leverkusen), 
Biomol (Hamburg), Biorad (Munich), Biozym Diagnostics GmbH (Hess, Oldendorf), Fluka 
(Neu-Ulm), Gibco/BRL (Eggenstein), ICN Biomedicals Inc. (Aurora, Ohio), Merck 
(Darmstadt), Riedel-de Häen (Seelze), Roche Diagnostics (Mannheim), Roth (Karlsruhe), 
Serva (Heidelberg) and Sigma (Deisenhofen) with the purity grade „pro analysis“. 
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2.2. Strains, plasmids and oligonucleotides 
Strains used in this study are listed in Table 2, plasmids in Table 3 and oligonucleotides in 
Table 4. 
 
Table 2: Strains used in this study. All strains are Escherichia coli derivates. 
Strain Feature Source 
  
DH5α  
F– Φ80lacZ∆M15 ∆(lacZYA-argF) U169 recA1 endA1 hsdR17 
(rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 Promega 
MG1655 E. coli K-12 reference strain (Blattner et al., 1997) 
P1#36 MG1655 yjeK643-1029::Tn10 (Kraxenberger, 2006) 
TK1 MG1655 yjeK643-1029::npt (Kraxenberger, 2006) 
BW25113 
∆(araD-araB)567, ∆lacZ4787(::rrnB-3), lambda-, rph-1, ∆(rhaD-
rhaB)568, hsdR514 (Baba et al., 2006) 
JW4116 BW25113 yjeA::npt (Baba et al., 2006) 
JW4106 BW25113 efp::npt (Baba et al., 2006) 
JW4094 BW25113 cadC::npt (Baba et al., 2006) 
MG-CL-1 MG1655 ∆lacZ::tet rpsL150 ∆cadA cadA::lacZ this study 
MG-CR MG1655 ∆lacZ::tet rpsL150 ∆cadBA cadBA::lacZ (Ruiz et al., 2011) 
MG-CL 1-3 MG1655 ∆lacZ::tet rpsL150 cadC::npt ∆cadCBA cadBA::lacZ (Schüppel, 2010) 
MG-CL-12-yjeA MG1655 ∆lacZ::tet rpsL150 yjeA::npt ∆cadBA cadBA::lacZ this study 
MG-CL-12-yjeK MG1655 ∆lacZ::tet rpsL150 yjeK642-1029::npt ∆cadBA cadBA::lacZ this study 
MG-CL-12-hflx MG1655 ∆lacZ::tet rpsL150 hflx1-750::npt ∆cadBA cadBA::lacZ this study 
MG-CL-12-hfq MG1655 ∆lacZ::tet hfq1-230::cat ∆cadBA cadBA::lacZ this study 
SU1 BW25113 yjeK643-1029::cat this study 
BL21 (DE3) E. coli B F-dcm ompT hsdS (rB-mB-) gal 
(Studier & Moffatt, 
1986) 
SU2 MG1655 yjeA::npt this study 
SU3 BL21 (DE3) yjeK643-1029::cat this study 
SU4 JW4106 hns::cat this study 
AM111 MC4100 ∆hfq (Muffler et al., 1996) 
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Table 3: Plasmids used in this study. Plasmid constructions are further explained in the middle 
column.  
Plasmid Feature / Construction comments Source 
 
  
General vectors   
pET16b Ampr-cassette, T7-promoter, pBBR322 origin, 5‘-His-tag coding 
sequence, lacI-coding sequence, lac operator 
Novagen 
(Merck 
Millipore) 
pBAD24 Ampr-cassette, pBBR322 origin, araC coding sequence, ara operator (Guzman et al., 
1995) 
pBBR1-MCS5 Gmr-cassette, pBBR broad host range origin of replication, mob region 
for conjugative transfer 
(Kovach et al., 
1995) 
pBBR1-MCS3-
LacZ 
Tetr-cassette, pBBR broad host range origin of replication, mob region 
for conjugative transfer, lacZ coding sequence 
(Fried et al., 
2012) 
pQE70 Ampr-cassette, 5‘-His-Tag coding sequence, lacI-coding sequence, lac 
operator 
Qiagen 
pIVEX2.3MCS Ampr-cassette, T7-promoter, 3‘-His-Tag coding sequence Roche 
pQE70-Eco_efp efp cloned using SphI, BamHI restrictions sites (Peil et al., 
2012) 
pQE70-Eco_efp 
K34A/ 
pQE70 plasmid harboring efp with a single mutation (K34A) Dr. Agata 
Starosta 
pQE70-Eco_efp 
K34R 
pQE70 plasmid harboring efp with a single mutation (K34R) Dr. Agata 
Starosta 
pAF/kamA Ampr-cassette,T7 promoter, pET23a origin (Ruzicka et al., 
2000) 
pAlter-Ex2/argU Tetr-cassette, tac promoter, p15a origin  (Ruzicka et al., 
2000) 
pET16b-His6-
YjeK 
yjeK in pET16b, 5´-His6-tag (Kraxenberger, 
2006) 
pBAD24-yjeA yjeA in pBAD24, with NdeI and XbaI, 5´-His6-tag, P121+P122 this study 
pBAD24-yjeK pBAD24 with NcoI-XmaI fragment from pUC19-rbs-his10-yjeK, 5´-His-
tag 
(Kraxenberger, 
2006) 
pBAD24-hfq hfq in pBAD24, with NdeI and EcoRI, P119+P120, 3´-His-tag this study 
   
cadC-lacZ promoter fusions 
p3LC-TF Fusion of cadC promoter with artificial RBS to lacZ / P1+P3 PCR 
fragment in pBBR1-MCS3-LacZ (XbaI +PstI) 
this study 
p3LC-TL02 Fusion of cadC promoter to sequence encoding 2 amino acids of cadC 
and lacZ/ P1+P4 PCR fragment in pBBR1-MCS3-LacZ (XbaI 
+PciI/NcoI) 
this study 
p3LC-TL02 (Ala, 
Gly, His, Leu, 
Met, Phe, Pro) 
cadC promoter fusion with artificial RBS to lacZ+variabel second aa 
(Ala, Gly, His, Leu, Met, Phe or Pro)/P1+P111-P117 PCR fragments in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30 Translational CadC’-LacZ fusion (sequence encodes 30 amino acids of 
cadC)/ P1+P5 PCR fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL66 Translational CadC’-LacZ (sequence encodes 66 amino acids of cadC)/ 
P1+P6 PCR fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL100 Translational CadC’-LacZ fusion (sequence encodes 100 amino acids of 
cadC)/ P1+P7 PCR fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL108 Translational CadC’-LacZ fusion (sequence encodes 108 amino acids of 
cadC)/ P1+P8 PCR fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL131 Translational CadC’-LacZ fusion (sequence encodes 131 amino acids of 
cadC)/ P1+P9 PCR fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL158 Translational CadC’-LacZ fusion (sequence encodes 158 amino acids of 
cadC)/ P1+P10 PCR fragment in pBBR1-MCS3-LacZ (XbaI+PciI/NcoI) 
this study 
p3LC -TL158-
CSPPP 
Translational CadC´-LacZ fusion; (sequence encodes 158 amino acids of 
cadC), S118C substitution in cadC, P11+12 PCR-OL-fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
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Plasmid Feature / Construction comments Source 
   
p3LC -TL158-
GSPPP 
Translational CadC´-LacZ fusion; (sequence encodes 158 amino acids of 
cadC), S118G substitution in cadC, P13+P14 PCR-OL-fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC -TL30-GPP Translational CadC´-LacZ fusion; sequence encodes 30 amino acids of 
cadC+sequence encoding GPP, P1+P15 fragment in pBBR1-MCS3-
LacZ (XbaI +PciI/NcoI) 
this study 
p3LC -TL30-PGP Translational CadC´-LacZ fusion; (sequence encodes 30 amino acids of 
cadC+sequence encoding PGP, P1+P16 fragment in pBBR1-MCS3-
LacZ (XbaI +PciI/NcoI) 
this study 
p3LC -TL30-PPG Translational CadC´-LacZ fusion; (sequence encodes 30 amino acids of 
cadC+sequence encoding PPG, P1+P17 fragment in pBBR1-MCS3-
LacZ (XbaI +PciI/NcoI) 
this study 
   
Artificial introduction of three consecutive prolines 
p3LC-TL02-P p3LC-TL02 + sequence encoding 1 proline / P1+P18 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL02-3P p3LC-TL02+ sequence encoding 3 prolines / P1+P19 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-3P p3LC-TL30 + sequence encoding 3 prolines / P1+P20 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL66-3P p3LC-TL66 + sequence encoding 3 prolines / P1+P21 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL100-3P p3LC-TL100 + sequence encoding 3 prolines / P1+P22 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL108-3P p3LC-TL108 + sequence encoding 3 prolines / P1+P23 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
   
Artificial modification of the proline stretch length in CadC´-LacZ TL30 
p3LC-TL30-5P p3LC-TL30 + sequence encoding 5 prolines / P1+P24 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-4P p3LC-TL30 + sequence encoding 4 prolines / P1+P25 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-2P p3LC-TL30 + sequence encoding 2 prolines / P1+P26 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-1P p3LC-TL30 + sequence encoding 1 proline / P1+P27 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
   
Artificial modification of the proline stretch codon usage 
p3LC-TL30-3P-
CCA 
p3LC-TL30 + sequence for 3 x CCA / P1+P28 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-3P-
CCG 
p3LC-TL30 + sequence for 3 x CCG / P1+P29 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-3P-
CCT 
p3LC-TL30 + sequence for 3 x CCT / P1+P30 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
   
Artificial introduction of sequences encoding stretches of various amino acids 
p3LC-TL30-5F p3LC-TL30 + sequence encoding 5 phenylalanines / P1+P31 PCR 
fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5G p3LC-TL30 + sequence encoding 5 glycines / P1+P32 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5A p3LC-TL30 + sequence encoding 5 alanines / P1+P33 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5V p3LC-TL30 + sequence encoding 5 valines / P1+P34 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5L p3LC-TL30 + sequence encoding 5 leucines / P1+P35 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5I p3LC-TL30 + sequence encoding 5 isoleucines / P1+P36 PCR fragment 
in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
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Plasmid Feature / Construction comments Source 
   
p3LC-TL30-5M p3LC-TL30 + sequence encoding 5 methionines / P1+P37 PCR 
fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5S p3LC-TL30 + sequence encoding 5 serines / P1+P38 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5T p3LC-TL30 + sequence encoding 5 threonines / P1+P39 PCR fragment 
in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5D p3LC-TL30 + sequence encoding 5 aspartates / P1+P40 PCR fragment 
in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5E p3LC-TL30 + sequence encoding 5 glutamates / P1+P41 PCR fragment 
in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5Y p3LC-TL30 + sequence encoding 5 tyrosines / P1+P42 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5N p3LC-TL30 + sequence encoding 5 asparagines / P1+P43 PCR fragment 
in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5K p3LC-TL30 + sequence encoding 5 lysines / P1+P44 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5H p3LC-TL30 + sequence encoding 5 histidines / P1+P45 PCR fragment 
in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5Q p3LC-TL30 + sequence encoding 5 glutamines / P1+P46 PCR fragment 
in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5C p3LC-TL30 + sequence encoding 5 cysteines / P1+P47 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5W p3LC-TL30 + sequence encoding 5 tryptophans / P1+P48 PCR fragment 
in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-TL30-5R p3LC-TL30 + sequence encoding 5 arginines / P+P49 PCR fragment in 
pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
   
Generation of CadC Pro to Ala substitution mutants 
p5C cadC native copy including the native promoter / P1+P2 PCR fragment 
in pBBR1-MCS5 (XbaI +PspOMI) 
this study 
p5C-P120A cadC mutant derivative P120A including the native promoter / P50+P51 
PCR-OL-fragment in pBBR1-MCS5 (XbaI +PspOMI) 
this study 
p5C-P121A cadC mutant derivative P121A including the native promoter / P52+P53 
PCR-OL-fragment in pBBR1-MCS5 (XbaI +PspOMI) 
this study 
p5C-P122A cadC mutant derivative P122A including the native promoter / P54+P55 
PCR-OL-fragment in pBBR1-MCS5 (XbaI +PspOMI) 
this study 
p5C-P/A cadC mutant derivative PPPIP/AAAIS including the native promoter / 
P56+P57 PCR-OL-fragment in pBBR1-MCS5 (XbaI +PspOMI) 
this study 
p3LC -TL158-
P120A 
p3LC-TL158 mutant derivative P121A / P1+P10 PCR fragment from 
p5C-P120A template in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC -TL158-
P121A 
p3LC-TL158 mutant derivative P121A / P1+P10 PCR fragment from 
p5C-P121A template in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC -TL158-
P122A 
p3LC-TL158 mutant derivative P121A / P1+P10 PCR fragment from 
p5C-P122A template in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC -TL158-
P/A 
p3LC-TL158 mutant derivative PPPIP/AAAIS / P1+P10 PCR fragment  
from p5C-P/A template in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
pET16b-CadC cadC native copy under control of IPTG inducible T7 polymerase 
dependent promote, His6-CadC 
(Küper & Jung, 
2005) 
pET16b-CadC-
P/A 
cadC mutant derivative PPPIP/AAAIS T7 polymerase dependent / PCR 
fragment from p5C-P/A template in pET16b 
this study 
 
Translational LacZ fusions of other EF-P target proteins fused to the CadC native promoter 
p3LC-cadA Translational CadA-LacZ fusion including complete cadA but replacing 
the cadAB promoter by the cadC promoter / 61+62 PCR-OL-fragment in 
pBBR1-MCS3-LacZ (XbaI +BspHI/NcoI) 
this study 
p3LC-cadB Translational CadB-LacZ fusion including the complete cadB but 
replacing the cadAB promoter by the cadC promoter / 58+59 PCR-OL-
Fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
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Plasmid Feature / Construction comments Source 
   
p3LC-flk Translational FlK-LacZ fusion; for construction see table 6 
PCR-OL-fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-amiB Translational AmiB-LacZ fusion; for construction see table 6 
PCR-OL-fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-flhC Translational FlhC-LacZ fusion; for construction see table 6 
PCR-OL-fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-nlpD Translational NlpD-LacZ fusion; for construction see table 6 
PCR-OL-fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-rzoR Translational RzoR-LacZ fusion; for construction see table 6 
PCR-OL-fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-tonB Translational TonB-LacZ fusion; for construction see table 6 
PCR-OL-fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-uvrB Translational UvrB-LacZ fusion; for construction see table 6 
PCR-OL-fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-hisD Translational HisD-LacZ fusion; for construction see table 6 
PCR-OL-fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-flhC-APP Translational FlhC-LacZ fusion; P/A substitute, P83-P84 PCR-OL-
fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-flhC-PAP Translational FlhC-LacZ fusion; P/A substitute, P85+P86 PCR-OL-
fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
p3LC-flhC-AAA Translational FlhC-LacZ fusion; P/A substitute, P87+P88 PCR-OL-
fragment in pBBR1-MCS3-LacZ (XbaI +PciI/NcoI) 
this study 
   
Bacterial two hybrid studies 
pKT25 ori-p15a T25 fragment for C-terminal fusion; Kmr Euromedex 
pKNT25 ori-p15a T25 fragment for N-terminal fusion; Kmr Euromedex 
pUT18 ori-ColE1 T18 fragment for N-terminal fusion; Ampr  Euromedex 
pUT18C ori-ColE1 T18 fragment for N-terminal fusion; Ampr Euromedex 
pUT18-zip Positive control plasmid; encoding for yeast leucine zipper GCN4 Euromedex 
pKT25-zip Positive control plasmid; encoding for yeast leucine zipper GCN4 Euromedex 
pKT25-CadC cadC in pKT25 (XbaI+BamHI), P166+P167 (Krönauer, 
2011) 
pKT25-LysP lysP in pKT25, (XbaI+BamHI), P168+P169 (Krönauer, 
2011) 
pKT25-YjeA yjeA in pKT25, (XbaI+BamHI), P170+P171 (Krönauer, 
2011) 
pKT25-YjeK yjeK in pKT25, (XbaI+BamHI), P174+P175 (Krönauer, 
2011) 
pKT25-EFP efp in pKT25, (XbaI+BamHI), P164+P165 (Krönauer, 
2011) 
pKT25-HNS hns in pKT25, (XbaI+BamHI), P172+P173 (Krönauer, 
2011) 
pKTN25-CadC cadC in pKTN25, (XbaI+BamHI), P166+P167 (Krönauer, 
2011) 
pKTN25-LysP lysP in pKTN25, (XbaI+BamHI), P168+P169 (Krönauer, 
2011) 
pKTN25-YjeA yjeA in pKTN25, (XbaI+BamHI), P170+P171 (Krönauer, 
2011) 
pKTN25-YjeK yjeK in pKTN25, (XbaI+BamHI), P174+P175 (Krönauer, 
2011) 
pKTN25-EFP efp in pKTN25, (XbaI+BamHI), P164+P165 (Krönauer, 
2011) 
pKTN25-HNS hns in pKTN25, (XbaI+BamHI), P172+P173 (Krönauer, 
2011) 
pUT18C-CadC cadC in pUT18C, (XbaI+BamHI), P166+P167 (Krönauer, 
2011) 
pUT18C-LysP lysP in pUT18C, (XbaI+BamHI), P168+P169 (Krönauer, 
2011) 
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Plasmid Feature / Construction comments Source 
   
pUT18C-YjeA yjeA in pUT18C, (XbaI+BamHI), P170+P171 (Krönauer, 
2011) 
pUT18C-YjeK yjeK in pUT18C, (XbaI+BamHI), P174+P175 (Krönauer, 
2011) 
pUT18C-EFP efp in pUT18C, (XbaI+BamHI), P164+P165 (Krönauer, 
2011) 
pUT18C-HNS hns in pUT18C, (XbaI+BamHI), P172+P173 (Krönauer, 
2011) 
   
Generation of CadC Ly to Ala mutants 
pET16b-K59A cadC mutant derivate K59A under control of IPTG inducible T7 
polymerase dependent promoter/PCR-OL-fragment in pET16b-CadC  
this study 
pET16b-K77A cadC mutant derivate K77A under control of IPTG inducible T7 
polymerase dependent promoter/PCR-OL-fragment in pET16b-CadC  
this study 
pET16b-K95A cadC mutant derivate K95A under control of IPTG inducible T7 
polymerase dependent promoter/PCR-OL-fragment in pET16b-CadC  
this study 
pET16b-K99A cadC mutant derivate K99A under control of IPTG inducible T7 
polymerase dependent promoter/PCR-OL-fragment in pET16b-CadC  
this study 
pET16b-K80A cadC mutant derivate K80A under control of IPTG inducible T7 
polymerase dependent promoter/PCR-OL-fragment in pET16b-CadC  
this study 
   
Generation of CadC Ly to Arg mutants 
pET16b-K59R cadC mutant derivate K59R under control of IPTG inducible T7 
polymerase dependent promoter/PCR-OL-fragment in pET16b-CadC  
this study 
pET16b-K77R cadC mutant derivate K77R under control of IPTG inducible T7 
polymerase dependent promoter/PCR-OL-fragment in pET16b-CadC  
this study 
pET16b-K95R cadC mutant derivate K95R under control of IPTG inducible T7 
polymerase dependent promoter/PCR-OL-fragment in pET16b-CadC  
this study 
pET16b-K99R cadC mutant derivate K99R under control of IPTG inducible T7 
polymerase dependent promoter/PCR-OL-fragment in pET16b-CadC  
this study 
pET16b-K80R cadC mutant derivate K80R under control of IPTG inducible T7 
polymerase dependent promoter/PCR-OL-fragment in pET16b-CadC  
this study 
   
PcadA-lacZ fusions 
P3C-PrA79 pBBR1-MCS3-LacZ harboring 79 bp of the sequence upstream of cadA 
+1, P200+P209 
this study 
P3C-PrA100 pBBR1-MCS3-LacZ harboring 100 bp of the sequence upstream of 
cadA +1, P201+P209 
this study 
P3C-PrA200 pBBR1-MCS3-LacZ harboring 200 bp of the sequence upstream of 
cadA +1, P202+P209 
this study 
P3C-PrA300 pBBR1-MCS3-LacZ harboring 300 bp of the sequence upstream of 
cadA +1, P203+P209 
this study 
P3C-PrA400 pBBR1-MCS3-LacZ harboring 400 bp of the sequence upstream of 
cadA +1, P204+P209 
this study 
P3C-PrA500 pBBR1-MCS3-LacZ harboring 500 bp of the sequence upstream of 
cadA +1, P205+P209 
this study 
P3C-PrA600 pBBR1-MCS3-LacZ harboring 600 bp of the sequence upstream of 
cadA +1, P206+P209 
this study 
P3C-PrA700 pBBR1-MCS3-LacZ harboring 700 bp of the sequence upstream of 
cadA +1, P207+P209 
this study 
P3C-PrA800 pBBR1-MCS3-LacZ harboring 800 bp of the sequence upstream of 
cadA +1, P208+P209 
this study 
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Table 4: Oligonucleotides used in this study. All primers were purchased from Sigma Aldrich and 
diluted in 1xTE buffer (10 mM Tris/HCl, pH 8.0, 1 mM EDTA) for storage at -20°C and -80°C.  
 
 Name Sequence Restric-tion site Source 
     
cadC-lacZ promoter fusions 
P1 XbaI-CadC-NP-Fw AGT CTA GAC CTG AGC TAT AGC ACT AAC TGA CG XbaI this study 
P2 PspOMI-CadC-Rev CCG GGC CCA AAC TCA ACA ACA AAT ATT TCC GAG CAT A PspOMI this study 
P3 PstI-CadC-TriF-Rev 
GCC TGC AGA ATA GAA ACT CAT 
TCG AAA AGG GAA TGA TG PstI this study 
P4 PciI-CadC-TF02-Gln-Rev 
GCA CAT GTG TTG CAT AAT AGA 
AAC TCA TTC GAA AAG GG PciI this study 
P5 PciI-TF30E-CadC-Rev GCA TAC ATG TGC TCA AGG GTA AGT TGA CGC CCA TTG CG PciI this study 
P6 PciI-TF66-CadC-Rev GCA CAT GTG ATT GGT GAC AAT ACT TCT CTT CCA G PciI this study 
P7 PciI-TF100-CadC-Rev GCA CAT GTT TAA TTT ATA GCC GCG CTT TGG TAC A PciI this study 
P8 PciI-CadC-LacZ-TL108-Rev 
CGA CAT GTG GCT GTA CCA GAT 
AAC CGG CAC C PciI this study 
P9 PciI-TF131-CadC-Rev GAA CAT GTC TGT GGC AGG AAC CGC CTC PciI this study 
P10 PciI-TF158-CadC-Rev GCA CAT GTA GGT AGT GAA TCG TTT GCT TTT AAC TGG PciI this study 
P11 CadC-CSPPP-fw GAA ATA ATG CTA TGT TCG CCT CCC  this study 
P12 CadC-CSPPP-rev GGG AGG CGA ACA TAG CAT TAT TTC  this study 
P13 CadC-GSPPP-fw GGA AAT AAT GCT AGG TTC GCC TCC  this study 
P14 CadC-GSPPP-rev GGA GGC GAA CCT AGC ATT ATT TCC  this study 
P15 PciI-TL30-CadC-GPP-Rev 
GTA CAT GTG CGG CGG GCC CTC 
AAG GGT AAG TTG ACG CCC ATT 
GCG 
PciI this study 
P16 PciI-TL30-CadC-PGP-Rev 
GTA CAT GTG CGG GCC CGG CTC 
AAG GGT AAG TTG ACG CCC ATT 
GCG 
PciI this study 
P17 PciI-TL30-CadC-PPG-Rev 
GTA CAT GTG GCC CGG CGG CTC 
AAG GGT AAG TTG ACG CCC ATT 
GCG 
PciI this study 
 
Artificial introduction of three consecutive prolines 
P18 PciI-CadC-TF02-Pro-Rev 
GCA CAT GTG CGG CAT AAT AGA 
AAC TCA TTC GAA AAG GG PciI this study 
P19 PciI-CadC-TF02-3xPro-Rev 
GCA CAT GTG TGG TGG AGG CAT 
AAT AGA AAC TCA TTC GAA AAG 
GG 
PciI this study 
P20 PciI-TF30-CadC-3Pro-Rev 
GTA CAT GTG TGG TGG AGG CTC 
AAG GGT AAG TTG ACG CCC ATT 
GCG 
PciI this study 
P21 PciI-TF66-CadC-3xPro-Rev 
GCA CAT GTG TGG TGG AGG ATT 
GGT GAC AAT ACT TCT CTT CCA G PciI this study 
P22 PciI-TF100-CadC-3xPro-Rev 
GCA CAT GTT TGG TGG AGG TAA 
TTT ATA GCC GCG CTT TGG TAC A PciI this study 
     
P23 PciI-CadC-LacZ-TL108-3xPro-Rev 
GCA CAT GTG TGG TGG AGG GCT 
GTA CCA GAT AAC CGG CAC C PciI this study 
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 Name Sequence Restric-tion site Source 
 
Artificial modification of the proline stretch length in CadC´-LacZ TL30 
P24 PciI-TF30-CadC-5Pro-Rev 
GTA CAT GTG TGG TGG AGG TGG 
TGG CTC AAG GGT AAG TTG ACG 
CCC ATT GCG 
PciI this study 
P25 PciI-TF30-CadC-4Pro-Rev 
GTA CAT GTG TGG TGG AGG TGG 
CTC AAG GGT AAG TTG ACG CCC 
ATT GCG 
PciI this study 
P26 PciI-TF30-CadC-2Pro-Rev 
GTA CAT GTG TGG TGG CTC AAG 
GGT AAG TTG ACG CCC ATT GCG PciI this study 
P27 PciI-TF30-CadC-1Pro-Rev 
GTA CAT GTG TGG CTC AAG GGT 
AAG TTG ACG CCC ATT GCG PciI this study 
     
Artificial modification of the proline stretch codon usage 
P28 PciI-TF30-CadC-3Pro-CCA-Rev 
GTA CAT GTG TGG TGGTGG CTC 
AAG GGT AAG TTG ACG CCC ATT 
GCG 
PciI this study 
P29 PciI-TF30-CadC-3Pro-CCT-Rev 
GTA CAT GTG AGG AGGAGG CTC 
AAG GGT AAG TTG ACG CCC ATT 
GCG 
PciI this study 
P30 PciI-TF30-CadC-3Pro-CCC-Rev 
GTA CAT GTG GGG GGGGGG CTC 
AAG GGT AAG TTG ACG CCC ATT 
GCG 
PciI this study 
 
Artificial introduction of stretches of all other amino acids 
P31 PciI-TF30-CadC-5Phe-Rev 
GTA CAT GTG GAA GAA AAA GAA 
GAA CTC AAG GGT AAG TTG ACG 
CCC ATT GCG 
PciI this study 
P32 PciI-TF30-CadC-5Gly-Rev 
GTA CAT GTG ACC GCC ACC GCC 
ACC CTC AAG GGT AAG TTG ACG 
CCC ATT GCG 
PciI this study 
P33 PciI-TF030-CadC-5Ala-Rev 
GTA CAT GTG CGC GGC CGC GGC 
CGC CTC AAG GGT AAG TTG ACG 
CCC ATT GCG 
PciI this study 
P34 PciI-TF30-CadC-5Val-Rev 
GTA CAT GTG CAC AAC CAC AAC 
CAC CTC AAG GGT AAG TTG ACG 
CCC ATT GCG 
PciI this study 
P35 PciI-TF30-CadC-5Leu-Rev 
GTA CAT GTG CAG CAGCAGCAGCAG 
CTC AAG GGT AAG TTG ACG CCC 
ATT GCG 
PciI this study 
P36 PciI-TF30-CadC-5Ile-Rev 
GTA CAT GTG AAT GAT AAT GAT 
AAT CTC AAG GGT AAG TTG ACG 
CCC ATT GCG 
PciI this study 
P37 PciI-TF30-CadC-5Met-Rev 
GTA CAT GTG CAT CATCATCATCAT 
CTC AAG GGT AAG TTG ACG CCC 
ATT GCG 
PciI this study 
     
P38 PciI-TF30-CadC-5Ser-Rev 
GTA CAT GTG CGA CGA TGA CGA 
TGA CTC AAG GGT AAG TTG ACG 
CCC ATT GCG 
PciI this study 
P39 PciI-TF30-CadC-5Thr-Rev 
GTA CAT GTG GGT CGT GGT CGT 
GGT CTC AAG GGT AAG TTG ACG 
CCC ATT GCG 
PciI this study 
P40 PciI-TF30-CadC-5Asp-Rev 
GTA CAT GTG ATC GTC ATC GTC 
ATC CTC AAG GGT AAG TTG ACG 
CCC ATT GCG 
PciI this study 
P41 PciI-TF30-CadC-5Glu-Rev 
GTA CAT GTG CTC TTC CTC TTC CTC 
AAG GGT AAG TTG ACG CCC ATT 
GCG 
PciI this study 
P42 PciI-TF30-CadC-5Tyr-Rev 
GTA CAT GTG ATA GTA ATA GTA 
ATA CTC AAG GGT AAG TTG ACG 
CCC ATT GCG 
PciI this study 
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P43 PciI-TF30-CadC-5Asn-Rev 
GTA CAT GTG ATT GTT ATT GTT ATT 
CTC AAG GGT AAG TTG ACG CCC 
ATT GCG 
PciI this study 
P44 PciI-TF30-CadC-5Lys-Rev 
GTA CAT GTG TTT CTT TTT CTT TTT 
CTC AAG GGT AAG TTG ACG CCC 
ATT GCG 
PciI this study 
P45 PciI-TF30-CadC-5His-Rev 
GTA CAT GTG ATG GTG ATG GTG     
CTC AAG GGT AAG TTG ACG CCC 
ATT GCG 
PciI this study 
P46 PciI-TF30-CadC-5Gln-Rev 
GTA CAT GTG CTG TTG CTG TTG 
CTG CTC AAG GGT AAG TTG ACG 
CCC ATT GCG 
PciI this study 
P47 PciI-TF30-CadC-5Cys-Rev 
GTA CAT GTG GCA ACA GCA ACA 
GCA CTC AAG GGT AAG TTG ACG 
CCC ATT GCG 
PciI this study 
P48 PciI-TF30-CadC-5Trp-Rev 
GTA CAT GTG CCA CCACCACCACCA 
CTC AAG GGT AAG TTG ACG CCC 
ATT GCG 
PciI this study 
P49 PciI-TF30-CadC-5Arg-Rev 
GTA CAT GTG GCG ACG GCG ACG 
GCG CTC AAG GGT AAG TTG ACG 
CCC ATT GCG 
PciI this study 
     
Generation of CadC Pro to Ala substitution mutants 
P50 CadC-OL-120A-fw TGC TAT CTT CGG CTC CCC CTA TAC C  this study 
P51 CadC-OL-120A-rev GGT ATA GGG GGA GCC GAA GAT AGC A  this study 
P52 CadC-P121A-Whobble-fw 
CTA TCT TCG CCT GCC CCT ATA CCA 
G  this study 
P53 CadC-P121A-Whobble-
rev 
GGT ATA GGG GGA GCC GAA GAT 
AGC A  this study 
P54 CadC-OL-122A-fw TCT TCG CCT CCC GCT ATA CCA GAG  this study 
P55 CadC-OL-122A-rev CTC TGG TAT AGC GGG AGG CGA AGA  this study 
P56 CadC(Pro/Ala)-OL-fw GCG GCGGCG ATA TCG GAG GCG GTT CCT GCC ACA G  this study 
P57 CadC(Pro/Ala)-OL-rev CTG TGG CAG GAA CCG CCT CCG ATA TCG CCG CCG C  this study 
 
Translational LacZ fusions of other EF-P target proteins fused to the CadC native promoter 
P58 NP-CadC-cadB-OL-Rev GCA GAA CTC ATA ATA GAA ACT CAT TCG AAA AGG GAA TGA TG  this study 
P59 NP-CadC-cadB-OL-Fw GAG TTT CTA TTA TGA GTT CTG CCA AGA AGA TCG G  this study 
P60 PciI-cadB-TAA-Rev CAC ATG TAA TGT GCG TTA GAC GCG GTG T PciI this study 
P61 NP-CadC-cadA-OL-Rev GCA ATA ACG TTC ATA ATA GAA ACT CAT TCG AAA AGG GAA TGA TG  this study 
P62 NP-CadC-cadA-OL-Fw GAG TTT CTA TTA TGA ACG TTA TTG CAA TAT TGA ATC ACA TG  this study 
P63 BspHI-cadA-TAA-Rev GCT CAT GAA TTT TTT GCT TTC TTC TTT CAA TAC CTT AAC BspHI this study 
P64 PciI-amiB-rev CAC ATG TCG TTT GGC AGC GTG CGA TCT GG PciI this study 
P65 flhC-OL-Fw GTT TCT ATT ATG AGT GAA AAA AGC ATT GTT CAG GAA GC  this study 
P66 flhC-OL-Rev CTT TTT TCA CTC ATA ATA GAA ACT CAT TCG AAA AGG GAA TGA T  this study 
P67 PciI-flhC-rev CAC ATG TCA ACA GCC TGT ACT CTC TGT TCA PciI this study 
P68 nlpD-OL-Fw GTT TCT ATT ATG GGC TGT TCT GAC ACT TCA AAT C  this study 
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P69 nlpD-OL-Rev GAA CAG CCC ATA ATA GAA ACT CAT TCG AAA AGG GAA T  this study 
P70 PciI-nlpD-rev CAC ATG TCT CGC TGC GGC AAA TAA CGC AGC PciI this study 
P71 rzoR-OL-Fw GTT TCT ATT ATG TGC ACA TCA AAG CAG TCT GTC  this study 
P72 rzoR-OL-Rev GAT GTG CAC ATA ATA GAA ACT CAT TCG AAA AGG GAA TGA T  this study 
P73 PciI-rzoR-rev CAC ATG TCC CAG TCG TTC CCG GAG GGT GAA PciI this study 
P74 tonB-OL-Fw GTT TCT ATT ATG GTA CAT CAG GTT ATT GAA CTA CCT G  this study 
P75 tonB-OL-Rev GAT GTA CCA TAA TAG AAA CTC ATT CGA AAA GGG AAT GAT   this study 
P76 PciI-tonB-rev CAC ATG TC CTG AAT TTC GGT GGT GCC GTT PciI this study 
P77 uvrB-OL-Fw GTT TCT ATT ATG AGT AAA CCG TTC AAA CTG AAT TCC G  this study 
P78 uvrB-OL-Rev GTT TAC TCA TAA TAG AAA CTC ATT CGA AAA GGG AAT GAT G  this study 
P79 PciI-uvrB-rev CAC ATG TCC GAT GCC GCG ATA AAC AGC TCA PciI this study 
P80 hisD-TF-OL-Fw GTT TCT ATT ATG AGC TTT AAC ACA ATC ATT GAC TGG AAT AG  this study 
P81 hisD-TF-OL-Rev TGT TAA AGC TCA TAA TAG AAA CTC ATT CGA AAA GGG AAT GAT  this study 
P82 PciI-hisD-TF-rev CAC ATG TCT GCT TGC TCC TTA AGG GCG TTA AC PciI this study 
P83 flhC-TF-OL-Fw-APP GCG CGG AAG CGC ACC GCC GAA AG  this study 
P84 flhC-TF-OL-Rev-APP CTT TCG GCG GTG CGC TTC CGC GC  this study 
P85 flhC-TF-OL-FW-pap CTG CGC GGA AGC CCA GCG CCG AAA GGC ATG  this study 
P86 flhC-TF-OL-rev-pap CAT GCC TTT CGG CGC TGG GCT TCC GCG CAG  this study 
P87 flhC-TF-OL-FW-aaa CTG CGC GGA AGC GCA GCG GCG AAA GGC ATG  this study 
P88 flhC-TF-OL-rev-aaa CAT GCC TTT CGC CGC TGC GCT TCC GCG CAG  this study 
 
qRT-PCR-Primer 
P89 Q-PCR-recA-Fw CGG TTC GCT TTC ACT GGA TAT CG  this study 
P90 Q-PCR-recA-Rev CCT GCA GCG TCA GCG TGG T  this study 
P91 Q-PCR-rpoD-Fw GCT GGC TGA AAA CAC CGC GG  this study 
P92 Q-PCR-rpoD-Rev GCC CAT TTC ACG CAT GTA CAT GC  this study 
P93 Q-PCR-cadC-Fw CGC AGA GTA TCT CAG AAC TAC GTA  this study 
P94 Q-PCR-cadC-Rev CCT CTC CCT CTT CTT CGC TGT  this study 
     
P95 Q-PCR-cadA-Fw CGC GTT CGC TAA TAC GTA TTC CA  this study 
P96 Q-PCR-cadA-Rev CGT CAG TGG TCT GCT TGA TCT TAT  this study 
P97 Q-PCR-cadB-Fw CGA CTG GCA ACA AAA AAC CCG C  this study 
P98 Q-PCR-cadB-Rev GCC AGG TTA CCA ATC CAG TTA GC  this study 
 
Primer deletion strains 
P99 yjeK-mid-50 
GAT TGT GAT CCC GGC ACG TAT CAC 
CGA GGC GCT GGT TGA ATG CTT TGC 
CCA ATT AAC CCT CAC TAA AGG GCG 
 
(Kraxenberger, 
2006) 
P100 yjeK-down-50 
AAG CGT AGC GAA TCA GGC AAT TTT 
AAT GTT TAA CTT CCC TGT TTA ATC 
AGT AAT ACG ACT CAC TAT AGG GCT 
C 
 
(Kraxenberger, 
2006) 
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 Name Sequence Restric-tion site Source 
     
P101 cadB-rpsl-up 
ATA CAT CAT GAC CCG GAC TCC AAA 
TTC AAA AAT GAA ATT AGG AGA AGA 
GCA TGG CAA CAG TTA ACC AGC TGG 
TAC GC 
 
this study 
P102 cadA-rpsl-up 
TTC ATT TTG TCC CAT GTG TTG GGA 
GGG GCC TTT TTT ACC TGG AGA TAT 
GAC TAT GGC AAC AGT TAA CCA GCT 
GGT ACG C 
this study 
P103 cadA-neo-low 
CTT ATG AGC AAA AAA GGG AAG 
TGG CAA GCC ACT TCC CTT GTA CGA 
GCT AAT CAG AAG AAC TCG TCA AGA 
AGG CG 
this study 
P104 cadB-lacZ-up 
ATA CAT CAT GAC CCG GAC TCC AAA 
TTC AAA AAT GAA ATT AGG AGA AGA 
GCA TGA CCA TGA TTA CGG ATT CAC 
TG 
 this study 
P105 cadA-lacZ-up 
TTC ATT TTG TCC CAT GTG TTG GGA 
GGG GCC TTT TTT ACC TGG AGA TAT 
GAC TAT GAC CAT GAT TAC GGA TTC 
ACT G 
 this study 
P106 cadA-lacZ-low 
CTT ATG AGC AAA AAA GGG AAG 
TGG CAA GCC ACT TCC CTT GTA CGA 
GCT AAT TAT TTT TGA CAC CAG ACC 
AAC TG 
 this study 
P107 cadC neo FRT up 
CGT TGG CGA ATG GCT TGT TAC TCC 
GTC CAT AAA CCA AAT TAG CCG CAA 
TGA ATT AAC CCT CAC TAA AGG GCG 
 (Schüppel, 2010) 
P108 cadC neo FRT low 
TTC AAT CCA GTA AAG GGT GTT TGC 
CCC TGG GCG TAA ATT AAA GGC GGT 
GAT AAT ACG ACT CAC TAT AGG GCT 
C 
 (Schüppel, 2010) 
P109 yjeK_642_cat_fw 
GAT TGT GAT CCC GGC ACG TAT CAC 
CGA GGC GCT GGT TGA ATG CTT TGC 
CGT GTA GGC TGG AGC TGC TTC 
 this study 
P110 yjeK_642_cat_rev 
AAG CGT AGC GAA TCA GGC AAT TTT 
AAT GTT TAA CTT CCC TGT TTA ATC 
AGG GAC CAT GGC TAA TTC CCA T 
 
this study 
P111 yjeA_rpsl_up 
TCG CGT TGC GAG TAG ACT TCG TGC 
CCT TGT CAA AAA CTG GAG ATT TAA 
CTG GCC TGG TGA TGA TGG CGG GAT 
CG 
 
this study 
P112 yjeA_neo_low 
ATG GCG CTT ATC ACG CCA TTC TTC 
GCT GTT AAT TCA GTA ATT TTT CAG 
AAT CAG AAG AAC TCG TCA AGA 
AGG CG 
 
this study 
P113 Hfq_Cm_fw 
TCA GAA TCG AAA GGT TCA AAG TAC 
AAA TAA GCA TAT AAG GAA AAG 
AGA GAG TGT AGG CTG GAG CTG CTT 
C 
 
this study 
P114 Hfq_Cm_rev 
TTG CGC GGA AGT ATT CTG CGC GCT 
GCT ACC ATG ATG GTA GTT ACT GCT 
GGA TGG GAA TTA GCC ATG GTC C 
 
this study 
P115 Hflx_750_Cm-fw 
GGA GCC AGC GAT CCT GCG TTC CCC 
GCT GAT CTA TTT AGA GGG TTA TAC 
GCG TGT AGG CTG GAG CTG CTT C 
 
this study 
P116 Hflx_750_Cm-rev 
AAA TGC CGC CAC CAG ATC 
GTG7CGG CAG GTG GCG AAT AAA 
CCC TAC GGT ATA TGG GAA TTA GCC 
ATG GTC C 
 
this study 
P117 His-C-terminal-Hfq_sense 
CCG AAT TCA TGG CTA AGG GGC AAT 
CTT TA EcoRI this study 
P118 His-C-terminal-Hfq_antisense 
AAC ATA TGT TCG GTT TCT TCG CTG 
TCC TG NdeI this study 
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 Name Sequence Restric-tion site Source 
     
P119 His-N-terminal-YjeA_sense 
AAC ATA TGA GCG AAA CGG CAT CCT 
GGC A NdeI this study 
P120 His-N-terminal-YjeA_antisense 
CCT CTA GAT TAT GCC CGG TCA ACG 
CTA AAG XbaI this study 
 
Check Primer deletion strains 
P121 defp-chk-Fw GCA AAG CAT TCA ACC AGC GCC  this study 
P122 defp-chk-Rev GAC TAA AGC CGT GGG TAT ATT TCA G  this study 
P123 cadB-fw-seq CAG TTT GGT CTG GTC AGG AAA TAG  this study 
P124 cadA-rev-seq GTG AGG GTG TTT TCA TGT GTT CTC  this study 
P125 cadC up GCA ACA ACC TGT AGT TCG  this study 
P126 cadC low AAC AGA AGT CTG GAA TAT ACC  this study 
P127 yjeA-fw-seq GCC CTT GTC AAA AAC TGG AG  this study 
P128 yjeA-rev-seq CGC TGT TAA TTC AGT AAT TTT TCA G  this study 
P129 walk-for-2 GCC GTA CTC ACT CTA TAT AAA CAG AA  
(Kraxenberger, 
2006) 
P130 walk-on-reverse ATC GCG CCC GGA TTC TCC ACC GAC  (Kraxenberger, 2006) 
P131 Hflx_check_fw GTT TCG GGC TGT TTT TTT ACA CG  this study 
P132 Hflx_check_rev GTT ATG CGG TGA TCC CTG TTG  this study 
P133 Hns-Cm-fw 
ATG AGC GAA GCA CTT AAA ATT CTG 
AAC AAC ATC CGT ACT CTT CGT GCG 
CAG TGT AGG CTG GAG CTG CTT C 
 this study 
P134 Hns-Cm-rev 
TTA TTG CTT GAT CAG GAA ATC GTC 
GAG GGA TTT ACC TTG CTC ATC CAT 
TGA TGG GAA TTA GCC ATG GTC C 
 this study 
P135 dhns-chk-Fw GGT AGT GGG TGA TGA ACC GGT AG  this study 
P136 dhns-chk-Rev GTG GGT ATA TGC GTT CTC CCT TAC  this study 
 
Sequencing Primers 
P137 T7 Promoter  TAA TAC GAC TCA CTA TAG GG   
P138 T7 Terminator TAT GCT AGT TAT TGC TCA G   
P139 Seq33-Fw-100 GGC GTC CAC ACT TTG CTA TGC  this study 
P140 pBAD-HisA-rev CAG TTC CCT ACT CTC GCA TG  this study 
P141 M13 (-21)uni TGT AAA ACG ACG GCC AGT   
P142 M13 (-29)rev CAG GAA ACA GCT ATG ACC   
P143 Hfq_antisense CCT CTA GAT TAT TCG GTT TCT TCG CTG TC  this study 
     
Artificial introduction of selected aa at positon two of the CadC ORF 
P144 PciI-CadC-TF02-Rev (His) 
GCA CAT GTG CAT AAT AGA AAC TCA 
TTC GAA AAG GG PciI this study 
P145 PciI-CadC-TF02-Gln-Rev 
GCA CAT GTG TTG CAT AAT AGA AAC 
TCA TTC GAA AAG GG PciI this study 
P146 PciI-CadC-TF02-Gly-GGC-Rev 
GCA CAT GTG GCC CAT AAT AGA AAC 
TCA TTC GAA AAG GG PciI this study 
     
P147 PciI-CadC-TF02-Ala-Rev (GCG) 
GCA CAT GTG CGC CAT AAT AGA AAC 
TCA TTC GAA AAG GG PciI this study 
P148 PciI-CadC-TF02-Leu-Rev 
GCA CAT GTG CAG CAT AAT AGA AAC 
TCA TTC GAA AAG GG PciI this study 
P149 PciI-CadC-TF02-Met-Rev 
GCA CAT GTG CAT CAT AAT AGA AAC 
TCA TTC GAA AAG GG PciI this study 
P150 PciI-CadC-TF02-Phe-TTT-Rev 
GCA CAT GTG AAA CAT AAT AGA AAC 
TCA TTC GAA AAG GG PciI this study 
P151 CadC-Gly-Fw GAG TTT CTA TTA TGG GCC AAC AAC CTG TAG  this study 
P152 CadC-Gly-Rev CTA CAG GTT GTT GGC CCA TAA TAG AAA CTC  this study 
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 Name Sequence Restric-tion site Source 
     
P153 CadC-Phe-Fw GAG TTT CTA TTA TGT TCC AAC AAC CTG TAG  this study 
P154 CadC-Phe-Rev CTA CAG GTT GTT GGA ACA TAA TAG AAA CTC  this study 
     
Primer for in vitro studies 
P155 EF-P K34 FOR GAATTCGTAAAACCGGGTGCA GGCCAGGCATTTGCTCGC  Dr. A. Starosta 
P156 EF-P K34 REV GCGAGCAAATGCCTGGCCTGCACCCGGTTTTACGAATTC  Dr. A.  Starosta 
P157 Flk1-10-REV CTA GTT ATT GCT CAG CGG TTT AAG GAG GAG GGC CGG AAA TAG GTT G  Dr. A. Starosta 
P158 FlhC1-53-REV CTA GTT ATT GCT CAG CGG TTT ACG GCG GTG GGC TTC CGC GCA GTT C  Dr. A. Starosta 
P159 RzoR1-18-REV CTA GTT ATT GCT CAG CGG TTT ACG GAG GCG GTG GTG GCT TCA C  Dr. A. Starosta 
P160 CadC1-125-REV 
CTA GTT ATT GCT CAG CGG TTT ATG 
GTA TAG GGG GAG GCG AAG ATA G  Dr. A. Starosta 
P161 CadC-NdeI-sense AGG AAA GGA CAT ATG CAA CAA CCT GTA  GTT CG NdeI 
(Küper & Jung, 
2005) 
P162 CadC-BamHI-stop AGT GGA TCC TTA TTC TGA AGC AAG AAA TTT GTC C BamHI 
(Küper & Jung, 
2005) 
P163 BamHI-TAA-CadC-131-Rev 
GCC GGA TCC TTA TTATTA TGG TAT 
AGG GGG AGG CGA AGA TA BamHI this study 
 
Bacterial two hybrid studies 
P164 XbaI-BTH-EF-P-Fw CGT CTA GAG GCA ACG TAC TAT AGC AAC GAT TTT C XbaI 
(Krönauer, 2011) 
P165 BamHI-BTH-EF-P-Rev CTG GAT CCG CCT TCA CGC GAG AGA CGT ATT CAC BamHI 
(Krönauer, 2011) 
P166 XbaI-BTH-CadC-Fw AGT CTA GAG CAA CAA CCT GTA GTT CGC GTT G XbaI 
(Krönauer, 2011) 
P167 BamHI-BTH-CadC-Rev CTG GAT CCG CTT CTG AAG CAA GAA ATT TGT CGA GAT A BamHI 
(Krönauer, 2011) 
P168 XbaI-BTH-LysP-Fw AGT CTA GAG GTT TCC GAA ACT AAA ACC ACA GAA G XbaI 
(Krönauer, 2011) 
P169 BamHI-BTH-LysP-Rev CTG GAT CCG CTT TCT TAT CGT TCT GCG GGA ACT TC BamHI 
(Krönauer, 2011) 
P170 XbaI-BTH-YjeA-Fw AGT CTA GAG AGC GAA ACG GCA TCC TGG XbaI 
(Krönauer, 2011) 
P171 BamHI-BTH-YjeA-Rev CTG GAT CCG CTG CCC GGT CAA CGC TAA AGG BamHI 
(Krönauer, 2011) 
P172 BamHI-BTH-H-NS-Rev CGT CTA GAG AGC GAA GCA CTT AAA ATT CTG AAC A XbaI 
(Krönauer, 2011) 
P173 XbaI-BTH-H-NS-Fw CTG GAT CCG CTT GCT TGA TCA GGA AAT CGT CGA G BamHI 
(Krönauer, 2011) 
P174 XbaI-BTH-YjeK-Fw AGT CTA GAG GCG CAT ATT GTA ACC CTA AAT ACC XbaI 
(Krönauer, 2011) 
P175 BamHI-BTH-YjeK-Rev CTG GAT CCG CCT GCT GGC GTA GCT GGA GAT BamHI 
(Krönauer, 2011) 
     
Generation of CadC Ly to Ala mutants 
P176 CadC_K59A_antisense CAA TAC TTC TCG CCC AGA CAT TAT C  
this study 
P177 CadC_K59A_sense GAT AAT GTC TGG GCG AGA AGT ATT G  
this study 
P178 CadC_K77A_antisense CTT TTA ATG ACG CAC GTA GTT C  this study 
P179 CadC_K77A_sense GAA CTA CGT GCG TCA TTA AAA G  this study 
P180 CadC_K80A_antisense CAT CAT TAT CTG CTA ATG ACT TAC G  
this study 
P181 CadC_K80A_sense CGT AAG TCA TTA GCA GAT AAT GAT G  
this study 
P182 CadC_K95A_antisense TAT AGC CGC GCG CTG GTA CAG  this study 
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P183 CadC_K95A_sense CTG TAC CAG CGC GCG GCT ATA  this study 
P184 CadC_K99A_antisense CAC CAT TAA TGC ATA GCC GC  this study 
P185 CadC_K99A_sense GCG GCT ATG CAT TAA TGG TG  this study 
P186 CadC_K80A_antisense GAA TCG TTT GCT TGC AAC TGG  this study 
P187 CadC_K80A_sense CCA GTT GCA AGC AAA CGA TTC  this study 
     
Generation of CadC Ly to Arg mutants 
P188 CadC_K59R_antisense CAATACTTCTCCTCCAGACATTATC   this study 
P189 CadC_K59R_sense GATAATGTCTGGAGGAGAAGTATTG  this study 
P190 CadC_K77R_antisense ATC TTT TAA TGA CCT ACG TAG TTC   this study 
P191 CadC_K77R_sense GAA CTA CGT AGG TCA TTA AAA GAT  this study 
P192 CadC_K80R_antisense CAT CAT TAT CTG CTA ATG ACT TAC G  
this study 
P193 CadC_K80R_sense CGT AAG TCA TTA GCA GAT AAT GAT G  
this study 
P194 CadC_K95R_antisense TAT AGC CGC GCC TTG GTA CAG  this study 
P195 CadC_K95R_sense CTG TAC CAA GGC GCG GCT ATA  this study 
P196 CadC_K99R_antisense CAC CAT TAA TCT ATA GCC GCG  this study 
P197 CadC_K99R_sense CGC GGC TAT AGA TTA ATG GTG  this study 
P198 CadC_K80R_antisense CAT CAT TAT CTC TTA ATG ACT TAC G  
this study 
P199 CadC_K80R_sense CGT AAG TCA TTA AGA GAT AAT GAT G  
this study 
     
PcadA-lacZ fusions 
P200 XbaI-PcadA79_fw AAT CTA GAT TAA AAG TAT TTT CCG AGG CTC CTC XbaI 
this study 
P201 XbaI-PcadA100_fw AAT CTA GAC TTC ATC GTC AGC CTG ATT ATC CT XbaI 
this study 
P202 XbaI-PcadA200_fw AAT CTA GAG TTA ACA TCC GCA ACT TTG TCA GC XbaI 
this study 
P203 XbaI-PcadA300_fw AAT CTA GAG TAA AGC ATC TGA CCT GTT CGG TG XbaI 
this study 
P204 XbaI-PcadA400_fw AAT CTA GAG AAG TCG ACA GCA ACG GTA TTC C XbaI 
this study 
P205 XbaI-PcadA500_fw AAT CTA GAC TTT GCG TGC CTG ACT TCT CTG XbaI 
this study 
P206 XbaI-PcadA600_fw AAT CTA GAC TAT CCT CGG TAA CTG GGC TGC GC XbaI 
this study 
P207 XbaI-PcadA700_fw AAT CTA GAG TTA AAA ACC CGA AAC GTA CCG TTC XbaI 
this study 
P208 XbaI-PcadA800_fw AAT CTA GAG AAT ACT GCG GAT ACC ACT GAT GG XbaI 
this study 
P209 PciI-PcadA600_rev AAA CAT GTA GTC ATA TCT CCA GGT AAA AAA GGC CCC TC PciI 
this study 
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2.3 Cultivation techniques 
According to the NaCl modification of Miller (Miller, 1972), Lysogeny Broth (LB) was used 
as complex medium (Bertani, 1951). When indicated, LB was buffered with 100 mM sodium-
phosphate to pH 7.6 or 5.8. Potassium buffered minimal medium (KE, pH 7.6 or 5.8) (Epstein 
& Kim, 1971) was supplemented with 0.4% (w/v) glucose as carbon source and, when 
indicated, with 10 mM lysine. LB plates contained 1.5% (w/v) agar. Antibiotics were used 
when necessary with following concentrations: 100 µg/ml ampicillin sodium salt, 50 µg/ml 
kanamycin sulfate, 34 µg/ml chloramphenicol, 50 µg/ml streptomycin sulfate, 15 µg/ml 
tetracycline hydrochloride or 15 µg/ml gentamycin sulfate. For blue-white selection, LB agar 
plates were additionally supplemented with 80 µM 5-bromo-4-chloro-3-indolyl β-D-
galactopyranoside (X-Gal) and 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). Unless 
otherwise stated, cells were grown at 37 °C. Under aerobic conditions, cells were shaken in 
baffled flasks (up to 1 l) or test tubes (up to 5 ml) at 200 rpm. Overnight cultures were always 
incubated aerobically. Microaerobic conditions were achieved by growing cells in bottleneck-
filled flasks or Greiner tubes with minimal agitation (2 rpm). To control cell growth, the 
optical densitiy was determined at 600 nm (OD600) in an Ultrospec 2100 pro photometer 
(Amersham Biosciences).  
2.3.1 Purification of YjeK 
For overproduction of YjeK, an overnight culture of strain Bl21(DE3) harboring plasmid 
pET16b-His6-YjeK was diluted (1:100) and aerobically grown in LB medium, which was 
supplemented with ampicillin. When cells had reached an OD600 of ≈ 0.5, 0.5 mM IPTG was 
added. After shaking for 3 h, cells were harvested by centrifugation (10 min; 6000 rpm; 4 °C; 
Sorvall® EvolutionTM RC) and washed once with a low ionic washing buffer containing 
50 mM Tris/HCl (pH 8.0) and 10 mM MgCl2. The cell pellet was shock-frozen and stored  at 
-80 °C. YjeK was then purified using Ni2+-NTA column chromatography (section 2.5.1). 
2.3.2 Lysine decarboxylase and β-galactosidase activity tests 
Cultivations for the lysine decarboxylase (LDC, CadA) and β-galactosidase activity tests were 
done in KE minimal medium or LB medium equally. To this end, an overnight culture was 
diluted to an OD600 of 0.05 in the corresponding medium. To induce the cad operon, 10 ml 
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cells were incubated microaerobically in low pH buffered medium and additionally with 
10 mM lysine in KE minimal medium. When cells had reached an OD600 of 0.3 - 0.7, 1 ml 
was harvested in a 2 ml Eppendorf tube by centrifugation (10 min; 13,200 rpm; 4 °C; 
Eppendorf 5415R). Before measuring the CadA or β-galactosidase activity (section 2.5.6 or 
2.5.7), cell pellets could be stored at -20 °C. 
For the bacterial two hybrid assay (section 2.5.8), cells were incubated at 30 °C in 4 ml LB 
medium, which was supplemented with ampicillin, kanamycin and IPTG. At an OD600 of 0.5 - 
0.9, cells were harvested by centrifugation (5 min; 13,200 rpm; 4 °C) and stored at -20°C.  
2.3.3 Cultivations for RNA isolation 
For Northern Blot analysis (section 2.4.12), wildtype cells or ∆yjeK cells were first grown 
aerobically in 5 l KE minimal medium (pH 7.6), until they reached an OD600 of 0.6 - 0.8. 
Then, cells were harvested by centrifugation (5 min, 6000 rpm, 37 °C) and immediately 
shifted to a 5 l fermenter containing KE minimal medium pH 5.8 with 10 mM lysine. To 
avoid sedimentations, the medium was stirred at 50 rpm. The pH was monitored by a pH 
sensor. At time points 0, 1, 5, 10, and 20 min after the shift, 10 ml were harvested in Greiner 
tubes by centrifugation (10 min; 10,000 rpm; 4 °C). Cell pellets were shock-frozen and stored 
at -80 °C. 
For quantitative real time PCR (qRT-PCR, section 2.4.13), cells grown exponentially to an 
OD600 of 0.4 - 0.6 in pH 7.6 buffered KE minimal medium were harvested by centrifugation 
(10 min; 4000 rpm; 4 °C). Subsequently, cells were exposed either to non-inducing conditions 
(pH 7.6) or inducing conditions (pH 5.8 + 10 mM lysine) for 25 min (Küper & Jung, 2005). 
At time points 0 min and 25 min, 10 ml of the culture were harvested by centrifugation 
(20 min, 4000 rpm, 0 °C). Cell pellets were immediately frozen in liquid nitrogen and stored 
at -80°C for further experiments.  
Pellets were further used for RNA isolation (section 2.4.10). 
2.3.4 CadC membrane vesicles 
For quantification of CadC in membrane vesicles (section 2.5.2), strains were aerobically 
cultivated in 1 l buffered KE or LB medium (pH 7.6). Cells having an OD600 of ≈ 1 were 
harvested by centrifugation (5 min, 6000 rpm, 37 °C) and shifted to inducing conditions (KE 
medium: pH 5.8 with 10 mM lysine, LB medium: pH 5.8) for 1 h without shaking. Cells 
grown in LB medium were additionally washed once with washing buffer containing 50 mM 
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Tris/HCl (pH 8.0) and 10 mM MgCl2, before harvesting them by centrifugation. Cell pellets 
were shock-frozen and stored at -80°C. 
2.3.5 Culture storage  
For storage, a fresh overnight culture was mixed with 17% (v/v) glycerol and immediately 
shock-frozen. Afterwards, the strain was stored at -20°C or -80°C.  
2.4 Molecular biological and genetic methods 
2.4.1 Isolation of plasmids and genomic DNA  
Plasmid isolations were done according to the manufacturer´s directions of the HiYield 
plasmid mini-kit (Süd Laborbedarf). Plasmids were stored at -20°C or -80°C.  
Genomic DNA was isolated according to the manufacturer´s directions of the DNeasy 96 
blood and tissue kit (Quiagen). Isolated DNA was diluted in 200 µl ddH2O and stored            
at -20°C. 
2.4.2 Modification of DNA 
The standard DNA techniques were, unless otherwise stated, carried out according to 
„Molecular Cloning, a Laboratory Handbook“ (Sambrook & Russel, 2001). In vitro 
modifications of DNA molecules, like ligations and restrictions, were performed as 
recommended by the manufacturer´s manual. The ends of linearized vectors were 
dephosphorylated by the enzyme alkaline phosphatase to avoid religations.  
2.4.3 Polymerase chain reaction 
Taq and Phusion DNA polymerases were employed for DNA amplification according to the 
manufacturer´s directions. As templates, 20 - 100 ng genomic DNA were used. To test the 
insertion of a fragment into the bacterial genome after transformation, a colony PCR was done 
by transferring cells of the clone of interest to the PCR tube with a sterile toothpick. The PCR 
was performed according to Mullis et al. (Mullis et al., 1986). Cyclers were products from 
Eppendorf and Biorad. 
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2.4.4 Electrophoretic separation of DNA 
DNA fragments were separated by agarose gel electrophoresis. Before loading the DNA on 
the gel, 10 x DNA loading dye [50% glycerol (v/v); 0.1 M EDTA; 1% SDS (w/v); 0.1% 
bromphenol blue (w/v)] was added. Gels consisted of 1% - 2% (w/v) agarose in 1 x TAE 
buffer (40 mM acetic acid; 1 mM EDTA; 40 mM Tris) and 0.2 µg/ml ethidium bromide. As 
standard DNA marker, the 2-log DNA ladder from NEB (0.1 - 10 kb) was employed. The gel 
run was carried out at 100 V in a „Mini Sub DNA Cell“ - and a “Wide Mini Sub cell GT”- 
agarose gel chamber (Biorad, München), respectively. DNA was detected by an UV-
transilluminator (304 nm) and gels were documented by the “Cybertec”-gel documentation 
system of Peqlab. 
2.4.5 DNA gel extraction and determination of nucleic acid concentration 
DNA fragments were purified from agarose gels by using the HiYield DNA extraction kit 
(Süd-Laborbedarf) according to the manufacturer´s instructions. The concentrations of DNA 
and RNA were measured by using the NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies).  
2.4.6 DNA sequencing analysis 
Sequencing analysis was performed by the sequencing service of the Institute of Genetics of 
the Ludwig-Maximilians-University (LMU) using the “ABI Prism Model 3730” (Applied 
Biosystems). The sequencing principle was based on the “Cycle Sequencing” of Sanger et al. 
(Sanger et al., 1977). Used primers are listed in Table 4.  
2.4.7 Strain construction 
Strains MG-CL-1, MG-CR, MG-CL-12-hflx, MG-CL-12-yjeA and SU2 were constructed by 
using the pRED®/ET® recombination technology together with the rpsL counter-selection 
(Heermann et al., 2008) in accordance to the technical protocol of the Quick & Easy E. coli 
Gene Deletion Kit of Gene Bridges (www.genebridges.com). For the construction of strains 
SU1, SU3, SU4 and MG-CL-12-hfq, plasmid pKD3 was employed for fragment 
amplification, in which each end of the pKD3 chloramphenicol cassette was enlarged by 50 
base pairs flanking the region of yjeK643-1029, hns1-230 or hfq1-230. Gene deletion was then 
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performed using the same protocol as mentioned above. Strain MG-CL-12-yjeK was 
constructed by P1 phage transduction (Miller, 1972). Preparation of the phage lysates of 
donor strains TK1 and transduction to the recipient strains was performed as described 
previously (Leder et al., 1977). 
2.4.8 Plasmid construction 
Plasmids and their constructions are described in Table 3. Some of the plasmids, which have 
been recently published in Ude et al. (2013), were constructed in cooperation with Dr. Jürgen 
Lassak. 
2.4.9 Preparation of competent cells and transformation 
For plasmid transformation, chemically competent E. coli cells were prepared using a 
modified RbCl procedure (Promega, 1994). To this end, 10 ml fresh LB medium 
supplemented with the corresponding antibiotic were inoculated with 100 µl overnight 
culture. Cells exponentially grown to an OD600 of 0.3 - 0.6 were harvested by centrifugation 
(5 min, 5000 rpm, 4 °C, Eppendorf table centrifuge). The pellet was resuspended in 5 ml cold 
solution A (10 mM MOPS; 10 mM RbCl; pH 7.0), and cells were again centrifuged. After 
resuspending the pellet in 5 ml cold solution B (100 mM MOPS; 50 mM CaCl2; 10 mM 
RbCl; pH 6.5), cells were incubated 30 min on ice and centrifuged. The supernatant was 
discarded and cells were dissolved in 1 ml cold solution B. After 1 h incubation on ice, 200 µl 
competent cells were mixed with 1 µl plasmid or an entire ligation sample. The mixture was 
left on ice for another hour. Subsequently, cells were exposed to heat shock (max. 90 sec, 
42 °C) and shaken at 37 °C and 11,000 rpm for 1 h. Afterwards, 100 µl (for plasmid 
transformation) or the whole sample (for ligation transformation) was plated out on a selective 
agar plate and incubated overnight at 37 °C.  
For the transformation of linear DNA, electrocompetent cells were prepared according to the 
technical protocol of the Quick & Easy E. coli Gene Deletion Kit of Gene Bridges 
(www.genebridges.com). 40 µl of the competent cells were mixed with 0.4 µg - 1 µg DNA 
and filled into an ice cold electroporation cuvette. Cells were immediately electroporated by 
an electric pulse of 2.5 kV on average, using the MicroPulser electroporator of Biorad.  
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2.4.10 Isolation of RNA 
Total RNA was extracted from E. coli cells using the hot-phenol method (Aiba et al., 1981). 
All buffers were prepared using 0.1% (v/v) DEPC water. Cell pellets were resuspended in 
200 µl cold Tris/HCl buffer (20 mM Tris/HCl, pH 8.0) and 3 ml lysis buffer A [20 mM 
sodium acetate; 0.5% (w/v) SDS; 1 mM EDTA, pH 8.0; adjusted to pH 5.5 with acetic acid]. 
The RNA was extracted by adding 3 ml hot phenol (60°C) and incubating the sampls at 60 °C 
for 5 min. After centrifugation (10 min; 13,000 rpm; 4 °C), the aqueous upper layer was 
transferred in a new tube. Subsequently, 3 ml hot phenol/chloroform/isoamylalcohol (25:24:1) 
were added and the samples were again centrifuged. The upper layer was decanted in a new 
Greiner tube. 8 ml cold 100% ethanol was added, and the RNA was precipitated overnight at -
20°C. After centrifugation (15 min; 13,000 rpm; 4 °C), the supernatant was discarded and the 
pellets were washed with 70% (v/v) cold ethanol. Subsequently, the pellets were dried at 
room temperature for approx. 30 min and resuspended in 0.1% (v/v) DEPC water. Residual 
chromosomal DNA was removed by DNAse I digestion (Thermo Scientific / Fermentas) 
according to the manufacturer´s instruction. The purified RNA was then used for Northern 
Blot analysis (section 2.4.12) and qRT-PCR (section 2.4.13) and stored at -20°C. 
RNA isolation for qRT-PCR experiments were done in cooperation with Dr. Jürgen Lassak. 
2.4.11 Denaturated gel electrophoresis  
Before the Northern Blot, 1.2% (w/v) denaturated agarose gels were prepared to avoid 
secondary structures of the RNA according to a standard protocol (Sambrook & Russel, 
2001). 120 ml of the gel contained 12 ml 10 x MOPS buffer (80 mM sodium acetat; 10 mM 
EDTA; 200 mM MOPS; pH 7.0) and 3.6 ml formaldehyde (37%). 20 µg of total RNA was 
mixed with 1 volume of pre-mix solution [64.5% (v/v) formamide; 8.4% (v/v) formaldehyde; 
1.3 x MOPS buffer], 0.002 ng/µl ethidium bromide and 1/10 volume 10 x RNA dye [50% 
(w/v) glycerol; 0.8% (w/v) bromphenol blue; 0.8% (w/v) xylencyanol; 1 mM EDTA, pH 8]. 
Probes were heated for 10 min at 65 °C and put on ice. Afterwards, probes and the RNA 
ladder (NEB) were loaded on the gel, which ran 2 - 3 h at 60 V. The loading buffer was 
composed of 1 x MOPS. All solutions were prepared using 0.1% (v/v) DEPC water. 
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2.4.12 Northern Blot analysis  
The transfer of RNA from the denaturated agarose gel to the Hybond-N nylon membrane (GE 
healthcare) was performed by following a standard protocol (Sambrook & Russel, 2001). 20 x 
SSC (3 M NaCl; 0.3 M sodium citrate; pH 7.0) was used as transfer buffer. The RNA was 
fixed on the membrane by UV light (304 nm), and the membrane was dried for 4 h at 80 °C. 
After the pre-hybridization of the membrane in 10 ml hybridization buffer [5 x SSC (0.75 M 
NaCl; 75 mM sodium citrate; pH 7.0); 5 x Denhardt´s reagents (Denhardt, 1966), 100 µg/ml 
denaturated salmon sperm DNA; 0.1% (w/v) SDS] at 60 °C for 1 h, the radioactive probe 
(against cadA, cadB or cadC) was prepared according to the “Rediprime II DNA Labeling 
System” kit (GE Healthcare). The labeling was done by using 0.05 mCi (millicurie) of [α32-
P]-dCTP per sample. The probe was mixed with 7.5 ml hybridization buffer and the 
membrane was incubated with the mixture at 60 °C overnight. Afterwards, the membrane was 
washed three times with 60 ml washing solution [2x SSC (0.3 M NaCl; 30 mM sodium 
citrate; pH 7.0)] for 5 min at 42 °C. The membrane was dried on air, and the exposition was 
done overnight by using a “Storage Phosphor Screen” (GE healthcare). Afterwards, the 
blotted screen was used for signal detection by a phosphoimager (Typhoon Trio, GE 
healthcare). 
2.4.13 qRT-PCR 
Extracted total RNA was applied as template for random-primed first-strand cDNA synthesis 
by using the RevertAid™ First Strand cDNA Synthesis Kit (Thermo Scientific / Fermentas) 
according to the manufacturer´s instructions. The cDNA was then used as template for qRT-
PCR (IQ5 optical system; Bio-Rad) by using the IQ SYBR Green Supermix (Bio-Rad). 
Samples were assayed at least in duplicates. The signal was normalized to recA (Gralnick et 
al., 2005). The cycle threshold (Ct) was automatically determined by use of the IQ5 optical 
system software (Bio-Rad) after 40 cycles. The efficiency of each primer pair was determined 
using five different concentrations of E. coli chromosomal DNA (100 µg/ml, 10 µg/ml, 
1 µg/ml, 100 ng/ml, 10 ng/ml) as templates for qRT-PCR.  
qRT-PCR experiments were done in cooperation with Dr. Jürgen Lassak. 
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2.5 Biochemical and analytical methods 
2.5.1 Purification of YjeK and CadC 
5´-His6-tagged YjeK was purified by Ni2+-NTA affinity chromatography using protocols 9 
and 12 of the manual “The QIAexpressionist” from Qiagen 
(http://kirschner.med.harvard.edu/files/protocols/QIAGEN_QIAexpressionist_EN.pdf). 
Following modifications were done: The lysis buffer was supplemented with 0.5 mM PMSF 
(phenylmethanesulfonylfluoride). The loaded column was washed twice with 10 ml ddH2O, 
and then 4 times with washing buffer. The protein was eluated with 12 x 300 µl steps. CadC 
was produced and purified as described earlier (Küper & Jung, 2005).  
2.5.2 Preparation of CadC membrane vesicles 
The protocol for preparation of membrane vesicles was based on the work of Siebers & 
Altendorf (Siebers & Altendorf, 1988), with modification in accordance to Jung et al. (Jung et 
al., 1997). 0.2 g of the cell pellet was resuspended in lysis buffer [50 mM Tris/HCl, pH 7.5; 
10% (v/v) glycerol; 0.5 mM PMSF; 10 mM MgCl2; 1 mM DTT; 30 ng/ml DNAse A] and 
incubated on ice with 10 µg/ml lysozyme for 30 min. Cells were disrupted by sonification 
(Sonifier W-250D, Branson) and harvested by centrifugation (10 min; 16,000 rpm; 4 °C). The 
cell debris was discarded and the supernatant was ultracentrifuged (1 h; 45,000 rpm; 4 °C). 
The pellet was washed (1 mM Tris/HCl, pH 7.5; 3 mM EDTA, pH 8.0; 0.5 mM PMSF) and 
ultracentifuged for a second time. Afterwards, the pellet was resuspended in TG buffer 
[50 mM Tris/HCl, pH 7.5; 10% (v/v) glycerol], shock-frozen and stored at -80 °C. 
2.5.3 Determination of the protein concentration 
The protein concentration in the cytoplasm was determined using the Bradford method as 
described before (Bradford, 1976). Concentration of proteins in membrane vesicles was 
determined in accordance to Lowry et al. (Lowry et al., 1951) with modifications (Peterson, 
1977). 
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2.5.4 SDS Page 
Proteins were separated by denaturating sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) in accordance to Lämmli (Lämmli, 1970). The stacking gels 
contained 4.9% (w/v) acrylamide, the separating gels 12.5% (w/v) acrylamide. Before loading 
on a gel, protein samples were mixed with SDS loading buffer [25 mM Tris/HCl, pH 6.8; 2% 
(v/v) glycerol; 2% (w/v) SDS; 5% (v/v) β-mercaptoethanol; 0.005% (w/v) bromphenol blue]. 
As markers, the Unstained Protein Molecular Weight Marker (14 - 116 kDa; Fermentas) and 
the PageRuler Prestained Protein Marker (10 - 170 kDa; Fermentas) were employed. For the 
preparation of native gels, the same protocol was employed as mentioned above, but without 
any SDS, β-mercaptoethanol or DTT. The gels run in “PerfectBlue double gel system Twin S 
or Twin M” (Biorad) at 200 V in Lämmli buffer [25 mM Tris; 192 mM glycin; 0.1% (w/v) 
SDS; pH 8.2 - 8.3). Afterwards, gels were stained with Serva Blue G-250 (Coomassie Blue) 
accordingly to Weber and Osborn (Weber & Osborn, 1969). The decoloration buffer 
contained 5% (v/v) methanol and 7.5% (v/v) acetic acid.  
2.5.5 Western Blot analysis 
Proteins, which were first separated by SDS-PAGE, were blotted on a nitrocellulose 
membrane with 0.45 µm pore diameter (Whatman, Protran BA85) by using a wet-blot 
apparatus (Mini Trans-Blot Cell, Biorad). The horizontal electrophoresis was performed for 
90 min at 300 mA for a small gel (10 x 10 cm) and 90 min at 800 mA for a big gel (14 x 
16 cm). The Western Blot analysis was performed in accordance to protocol 8 of the 
“QIAexpress Detection and Assay Handbook 10/2002” from Qiagen 
(http://www.qiagen.com/selectlocation.aspx?redirect=%2fliterature%2frender.aspx%3fid%3d
129). To detect proteins with histidine (His) - tags, the antibody "Penta-His-Anti-Mouse-IgG" 
was used as primary antibody with an end concentration of 1:2000, and the "anti-Mouse IgG 
(chicken) antibody conjugated with alkaline phosphatase (AP)" was employed as secondary 
antibody (1:5000). To detect CadC, the blot membrane was incubated first with a specific pre-
adsorbed CadC antibody (rabbit, 2006) (1:10,000) and then with an “anti-Rabbit IgG 
antibody, AP conjugated” (1:2500). As last step, the immunoblot was incubated with a dye 
solution [50 mM sodium carbonate (pH 9.5); 0.01% (w/v) NBT; 0.045% (w/v) BCIP] for 5 - 
15 min. 
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2.5.6 Lysine decarboxylase activity test 
Specific lysine decarboxylase (CadA) activity was measured in cell-free extracts as previously 
described (Lemonnier & Lane, 1998) with minor modifications (Tetsch et al., 2008). 1 ml 
cells were harvested by centrifugation, and the cell pellet was adjusted to an OD600 of 1 with 
cold potassium phosphate buffer (20 mM, pH 5.6). For cell lysis, 200 µl of the cell suspension 
were transferred into a new Eppendorf tube, and 20 µl chloroform were added. After 
vortexing, 10 µl of the upper phase was transferred into 120 µl of pre-warmed reaction buffer 
[16 mM potassium phosphate buffer, pH 5.6; 0.1 mM pyridoxal phosphate (PLP)]. For each 
sample, four tubes with reaction buffer were used, whereby two tubes were additionally 
supplemented with 10 mM lysine as substrate for CadA, whereas the samples without lysine 
served as negative controls. After 15 min incubation time at 37 °C, 120 µl Na2CO3 were 
added to neutralize the medium and therefore to stop the CadA activity. The lysate was put on 
ice, and 120 µl trinitrobenzenesulfonic acid (TNBS, 10 mM) were added. TNBS reacts with 
lysine, but also with the endproduct of CadA, cadaverine, resulting in N,N'-
bistrinitrophenyllysine (TNP-lysine) and N,N'-bistrinitrophenylcadaverine (TNP-cadaverine). 
After mixing the lysate with 1 ml toluol for 20 sec, TNP-cadaverine could be separated from 
TNP-lysine, as it is soluble in the organic phase of toluol - in contrast to TNP-lysine. The 
TNP-cadaverine standard curve was done before by Christiane Koller (Koller, 2008). An 
absorption of 1 at 340 nm corresponds to 106 nmol cadaverine.  
2.5.7 β-Galactosidase activity test 
β-Galactosidase activities were determined as described before (Tetsch et al., 2008) for at 
least three independent experiments and are given in Miller units (MU) (Miller, 1992). The 
significance of the results was determined by applying two-sided students t-test and stating a 
result as significantly different if p < 0.05. For the test, the cell pellet was resuspended in 1 ml 
buffer Z (60 mM Na2HPO4; 40 mM NaH2PO4; 10 mM KCl; 1 mM MgSO4; 50 mM β-
mercaptoethanol; pH 7.0). After cell lysis with 100 µl chloroform and 50 µl 0.1% (v/v) SDS, 
lysates were incubated at 30 °C for 5 min. Then, 200 µl ONPG (4 mg/ml) were added as 
substrate for the β-galactosidase. When yellowing, the reaction was stopped after 0.5 – 10 min 
with 500 µl sodium carbonate (1 M). Cells were centrifuged (5 min; 13,200 rpm; RT) and the 
colour was determined photometrically at an absorption of 420 nm using following formula: 
 
β-galactosidase-activity [Miller-Units] = (A420 * 1000) * (t[min] * V[ml] * OD600)-1 
2. Materials and Methods 
 
38 
 
β-Galactosidase activity assays concerning the bacterial two hybrid system were performed 
by Christina Krönauer in her research internship in the AG K. Jung. β-Galactosidase activity 
assays concerning the search for the EF-P signal sequence were done in cooperations with 
Dr. Jürgen Lassak. 
2.5.8 Bacterial two hybrid system 
This system is based on the split of Bordetella pertussis adenylate cyclase into a T18 and a 
T25 fragment (Karimova et al., 1998; Karimova et al., 2000). Separate fragments reveal no 
enzymatic activity, but if two proteins come in close proximity, a fully functional adenylate 
cyclase reconstitutes and allows expression of lacZ from a CRP inducible promoter. The 
resulting β-galactosidase activity can be measured by cleavage of ONPG and reflects the 
strength of protein-protein interaction. To this end, cadC, lysP, hns, yjeA, yjeK,and efp were 
cloned into pKT25, pKNT25 and pUT18C (Table 5). The strain E. coli BTH101 was then co-
transformed with the resulting plasmids leading to strains harboring N/C-terminal T25 fusion 
in combination with a N-terminal T18 fusion. The β-galactosidase activity was measured as 
described above.  
Bacterial two hybrid system experiments were done in cooperation with Christina Krönauer 
and Dr. Jürgen Lassak. 
2.5.9 In vitro translation assay 
In vitro translations of CadC and the proline rich proteins were performed using PURExpress 
∆aa ∆tRNA (NEB), according to manufacturer’s instructions. Briefly, translation was coupled 
to transcription using PCR templates containing a T7 promoter and supplemented with [35S]-
methionine (Perkin Elmer) and 1 µM EF-P. Reactions were incubated at 30°C, 2.5 µl aliquots 
were removed at specified time points and stopped by placing them on ice or by addition of 
20 µM thiostrepton (Sigma). RNase A treatment involved addition of 12.5 µg RNaseA 
(Roche) per reaction and incubation for 10 min at 30°C. Translation products were separated 
by double-layered 15%/18% Schägger-von Jagow SDS-PAGE (Schagger & von Jagow, 1987) 
and detected by autoradiography using Kodak BioMax MR Film. In vitro translation was 
done by Dr. Agata Starosta of the group of Dr. Daniel Wilson (Gene Center, LMU). 
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2.6 Bioinformatical methods 
Primers for the polymerase chain reaction (PCR) were constructed by using the programs 
Artemis (Sanger Institute) (Rutherford et al., 2000) and OligoCalc (Oligonucleotide 
Properties Calculator, http://www.basic.northwestern.edu/biotools/oligocalc.html) (Kibbe, 
2007). Predictions of secondary structures were done computer based using the tools 
PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred) (Jones, 1999) and MINNOU 
(http://minnou.cchmc.org) (Cao et al., 2006). Prediction of signal recognition sites were made 
computer based using SignalP 4.0 (http://www.cbs.dtu.dk/services/SignalP) (Petersen et al., 
2011). Molecular graphics were constructed with the UCSF Chimera package (Resource for 
Biocomputing, Visualization, and Informatics at the University of California, San Francisco) 
(Pettersen et al., 2004). Amino acid alignments were performed using Artemis and the NCBI 
database (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Protein&itool=toolbar) (Sayers 
et al., 2009) for sequences, and Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo) 
(Sievers et al., 2011) for the alignment. All Western Blot quantifications were performed by 
using the software ImageJ (http://rsbweb.nih.gov/ij/) (Schneider et al., 2012). 
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3. Results 
3.1. Importance of YjeK, YjeA and EF-P for cadBA expression 
The regulation of the acid stress resistance system Cad has been investigated for more than 
twenty years. Many new discoveries have been made recently (Eichinger et al., 2011; 
Haneburger et al., 2011; Haneburger et al., 2012; Ruiz et al., 2011), but the system is still not 
fully understood. Neeley et al. reported that chloramphenicol, an inhibitor of translation, 
abolishes cadBA expression, thereby suggesting that de novo synthesis of CadC or another yet 
unkown protein is required for induction of the Cad system (Neeley & Olson, 1996). To find 
out, if additional proteins are important for cadBA expression, a random mutagenesis 
approach was employed by Tobias Kraxenberger in his diploma thesis (Kraxenberger, 2006). 
This experiment revealed YjeK as a new protein involved in the Cad system.  
3.1.1. CadA activity in yjeK, yjeA and efp mutants in E. coli 
cadBA expression shows maximal induction under conditions of low external pH, low oxygen 
concentration and in the presence of exogenous lysine (Gale, 1946; Sabo et al., 1974). The 
enzyme of the Cad system, CadA, decarboxylases lysine to CO2 and cadaverine. The increase 
in the external pH as a result of CadA activity can be monitored by adding bromocresol 
purple to the growth medium, which turns to blue at pH values higher than 6.8. At low pH, 
bromocresol purple gives a yellow colour. This test was previously used by Tobias 
Kraxenberger to screen a mini-Tn10 KanR library for new players of the Cad system in E. coli 
(Kraxenberger, 2006). Eight of the tested mutants revealed a lysine decarboxylase (CadA) 
negative phenotype, but only one mutant (P1#36) had intact cad genes. The insertion of the 
mini-Tn10 KanR cassette was mapped downstream of nucleotide 642 in yjeK (Kraxenberger, 
2006). 
To confirm that the negative CadA phenotype is due to disruption of yjeK and not to any other 
effect caused by multiple transposon insertions or secondary effects, a yjeK in frame deletion 
mutant was constructed (Fig. 5A). To avoid polar effects on the neighbouring gene efp, only 
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nucleotides 643 to 1029 of yjeK were replaced in MG1655 by a neomycin resistance cassette 
resulting in strain TK1 (MG1655 yjeK643-1029::npt) (Kraxenberger, 2006). 
 
 
 
Figure 5: Genomic characterization and CadA activity in the yjeK mutant TK1. 
A) Depiction of the yjeK mutation in strain TK1 and genomic localizations of yjeK, efp and 
yjeA. Corresponding to the transposon mutant P1#36, nucleotides 643 to 1029 of yjeK were replaced 
by a neomycin resistance cassette. The genomic positions of yjeK, efp and yjeA are depicted below the 
genes. Gene lengths are marked above the genes (in nucleotides). 
B) CadA activity in the wildtype (E. coli MG1655), TK1 (∆yjeK) and TK1 complemented 
with plasmid pBAD24-yjeK. Cells were cultivated microaerobically in KE minimal medium under 
inducing (pH 5.8 + 10 mM lysine) and non-inducing (pH 5.8, pH 7.6 + 10 mM lysine, pH 7.6) 
conditions.  
 
 
The lysine decarboxylase phenotypes of TK1 and its parental strain MG1655 were determined 
via measurements of the specific CadA activity. Cells were grown microaerobically in KE 
minimal medium under inducing (pH 5.8 with 10 mM lysine) and non-inducing (pH 5.8, 
pH 7.6 with or without 10 mM lysine) conditions. In concert with the transposon mutant, TK1 
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showed a CadA negative phenotype (Fig. 5B). Complementation of TK1 with plasmid 
pBAD24-yjeK could restore the wildtype phenotype, which revealed CadA activity only 
under inducing conditions. 
It has been recently shown that the elongation factor EF-P (encoded by the efp gene) is post-
translationally modified by the lysine 2,3-aminomutase YjeK and the truncated lysyl-tRNA 
synthetase YjeA (Bailly & de Crecy-Lagard, 2010). To test if yjeA also affects expression of 
the Cad system, a yjeA deletion mutant was constructed. Similar to TK1, no CadA activity 
could be detected in strain SU2 (MG1655 yjeA::npt), when cells were grown in KE medium 
under inducing conditions. Providing yjeA in trans in strain SU2 by introducing plasmid 
pBAD24-yjeA led to complementation of the wildtype CadA activity (Fig. 6A).  
As EF-P is important for cell viability in E. coli (Aoki et al., 1997b), the construction of strain 
MG1655 ∆efp using the pRED/ET method failed. By contrast, efp could be deleted in the 
alternative E. coli K-12 strain BW25113 (Baba et al., 2006). To investigate, if a disruption of 
the efp gene leads to greatly reduced CadA activity comparable to that in the yjeA and yjeK 
mutants, strains JW4116 and JW4107 harboring a start to stop deletion in yjeA and efp, 
respectively, and BW25113 (wildtype) were purchased from the Keio collection (Baba et al., 
2006). Additionally, strain SU1 (BW25113 yjeK643-1029::cat) was constructed by replacing the 
3´ region of yjeK by a chloramphenicol resistance cassette in a similar way as for TK1. Strains 
were grown microaerobically in KE minimal medium under inducing conditions and were 
further tested on CadA activity. In line with the results obtained for the MG1655 strains, 
wildtype BW25113 was able to decarboxylate lysine under inducing conditions, whereas the 
mutant derivatives lacking either yjeA or yjeK exhibited no significant CadA activity 
(Fig. 6B). Moreover, a deletion of efp led to abolished CadA activity as well. All deletions 
were complemented by providing the corresponding gene copy in trans. As previous results 
have shown that modification of lysine 34 is crucial for EF-P activity (Navarre et al., 2010; 
Zou et al., 2011), plasmids pQE70-Eco_efp K34A and pQE70-Eco_efp K34R encoding 
inactive EF-P variants with a substitution of lysine 34 either by alanine or arginine were 
introduced into the efp mutant. None of these plasmids could rescue the CadA-negative 
phenotype of the efp mutant (Fig. 6B), thus confirming the results obtained by Navarre et al. 
and Zou et al. (Navarre et al., 2010; Zou et al., 2011). 
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Figure 6: CadA activity in yjeA, yjeK and efp mutants. 
A) CadA activity in the yjeA mutant. Cells of MG1655 (wildtype), SU2 (MG1655 ∆yjeA) and 
the mutant complemented with pBAD24-yjeA were grown microaerobically in KE minimal medium 
under inducing conditions (pH 5.8 with 10 mM lysine). 
B) CadA activity in strains with BW25113 (Keio collection) background. Cells of BW25113 
(wildtype), JW4116 (∆yjeA), SU1 (yjeK643-1029::cat), JW4107 (∆efp) and the mutants provided with the 
corresponding gene in trans were grown microaerobically in KE minimal medium under inducing 
conditions (pH 5.8 with 10 mM lysine). Plasmids pQE-efp K34A and K34R possess a point mutation 
at the modification site of EF-P. 
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3.1.2. Complementation of a yjeK mutant with KamA of Clostridium subterminale 
Two different mechanisms have been previously proposed how EF-P is modified (Bailly & de 
Crecy-Lagard, 2010): Firstly, YjeA activates and transports α-lysine to K34 of EF-P which - 
after binding to EF-P - is then converted to β-lysine by YjeK. Secondly, YjeK transforms α-
lysine to β-lysine, and subsequently YjeA transports the newly built β-lysine to EF-P. 
Yanagisawa et al. supported the first possibility due to the crystal structure of YjeA 
(Yanagisawa et al., 2010), whereas Gilreath et al. and Roy et al. demonstrated that β-lysine 
and not α-lysine is the substrate for YjeA in vitro (Gilreath et al., 2011; Roy et al., 2011). 
Assuming that the second mechanism is true, YjeK would act as independent supplier of β-
lysine. Therefore, a non-related 2,3-aminomutase like KamA of Clostridium subterminale 
should rescue the CadA-negative phenotype of the yjeK mutant. KamA shows 33% identity to 
YjeK and converts (S)-α-lysine to (S)-β-lysine, whereas YjeK catalyzes the isomerization of 
(S)-α-lysine to (R)-β-lysine (Behshad et al., 2006). To test if KamA can replace YjeK, the 
yjeK gene in strain BL21(DE3) was deleted resulting in strain SU3 (BL21(DE3) yjeK643-
1029::cat). The mutant was co-transformed with plasmids pAF/kamA and pAlter-Ex2/argU. As 
the clostridial codon AGA for arginine is only rarely used in E. coli, the second plasmid was 
needed for expression of the E. coli argU gene encoding for the required arginine t-RNA 
(Ruzicka et al., 2000). 
 
Figure 7: Complementation of the yjeK mutant (SU3) with KamA of C. subterminale. Cells were 
grown microaerobically in KE minimal medium under inducing conditions (pH 5.8 with 10 mM 
lysine).  
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Interestingly, KamA provided in trans to SU3 could restore CadA production, which was 
abolished in the mutant (Fig. 7). When yjeK mutant cells harboring pAF/kamA were induced 
by IPTG, CadA activity was even higher as in the BL21(DE3) wildtype (data not shown). 
This finding confirms that YjeA transports β-lysine to EF-P for modification, and that YjeK is 
an independent β-lysine supplier. Additionally, this result indicates that the substrate for YjeA 
can be (R)- as well as (S)-β-lysine.  
3.2. Interaction studies 
E. coli YjeK has a size of 38.75 kDa and shows only 0.1% enzymatic activity in comparison 
to KamA of Clostridium subterminale (Behshad et al., 2006). The primary structural 
difference between these two enzymes is the absence of the C-terminal domain responsible 
for multimerization in YjeK (Bailly & de Crecy-Lagard, 2010). To find out if YjeK is still 
able to form dimers, in vivo and in vitro tests were performed. Moreover, the bacterial two 
hybrid system (BACTH) was employed to investigate the ability of YjeK, YjeA and EF-P to 
specifically interact with each other or with components of the Cad system.  
3.2.1. Dimerization of YjeK in vitro 
To characterize YjeK in more detail, the His-tagged protein was purified using Ni2+-NTA 
affinity chromatography. Purification and the preceding cultivation are described in 2.3.1 and 
2.5.1. Immediately after purification, the protein was loaded onto a SDS gel and 
simultaneously onto a native gel. As YjeK contains a [4Fe-4S] cluster (Behshad et al., 2006), 
protein eluates showed a yellow coloring after the purification, but the color vanished when 
the protein was frozen or left on air for several hours (data not shown).  
Western Blot analysis was performed using antibodies against His6-YjeK. Figure 8A depicts 
the blot with the denaturated gel, where YjeK could be detected at about 40 kDa. By contrast, 
the native gel clearly showed a band at approximately 80 kDa indicating that YjeK lacking the 
COOH-terminus of KamA still forms dimers (Fig. 8B).  
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Figure 8: Western Blots using antibodies against purified His6-YjeK.  
A) SDS-PAGE. M: marker (PageRuler Prestained Protein Marker, Fermentas). W: wash 
fraction. LP: low speed pellet. LP/SN: supernatant of the low speed pellet. Cy: cytosol. EL2-EL4: 
eluates 2 (5 µg), eluate 3 (25 µg), eluate 4 (46 µg). The protein amount of eluate 1 (EL1) has not been 
determined. 
B) Native gel. M: marker (PageRuler Prestained Protein Marker, Fermentas). Amounts of 
eluates 2-4 (EL2-4) are equal to the amounts in Fig. 8A. The protein amount of eluate 1 (EL1) has not 
been determined.  
 
 
3.2.2. Dimerization of YjeK, YjeA and EF-P with Cad components 
Further in vivo interaction studies were performed using the bacterial two hybrid system. To 
this end, yjeA, yjeK and efp or genes belonging to the Cad system were N- or C-terminally 
fused to the T25 fragment in vector pKNT-25 or pKT-25, respectively, and additionally C-
terminally to the T18 fragment in vector pUT-18C. Only when T18 and T25 fragments come 
in close proximity due to interaction of the proteins of interest, β-galactosidase activity can be 
measured. The practical work was done by Christina Krönauer during her bachelor thesis 
(Krönauer, 2011), the experimental design was done in cooperation with Dr. Jürgen Lassak.  
As shown before in vitro, YjeK interacted itself in vivo, too [2,500 Miller Units (MU) and 
3,400 MU] (Table 5). Additionally, strong self-interaction was also observed for CadC 
(3,869 MU), H-NS (3,700 MU and 4,600 MU) and YjeA (1,100 MU and 2,600 MU). This 
was expected as previous studies reported dimerization/multimerization of these proteins 
(Eichinger et al., 2011; Smyth et al., 2000; Ueguchi et al., 1996; Yanagisawa et al., 2010).  
Moreover, the lysine permease LysP also showed dimerization. This ability for self-
interaction (900 MU) is in good agreement with earlier findings for the Na+/H+ antiporter 
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NhaA (Hilger et al., 2007; Williams, 2000; Williams et al., 1999). Furthermore, it was 
previously suggested that CadC interacts with LysP (Tetsch et al., 2008). Indeed, high β-
galactosidase activities were observed using CadC and LysP containing plasmids (3,000 MU) 
indicating stable hetero-dimerization of both proteins in vivo. 
 
 
Table 5: Bacterial two hybrid studies. cadC, lysP, hns, yjeA, yjeK and efp were cloned into the vectors 
of the bacterial two hybrid system by N-terminal (pKNT-25) or C-terminal (pKT-25, pUT-18C) fusion 
to the T25 or T18 fragment of the adenylate cyclase of Bordetella pertussis. β-Galactosidase activity 
resembles the strength of interaction: high (++, over 800 MU), low (+, over 200 MU), no (-, under 
200 MU) interaction.  
 
 
Additionally, YjeK and EF-P or YjeK and YjeA, respectively, showed no interactions at all. 
By contrast, YjeA interacted with EF-P, when strains harbored plasmids pK(N)T25-yjeA and 
pUT18C-efp (300 MU). In line with this, co-crystals of YjeA in complex with EF-P suggested 
stereospecific interaction of these proteins in vivo (Yanagisawa et al., 2010). These results 
support once again that YjeK first converts α-lysine to β-lysine, which is then activated and 
transported to EF-P by YjeA (Bailly & de Crecy-Lagard, 2010).  
It would be conceivable that also CadC is post-translationally modified, as exchanges of 
lysines against alanines or arginines revealed lysine residue 95 as possible candidate for 
modification in CadC (Fig. A1). However, neither CadC and H-NS nor LysP showed any 
specific interaction with YjeA or YjeK (Table 5) making a post-translational modification of 
other proteins by YjeA and YjeK rather unlikely.  
pUT-18C 
PK
(N
)T
-
25
 
 CadC LysP H-NS YjeA YjeK EF-P 
CadC-N ++ ++ - - - - 
LysP-N ++ ++ - - - - 
LysP-C ++ ++ - - - - 
H-NS-N - - ++ - - - 
H-NS-C - - ++ - - - 
YjeA-N - - - ++ - + 
YjeA-C - - - ++ - - 
YjeK-N - - - - ++ - 
YjeK-C - - - - ++ - 
EF-P-N - - - - - - 
EF-P-C - - - - - + 
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3.3. Determining the target of EF-P in the Cad system 
3.3.1. cadBA expression in yjeA, yjeK and efp mutants 
According to the results described above, a deletion of efp or any of its modifiers leads to a 
negative CadA activity. No direct target for EF-P has ever been identified before, therefore it 
was suggested that EF-P as well as eIF5A are not essential for global protein synthesis, but 
are required for only a limited number of mRNAs (Kang & Hershey, 1994; Yanagisawa et al., 
2010; Zou et al., 2011). To this end, it was further investigated, if EF-P influences the 
translation of one or more Cad proteins or if another yet unknown protein is involved. 
3.3.1.1. Expression of lacZ under control of the cadBA promoter 
The phenotypical analysis of the yjeK, yjeA and efp mutants described above focus on CadA 
activity, but does not answer the question which protein is directly influenced by active EF-P. 
Hence, the observed effect could result from reduced CadA translation, activity or from 
reduced cadA transcription. To address this question, the cadBA operon was replaced by a 
promoterless lacZ in strain MG1655 ∆lacZ. The mutation resulted in strain MG-CR (MG1655 
∆lacZ ∆cadBA cadBA::lacZ) containing a PcadBA-lacZ fusion. Additionally, gene yjeK or yjeA 
was deleted by an exchange with a kanamycin cassette resulting in strain MG-CR-yjeK or 
MG-CR-yjeA. In the case of reduced CadA translation or activity in the mutants, one would 
expect to observe lacZ expression, but in the case of reduced cadBA transcription, the 
expression of lacZ should also be lowered. 
All strains were incubated microaerobically in KE medium under inducing (pH 5.8 with 
10 mM lysine) or non-inducing (pH 5.8) conditions and cells were harvested at their 
exponential growth phase (OD600 = 0.3 - 0.8). Under inducing conditions, lacZ was only 
expressed in the parental strain MG-CR, but not in the yjeK and yjeA mutants (Fig. 9). The 
same result was achieved with strains MG-CL-1 (cadA::lacZ), MG-CL-1-yjeA (cadA::lacZ 
∆yjeA) and MG-CL-1-yjeK (cadA::lacZ ∆yjeK) (Fig. A2-A). By contrast, the two mutants 
harboring plasmids pBAD24-yjeA or pBAD24-yjeK encoding the missing genes in trans 
showed β-galactosidase activity values similar to their parental strains (Fig. 9). This result 
clearly shows that modified EF-P is crucial for cadBA expression. 
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Figure 9: Expression of PcadBA-lacZ in yjeA and yjeK mutants. Strains MG-CR (MG1655 ∆lacZ 
∆cadBA cadBA::lacZ), MG-CR-yjeA (∆yjeA), MG-CR-yjeK (∆yjeK) and the complemented mutants 
were grown microaerobically in KE medium under inducing (pH 5.8 with 10 mM lysine) and non-
inducing (pH 5.8) conditions. 
 
 
3.3.1.2. cadB and cadA transcription in yjeK, yjeA and efp mutants 
To investigate, if the reduced β-galactosidase activity in the yjeK and yjeA mutants attributes 
to an impaired LacZ translation or to reduced cadBA expression, transcript levels of the 
cadBA operon were examined in wildtype MG1655 and in TK1 (∆yjeK643-1029). For this 
experiment, cells were grown in KE medium aerobically under non-inducing conditions 
(pH 7.6) at 37 °C to an OD600 of 1. Subsequently, cells were shifted to inducing conditions 
(KE minimal medium, pH 5.8 with 10 mM lysine) in a 5 liter fermenter. Samples for RNA 
isolation were taken 0 / 15 / 20 / 25 min after the shift. The isolated RNA was used to perform 
Northerns Blot with probes against cadA and cadB. For control, also a probe against cadC 
was employed.  
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Figure 10: Northern Blot analysis with probes against cadA, cadB and cadC. Cells of MG1655 
(wildtype) and TK1 (∆yjeK643-1029) were first grown under non-inducing conditions (pH 7.6) and then 
shifted to inducing conditions (pH 5.8 with 10 mM lysine) in KE minimal medium. Time is given in 
minutes after the shift. Radioactive probes were directed against cadA (A), cadB (B) and cadC (C). 
For cadC as control, only time point 20 (min) is shown. The figure depicts the cadBA operon. 
 
 
As expected, the two cad genes were transcribed in the wildtype strain and revealed an 
expression peak at 25 min (Fritz et al., 2009). It has been previously published that mRNAs of 
operons are preferably degraded in 5´ to 3´ direction, and that the half-life of cadB is very 
short in comparison to other mRNAs (Selinger et al., 2003). This finding is well reflected by 
the higher amount of cadA than cadB in the Northern Blot (Fig. 10A, B). Accordingly, β-
galactosidase activities in cells of strain MG-CL-1 (cadA::lacZ) were approximately two 
times higher than in cells of strain MG-CR (cadBA::lacZ) cells, when they were cultivated 
under inducing conditions (Fig. 9 and Fig. A2-A). An additional promoter upstream of cadA 
was excluded (Fig. A2-B). 
Interestingly, the amount of both cadA and cadB mRNA was highly reduced in TK1 
(Fig. 10A, B). Transcription of cadC was low, but no difference could be detected between 
the wildtype and the mutant (Fig. 10C).  
Additionally, cadBA expression of strains BW25113, JW4094 (∆cadC), JW4116 (∆yjeA), 
SU1 (∆yjeK643-1029) and JW4107 (∆efp) were analyzed from induced cells by quantitative real 
time PCR (qRT-PCR). As in the Northern Blot, a strong induction could be measured for 
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cadA mRNA (10,000 fold) as well as cadB mRNA (5,000 fold) in the wildtype (Fig. 11). By 
contrast, expression of the cad genes was highly reduced in the ∆yjeA/yjeK/efp mutants 
indicating that active EF-P is crucial for cadBA expression. 
 
 
 
Figure 11: cadA and cadB transcript levels in the wildtype and yjeA, yjeK, efp mutants. Transcript 
levels were determined by qRT-PCR in BW25113 (wildtype), JW4094 (∆cadC), JW4116 (∆yjeA), 
SU1 (∆yjeK643-1029) and JW4107 (∆efp). JW4094 served as negative control. Cells were grown and 
harvested under inducing conditions (KE minimal medium, pH 5.8 + 10 mM lysine).  
 
 
3.3.2. CadC as possible target of EF-P 
The phenotypic analysis of the yjeA, yjeK and efp deletion mutants aimed on cadBA 
expression, but left the question open which protein of the Cad-regulatory system is EF-P 
dependent. As CadC acts as positive regulator of the cad operon, further experiments focused 
on cadC translation. 
3.3.2.1. CadC protein levels in the wildtype and yjeA, yjeK, efp mutants 
In a next experiment, the amount of CadC in E. coli wildtype cells was determined and 
compared to mutants lacking yjeA, partially yjeK or efp. As CadC is not an abundant protein 
in the cell, its detection in Western Blot analysis can be difficult (Tetsch et al., 2008). 
Therefore, the cadC encoding plasmid p5C (pBBR1-MCS5-cadC) was used to increase the 
signal intensitiy of CadC. The protein was left under control of its native promoter. Thus, a  
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potential increase in signal intensity should be caused only by an increase of the plasmid copy 
number, which was reported to be 30-40 copies per cell (Antoine & Locht, 1992), but not by 
different transcription levels. To this end, E. coli BW25113, JW116 (∆yjeA), SU1 (yjeK643-
1029) and JW4107 (∆efp) harboring p5C, respectively, and JW4095 (∆cadC) as a negative 
control were grown aerobically in KE medium to exponential phase (OD600 = 0.4-0.6) under 
non-inducing conditions (pH 7.6). Subsequently, cells were shifted to inducing conditions 
(pH 5.8, 10 mM lysine, without shaking) for 1 h. After preparation of the membrane vesicles, 
the total protein amount was determined, and 150 µg per sample were loaded onto a SDS gel. 
CadC accumulation was measured by Western Blot analysis using CadC specific antibodies, 
and the CadC signal intensity was analyzed using the program ImageJ. Strikingly, the 
Western Blot data clearly showed that the CadC amount is significantly reduced to 26%, 25% 
and 17% of wildtype CadC in cells harboring a deletion of yjeA, yjeK and efp, respectively 
(Fig. 12).  
 
 
Figure 12: CadC levels in the wildtype and yjeA, yjeK, efp mutants. Cells were grown and 
harvested under inducing conditions (KE minimal medium, pH 5.8 + 10 mM lysine). The Western 
Blot was performed using antibodies against CadC and RpoS, respectively. The RpoS levels served as 
control. 
 
 
As a control, the protein levels of the alternative sigma factor RpoS were determined. If the 
cadC mRNA is a specific target of EF-P, RpoS protein levels should not differ in the wildtype 
and the mutants. Indeed, the amount of RpoS was very similar in logarithmically grown cells 
of the wildtype and the mutants (Fig. 12).  
 
 
3. Results 
 
53 
 
3.3.2.2. cadC transcription in the wildtype and yjeA, yjeK, efp mutants 
To exclude an indirect effect on cadC transcript levels in ∆yjeK643-1029, ∆yjeA and ∆efp 
mutants caused by transcriptional regulation, the cadC mRNA levels were compared by qRT-
PCR. Cells of wildtype BW25113, JW116 (∆yjeA), SU1 (∆yjeK643-1029), JW4107 (∆efp) and 
JW4095 (∆cadC) were grown aerobically in KE medium, pH 7.6, to an OD600  of 0.4 – 0.6. 
Subsequently, cells were shifted to inducing conditions (KE medium, pH 5.8 with 10 mM 
lysine) and were incubated microaerobically for 25 min. Samples were then taken to isolate 
RNA for the qRT-PCR analysis.  
No difference in the cadC transcription levels could be observed between the tested strains 
indicating that the transcription of cadC is unaffected by EF-P (Fig. 13A).  
 
 
 
Figure 13: cadC transcription in the wildtype and yjeA/yjeK/efp mutants. Transcript levels were 
determined either by qRT-PCR (A) or by β-galactosidase activity using a transcriptional PcadC::lacZ 
fusion in plasmid p3LC-TF (B). 
 
 
According to these data, a transcriptional fusion of the cadC promoter to lacZ in plasmid 
pBBR-MCS3 was constructed. Strains BW113, JW4115, SU1 and JW4107 harboring the 
resulting plasmid p3LC-TF revealed no remarkable variations in β-galactosidase activity in 
the wildtype compared to the mutants, either under non-inducing conditions (LB medium, 
pH 7.6) nor under inducing conditions (LB medium, pH 5.8) (Fig. 13B). 
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3.4. The role of EF-P in translation 
It was previously shown that EF-P stimulates peptide bond formation between small amino 
acids like glycine, but not between bulky or charged amino acids like phenylalanine and the 
ribosome bound fMet-tRNA in vitro (Aoki et al., 1997a; Ganoza & Aoki, 2000; Glick et al., 
1979). Thus, it was suggested that EF-P could be a helper protein of the ribosome driven first 
peptide bond synthesis (Glick et al., 1979). By contrast, other investigations to eIF5A pointed 
more into the direction that EF-P and its eukaryotic orthologue act as translation elongators 
(Gregio et al., 2009; Saini et al., 2009). CadC as first direct target of EF-P opened now the 
possibility to shed light on this controverse discussion.  
3.4.1. EF-P as possible helper protein for first peptide bond formation 
To focus on the question, if EF-P helps the ribosome to form the first peptide bond, wildtype 
cadC and its native promoter were cloned into plasmid pBBR-MCS5, thus giving plasmid 
p5C. Additionally, the second amino acid of CadC (glutamine) was exchanged by a glycine or 
phenylalanine in plasmids p5C-Q02G and p5C-Q02F. Strains MG-CL-123 (cadC::npt PcadBA-
lacZ), MG-CL-12-yjeA (yjeA::npt PcadBA-lacZ) and MG-CL-12-yjeK (yjeK643-1029::npt PcadBA-
lacZ) harboring one of the plasmids, respectively, were grown microaerobically at 37 °C in 
KE medium under inducing conditions (pH 5.8 with 10 mM lysine). Cells were harvested at 
their exponential growth phase (OD600 of 0.4 – 0.6), and subsequently β-galactosidase activity 
was measured. In the case of EF-P being important for first peptide bond synthesis, EF-P 
would only be needed when the second amino acid is small like glycine, but not when it is 
bulky like phenylalanine. Thus, one would expect wildtype like cadBA expression in the yjeA 
and yjeK mutants, when they harbor plasmid p5C-Q02F, but no expression with plasmid p5C-
Q02G. Indeed, yjeA and yjeK mutants showed an approximately three times higher β-
galactosidase activity with plasmid p5C-Q02F than with plasmid p5C encoding wildtype 
cadC (Fig. 14A). However, β-galactosidase activities obtained with plasmid p5C-Q02F only 
reached 14% (∆yjeA) and 11% (∆yjeK643-1029) of the MG-CL-123 (∆cadC) values. 
Furthermore, strains harboring plasmid p5C-Q02G revealed not only very low β-galactosidase 
activities in the yjeA and yjeK mutants, but also in the MG-CL-123 strain. 
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Figure 14: Influence of the second amino acid of CadC on cadBA expression. 
A) Determining PcadBA-lacZ expression by β-galactosidase activity in ∆cadC, ∆yjeA and 
∆yjeK643-1029 mutants triggered by different CadC variants with glutamate, phenylalanine or glycine at 
amino acid position two. Mutants derived from strain MG-CR were cultivated in KE minimal medium 
under inducing conditions (pH 5.8, 10 mM lysine). 
B) CadA activity in JW4095 (∆cadC) and JW4107 (∆efp) harboring the same CadC variants 
as described in A.  
 
 
Accordingly, plasmids p5C, p5C-Q02F and p5C-Q02G expressed in JW4107 (∆efp) and 
JW4095 (∆cadC) led to similar results, when the specific CadA activity was measured. The 
∆efp mutant containing plasmid p5C-Q02F could not achieve wildtype like CadA activity, 
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whereas plasmid p5C-Q02G led to minimal β-galactosidase activity in both tested strains 
(Fig. 14B).  
In a parallel experiment it was investigated, if EF-P could trigger first peptide bond formation 
in LacZ synthesis. Therefore, lacZ was set under control of the cadC promoter in plasmid 
pBBR-MCS3-NP-CadC (p3LC) to have similar transcriptional regulation as cadC. 
Additionally, the second amino acid of LacZ, which is normally represented by a histidine in 
plasmid p3LC, was exchanged by a glycine, proline, leucine, alanine, methionine, 
phenylalanine or glutamine. The resulting plasmids p3LC-TL02-Gly, -Pro, -Leu, -Ala, -Met, -
His, -Phe and -Gln were transformed into strains BW25113 and JW4107 (∆efp), respectively. 
Cells were grown microaerobically in LB medium at 37 °C, until they were harvested at their 
exponential growth phase. Subsequently, β-galactosidase activity was measured. In contrast to 
the in vitro experiments of Glick et al. (Glick et al., 1979), β-galactosidase activities in 
wildtype and ∆efp cells varied with none of the plasmids (Fig. 15A). Therefore, the results 
obtained with cadC and lacZ exclude a role of EF-P in first peptide bond formation in vivo. 
 
 
Figure 15: Influence of the second amino acid on the protein amount. 
A) Comparison of the expression of various PcadC-lacZ variants in the wildtype (BW25113) 
and JW4107 (∆efp). The second amino acid of LacZ was exchanged by different amino acids. Strains 
were cultivated in LB medium. 
B) Comparison of the CadC amounts of different CadC variants in JW4095 (∆cadC). Cells 
were cultivated in LB medium. The CadC signal intensity was analyzed by using the program ImageJ. 
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As demonstrated before, expression levels of proteins highly depend on the nature of the 
second amino acid. To confirm that a glycine at amino acid position two reduces the 
translation rate in E. coli proteins, whereas phenylalanine enhances it, wildtype BW25113 
strain harboring plasmid pBBR-MCS5 (empty plasmid), p5C (wildtype CadC), p5C-Q02F or 
p5C-Q02G and strain JW4095 (∆cadC) were cultivated aerobically in 500 ml LB medium. 
When cells have reached an OD600 of 1, membrane vesicles were prepared. 150 µg of the total 
protein amount per lane was loaded onto a SDS gel, and a Western Blot was performed using 
CadC specific antibodies. Indeed, the CadC amount in the strain harboring p5C-Q02G 
reached only 60% in comparison to the strain harboring p5C, whereas plasmid p5C-Q02F 
lead to 1.7 times more CadC as in the wildtype strain (Fig. 15B). 
3.4.2. EF-P as specific translation elongation factor of CadC 
Earlier reports suggested that eIF5A plays a role in translation elongation rather than 
translation initiation (Gregio et al., 2009; Saini et al., 2009; Zanelli et al., 2009). To 
investigate if EF-P acts as translation elongation factor of CadC, the promoter and 2, 30, 66, 
100, 131 and 158 codons of cadC were fused to lacZ in vector pBBR-MCS3 resulting in 
plasmids p3LC-TL02, -TL30, -TL66, TL100, -TL131 and -TL158, respectively. Thus, various 
lengths of the DNA-binding domain and the linker region of CadC were comprised in the 
fusion proteins (Fig. 16A). The plasmids were transformed into wildtype cells and ∆efp cells. 
Cells were grown in LB medium at 37 °C, harvested at exponential growth phase and the β-
galactosidase activities of the wildtype (efp+) and the mutant (efp-) were compared.  
No difference in β-galactosidase activity could be observed between wildtype and mutant 
cells harboring plasmids p3LC-TL02, -TL30, -TL66 and -TL100 indicated by an efp-/efp+ 
ratio of ~1.0 (Fig. 16B). By contrast, the β-galactosidase activities of TL131 and TL158 were 
significantly decreased in the efp mutant strain, as exemplified by a decreased ratio of 0.3 and 
0.15, respectively. This observation provided the first hint that EF-P dependent translation of 
CadC relies on a motif located between amino acids 108 and 158. 
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Figure 16: EF-P as specific translation elongation factor of CadC. 
A) Schematic depicting the domain structure of full-length CadC in comparison with CadC’-
LacZ hybrids.  
B) The β-galactosidase activities of CadC’-LacZ (TL02-TL158) hybrids from (A) were 
determined in JW4107 (efp-) and BW25113 (efp+) as ratio (efp-/efp+). Strains were cultivated in LB 
medium. 
C) Effect of EF-P on translation of CadA, CadB and PoxB. The β-galactosidase activities of a 
translational fusion of full length cadA, cadB or poxB, respectively, and lacZ were measured in efp- 
and efp+ strains as ratio (efp-/efp+). Strains were cultivated in LB medium. 
 
 
To address the question if not only CadC, but also CadA und CadB are targets of EF-P, 
translational lacZ fusions of full-length cadA and cadB were designed. Additionally, the 
pyruvate oxidase PoxB was tested. It has previously been shown that a mutation of poxA 
(synonymous with yjeA) reduces the pyruvate oxidase activity (Kaniga et al., 1998), which 
could be caused by diminished translation of poxB. The cadA-lacZ, cadB-lacZ and poxB-lacZ 
fusions were set under control of the cadC promoter to maintain equal transcriptional 
regulation. The plasmids were transformed into wildtype and ∆efp cells and after growth in 
LB medium, the β-galactosidase activities of efp+ and efp- cells were compared. No 
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remarkable difference in β-galactosidase activities could be observed in any of the LacZ-
hybrid proteins (Fig.16C). This result not only confirms that CadA, CadB and PoxB are no 
targets for EF-P, but also corroborates strongly that EF-P is not a general translation factor, 
but is rather needed for the translation elongation of a small subset of proteins as suggested by 
Navarre et al. (Navarre et al., 2010). 
3.5. Searching for the EF-P signal sequence  
3.5.1. The CadC proline cluster and its role for EF-P dependency 
CadC belongs to the family of ToxR-like transcriptional activators (Watson et al., 1992). 
These proteins are characterized by a conserved modular composition consisting of a N-
terminal cytoplasmic winged helix-turn-helix DNA-binding motif followed by a single 
transmembrane domain and a C-terminal periplasmic sensing domain (Egan et al., 2002, Hase 
& Mekalanos, 1998; Merrell & Camilli, 2000; Miller et al., 1987) (Fig. 17A). A cytoplasmic 
putative unstructured region between aa 104 and aa 158 interconnects the input and output 
domains. As shown before, impaired translation elongation of CadC in efp mutant strains is 
restricted to this part (Fig. 16B). This raises the question for a specific recognition sequence. 
Interestingly, a cluster of four prolines (Pro120-Pro121-Pro122-Ile123-Pro124) was found in 
this region (Fig. 17B). Three of the prolines are consecutive, the last one is separated by an 
isoleucine. When the unstructured region of E. coli and four additional species of the 
Enterobacteriaceae were blasted, the proline cluster could be observed in all of these species 
(Fig. 17B).  
Of the 20 canonical amino acids, proline is very special in that it has a secondary α-amino 
group. Accordingly, proline is a particularly poor acceptor during peptide-bond formation 
(Muto & Ito, 2008; Pavlov et al., 2009). Since EF-P has been shown to stimulate peptide-
bond formation in vitro (Glick et al., 1979; Glick & Ganoza, 1975), it was hypothesized that 
EF-P might support translation by overcoming the detrimental effect of the consecutive 
prolines and releasing ribosomal stalling. To test this hypothesis, two in vivo approaches were 
used: 
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Figure 17: The proline cluster in the unstructured loop region of CadC.  
A) CadC domains. CadC consists of a N-terminal helix-turn-helix (HTH) motif for DNA 
binding and a periplasmic domain for pH sensing. Domain models were based on the crystal structures 
of the periplasmic domain of E. coli CadC (PDB code: 3LY7) (Eichinger et al., 2011) and of the 
DNA-binding domain of E. coli PhoB (PDB code: 1QQI) (Blanco et al., 2002), which shows high 
similarity to CadC. TM (grey): transmembrane domain. Dark red: unstructured loop region. 
B) Amino acid alignment of the unstructured region of CadC in some selected enterobacteria 
(E. coli, Escherichia fergusonii, Klebsiella pneumonia, Edwardsiella tarda and Salmonella enterica). 
Sequences were compared using Clustal Omega (Sievers et al., 2011). Proline clusters are marked by 
black boxes. 
 
 
Firstly, each single proline of full length CadC was exchanged in plasmid p5C (pBBR-MCS5 
PcadC-cadC) by alanine resulting in plasmids p5C-P120A, p5C-P121A, p5C-P122A and p5C-
124A. Additionally, the complete proline cluster was substituted in plasmid p5C-P/A. Strain 
JW4107 (∆efp) harboring plasmids p5C-P120A, p5C-P121A, p5C-P122A and p5C-124A, 
respectively, and the BW25113 wildtype were cultivated in LB medium and harvested at an 
OD600 of 1. After purification of the membrane vesicles, 150 µg were loaded onto a SDS gel 
and the CadC amount was compared. Strikingly, CadC with P/A substitutions expressed in 
the ∆efp mutant reached nearly fully (p5C-P/A) or partially (p5C-P120A, p5C-P121A, p5C-
P122A) wildtype like protein amounts (Fig. 18A) confirming that the three consecutive 
prolines are crucial for EF-P dependency. By contrast, mutants harboring plasmid p5C-P124A 
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remained EF-P dependent. This result indicates that three prolines in a row are sufficient for 
the EF-P dependent ribosomal stalling. 
Secondly, the CadC´-LacZ-translational fusion TL158 in plasmid p3LC-TL158 was employed 
to generate proline to alanine derivatives as well and to depict the translational rate as 
function of relative β-galactosidase activity. The β-galactosidase activities of the wildtype 
(efp+) and the mutant (efp-) were compared and indicated by an efp-/efp+ ratio. In accordance 
to Fig. 16B, the ∆efp mutant harboring plasmid p3LC -TL158 showed a highly decreased β-
galactosidase activity (0.13) (Fig. 18B). By contrast, constructs p3LC-TL158-P121A and 
p3LC -TL158-P/A resulted in an EF-P independent phenotype with a ratio of 0.75 and 0.85, 
respectively. Comparable to the Western Blot results, mutants harboring p3LC-TL158-P120A 
(0.3) or p3LC-TL158-P122A (0.4) were partially EF-P independent, the mutant harboring 
p3LC-TL158-P124A remained fully EF-P dependent (0.13). These results confirm again the 
importance of three consecutive prolines for EF-P dependent translation. Furthermore, this 
hypothesis is supported by the fact that an interruption of consecution in p3CL-TL158-P121A 
led to a stronger EF-P independent phenotype compared to p3LC-TL158-P120A and p3LC-
TL158-P122A (Fig. 18B). 
 
To examine if the disruption of the proline cluster results not only in higher CadC amounts, 
but also in increased CadA activities in the ∆efp mutant, strain JW4095 (∆cadC) and JW4107 
(∆efp) harboring plasmids p5C-P120A, p5C-P121A, p5C-P122A, p5C-124A and p5C-P/A 
were cultivated microaerobically in pH 5.8 buffered KE medium. Cells were harvested at their 
exponential growth phase and the β-galactosidase activities between efp+ and efp- cells were 
compared. Remarkably, plasmids p5C-P121A and p5C-P/A led to full complementation of the 
∆efp phenotype and even to higher CadA activities in wildtype cells containing plasmid p5C. 
∆efp cells harboring plasmids p5C-P120A and p5C-P122A achieved only 21% and 47% of 
the wildtype β-galactosidase activities, respectively (Fig. 18C). As expected, wildtype CadC 
(p5C) and the P124A exchange failed to show any remarkable CadA activity in the ∆efp 
mutant. 
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Figure 18: Disruption of the CadC proline cluster leads to EF-P independency. 
A) CadC protein levels in various mutants. The protein levels of full-length CadC were 
determined by quantitative Western blotting using CadC-specific antibodies. A cadC deletion mutant 
was used as negative control, and wildtype CadC in the efp+ strain was assigned to 100%. The CadC 
signal intensity was analyzed by using the program ImageJ. 
B) β-Galactosidase activities in wildtype BW25113 (efp+) and JW4107 (efp-) cells harboring 
translational CadC´-LacZ fusions (TL158) and the corresponding proline/alanine CadC substitutes. 
C) The CadA phenotype in in wildtype BW25113 (efp+) and JW4107 (efp-) cells harboring 
p5C (full-length cadC) and the corresponding proline/alanine CadC substitutes. 
 
 
3.5.2. The specificity of the consecutive prolines 
It could be shown above that E. coli CadC contains three consecutive proline residues, which 
are sufficient for ribosomal stalling and EF-P dependency. To determine if three prolines are 
generally effectual or if the number of prolines can vary, five cadC’-lacZ reporter fusions 
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were generated in plasmid p3LC encoding truncated CadC1-30 (TL30) followed by one to five 
consecutive prolines and the LacZ reporter. The resulting plasmids p3LC-TL30-5Pro, p3LC-
TL30-4Pro, p3LC-TL30-3Pro, p3LC-TL30-2Pro and p3LC-TL30-1Pro were expressed in 
wildtype BW25113 and JW4107 (∆efp), repectively. Cells were cultivated in LB medium, 
harvested at exponential growth phase and the β-galactosidase activities were measured 
(Fig. 19A). When one or two prolines were inserted (TL30-1xPro and TL30-2xPro), the β-
galactosidase activities were as high as in the control TL30-hybrid (no Pro) in efp+ and efp- 
cells. By contrast, β-galactosidase activities were highly reduced in the ∆efp mutant, when the 
cadC’-lacZ reporter fusions contained three or more consecutive prolines (TL30-3xPro, 
TL30-4xPro, TL30-5xPro). Moreover, the EF-P dependency seemed not to be enhanced with 
more than three prolines. Thus, three prolines in a row are sufficient for full EF-P dependent 
translation.  
To define the amino acid specificity of EF-P mediated translation, several reporter fusions 
were constructed. Hence, a five amino acid stretch of each of the 20 proteinogenic amino 
acids was inserted after 30 aa of CadC (TL30) followed by a fusion to LacZ. After the strains 
BW25113 and JW4107 (∆efp) harboring the plasmids were grown in LB medium and 
harvested at exponential growth phase, the β-galactosidase activities were measured. 
Strikingly, EF-P dependency was only visible in cells expressing the TL30-3xPro hybrid, but 
not in any of the other CadC´-LacZ reporters (Fig. 19B) indicating that proline is an exclusive 
amino acid for EF-P dependent translation.  
Next, the role of proline codon usage for ribosomal stalling was examined. To rule out mRNA 
specific effects, four cadC’-lacZ reporter fusions were generated in plasmid p3LC encoding 
truncated CadC1-30 (TL-30) followed by three consecutive prolines and the LacZ reporter. 
Repeats of the proline codons CCA, CCG or CCU were used to generate the constructs TL30-
CCA, -CCG and -CCT, respectively, as well as a construct with the codon mixture CCA-
CCA-CCT (TL30-Mix). β-Galactosidase activities were measured in strain BW25113 and 
JW4107 (∆efp) for each of the four hybrids and were compared with the control TL30 that 
lacks the proline cluster (Fig. 20A). Translation of all four proline constructs was found to be 
impaired in strain JW4107 indicating that the amino acid proline in the nascent chain, rather 
than the type of proline codon in the mRNA, causes the EF-P dependency. This is consistent 
with the fact that the proline cluster of CadC is encoded by different proline codons, having 
the sequence CCU-CCC-CCU-ATA-CCA.  
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Figure 19: Three prolines are sufficient for ribosomal stalling. 
A) The β-galactosidase activities of CadC1-30-LacZ (TL30) hybrids bearing up to 5 prolines 
(see scheme) were measured in BW25113 wildtype and in JW4107 (∆efp). 
B) The β-galactosidase activities of CadC1-30-LacZ (TL30) hybrids bearing five consecutive 
repeats of each of the 20 proteinogenic amino acids (see scheme) were measured in BW25113 
wildtype and in JW4107 (∆efp). 
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Figure 20: EF-P relieves stalling at polyproline-stretches. 
A) Effect of codon variations of three consecutive prolines on EF-P mediated translation. The 
β-galactosidase activities of cells expressing the truncated CadC’-LacZ translational fusion TL30 with 
three consecutive prolines (3xPro) composed of different proline codons or a codon mixture were 
determined in BW25113 wildtype and JW4107 (∆efp) cells.  
B) Effect of the context of three consecutive prolines on EF-P mediated translation. Three 
prolines were positioned at the C-terminal end of truncated CadC’ variants of various lengths fused to 
LacZ as depicted in Fig. A. The β-galactosidase activities of cells expressing these translational 
fusions with (3xPro) or without (no Pro) three consecutive prolines were determined in BW25113 
wildtype and JW4107 (∆efp) cells. 
 
 
In a parallel approach it was examined whether the context of the cluster of prolines is 
important for EF-P dependent stalling. Five cadC’-lacZ reporter fusions encoding truncated 
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CadC of varying lengths, namely 2, 30, 66, 100 and 108 amino acids, followed by three 
consecutive prolines (3xPro) and LacZ were generated (TL02-3xPro, TL30-3xPro, TL66-
3xPro, TL100-3xPro, TL108-3xPro). In addition, respective CadC´-LacZ constructs were 
designed lacking the 3xPro insertion. As expected, β-galactosidase activities of these control 
constructs were indistinguishable between strain BW25113 and JW4107 (∆efp) (Fig. 20B, no 
Pro). By contrast, translation was strongly impaired for all 3xPro constructs in the ∆efp cells 
(3xPro) indicating that the context of the three prolines is of negligible importance for EF-P 
dependent translation. However, the strength of EF-P dependency varied (see 3.9.1). 
3.5.3. Testing ribosomal stalling in vitro  
To investigate whether the ribosome stalls at the position of the proline cluster of CadC 
during translation in the absence of EF-P, an in vitro transcription-translation system 
reconstituted from purified components was employed (Shimizu et al., 2001). This work was 
done by Dr. Agata Starosta (Gene Center, Munich). Translation of wildtype CadC over a 
period of 5-30 min was monitored using incorporation of radiolabelled [35S]-methionine into 
synthesized polypeptides (Fig. 21A, lanes 1-4). Synthesis of full-length CadC (FL at 
~60 kDa) was observed after 10 min (lane 2) and increased with longer incubation (lanes 3-4). 
Interestingly, a prominent band of 35 kDa was observed at 5 min and persisted for 15 min 
(lanes 1-3), before becoming reduced or absent at 30 min (lane 4), consistent with a 
translation intermediate that eventually elongates to form the FL CadC product. Furthermore, 
this band was absent when the same reaction was performed in the presence of modified EF-P 
(Fig. 21A, lanes 5-8). The size of the 35 kDa product matches that of a CadC nascent 
polypeptide chain translated up to the proline cluster (~15 kDa), but still remaining attached 
to a tRNA (~20 kDa). The in vitro translation of CadC-PPPIP/AAAIS was also performed in 
the presence and absence of EF-P (Fig. 21B, lanes 9-14). In this case, the 35 kDa band was 
absent, and the presence or absence of EF-P had no influence on the reaction. As additional 
controls, in vitro translation was performed using CadC truncated directly after the proline 
cluster (CadC1-125) revealing a product of the same size as in wildtype CadC (compare lanes 
15 and 17 in Fig. 21B). Moreover, both the 10 min 35 kDa CadC intermediate (lane 15) and 
35 kDa CadC1-125 product (lane 17) could be reduced in size to 15 kDa via degradation of the 
tRNA by RNase A treatment (Fig. 21B, lanes 16 and 18). Collectively, these data suggest that 
the ribosome stalls at the proline cluster during CadC translation in the absence of EF-P and 
that the presence of EF-P alleviates the translational stalling. 
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Figure 21: In vitro translation of CadC. Autoradiographs of SDS-PAGE analysis of [35S]Met-
labeled in vitro translation time courses of CadC and CadC-PPPIP/AAAIS, in the absence and 
presence of modified EF-P. Control reactions of CadC and truncated CadC1-125 in the presence and 
absence of RNase A were performed. Positions of full-length CadC (FL), peptidyl-tRNA and free 
peptide are arrowed. This work was done by Dr. Agata Starosta (Gene Center, Munich). 
 
 
3.6. EF-P and its physiological role in the Cad system 
3.6.1. Comparison of E. coli and V. harveyi CadC 
Enterobacterial and vibrional CadC proteins are conserved with respect to the domain 
architecture and share a high sequence homology comparing the HTH-DNA binding domain, 
though sequence similarity especially in the cytoplasmic region is low (Fig. 22A, B). 
Interestingly, the proline cluster present in E. coli is not found in Vibrio species (Fig. 22B). In 
addition, Vibrio lacks LysP. LysP acts as inhibitor of CadC and its overproduction leads to 
abolished cadBA expression even under inducing conditions (Neely et al., 1994). This raises 
the hypothesis that EF-P might work as novel kind of translational regulator to control certain 
protein levels in E. coli. In the case of CadC this would mean that the level of CadC is crucial 
to overcome LysP expression and thus to induce cadBA expression under stress conditions. 
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Fig. 22: Comparison of CadC in V. harveyi and E. coli. 
A) Secondary structure prediction of V. harveyi and E. coli CadC1-200 using PSIPRED. 
B) Amino acid alignment of V. harveyi and E. coli CadC using Clustal Omega. 
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C) Vibrio CadC lacking the three consecutive prolines is EF-P indendent. Cells of wildtype 
BW25113 (efp+) and JW4107 (efp-) were grown in LB medium. Relative β-galactosidase activity is 
given as ratio efp-/efp+ values. P/E: promoter of E. coli. P/V: promoter of V. harveyi. 171 amino acids 
of Vibrio CadC were N-terminally fused to LacZ. 
 
 
To test this hypothesis, the translational cadC´-lacZ fusion TL158 was employed replacing 
E. coli cadC by the orthologous 171 codon long counterpart of Vibrio harveyi (TL171). The 
gene was set either under the control of the E. coli cadC promoter or the V. harveyi cadC 
promoter. The resulting plasmids p3LC- P/E-TL171V (P/E stands for the E. coli promoter) 
and p3LC- P/V-TL171V (P/V stands for the Vibrio promoter) were expressed in wildtype 
BW25113 and in JW4107 (∆efp) cells in LB medium. β-Galactosidase activities of the 
wildtype (efp+) and the mutant (efp-) were compared and indicated by an efp-/efp+ ratio. If EF-
P would act as specific translational regulator, an EF-P independent phenotype is expected for 
V. harveyi CadC lacking the prolines. Indeed, cells harboring p3LC-P/E-TL171V and p3LC-
P/V-TL171V revealed no reduced β-galactosidase activities when expressed in JW4107 
(Fig. 22C). This result stands in contrast to the result obtained with E. coli CadC (Fig. 16B).  
3.6.2. The consequence of EF-P independent CadC for cadBA expression 
cadBA expression is regulated by the lysine dependent CadC inhibitor LysP, the small DNA 
binding protein H-NS and the transcription activator CadC. To define the regulatory role of 
EF-P in the Cad system, the influence of the EF-P independent CadC variant P/A on cadBA 
expression was further investigated. Cells of strain MG-CL-123 were transformed with 
plasmids p5C (wildtype CadC) and p5C-P/A (CadC-P/A). Cells were grown microaerobically 
in KE medium under inducing (pH 5.8 with 10 mM lysine) and non-inducing conditions (pH 
5.8, pH 7.6 with or without 10 mM lysine) and harvested at their exponential growth phase. 
Then, β-galactosidase activities were measured. As mentioned before, activation of wildtype 
CadC requires the two stimuli exogenous lysine and low pH to induce cadBA expression. For 
strain MG-CL-123 harboring plasmid p5C-P/A, only one stimulus (either exogenous lysine or 
low pH) was sufficient for the induction of the cadBA operon (Fig 23A). In addition, partial 
induction was even observed without any stimulation. 
To find out, if the unregulated cadBA expression in cells harboring plasmid p5C-P/A is 
related to an enhanced cadC translation, the amount of CadC was determined by Western Blot 
analysis using CadC specific antibodies.  
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Figure 23: EF-P controls the tight copy number of CadC. 
A) cadBA expression induced by wildtype CadC or the EF-P independent variant CadC-P/A. 
Cells of strain MG-CL-123 (MG1655 ∆lacZ ∆cadBA ∆cadC PcadBA-lacZ) harboring plasmid p5C 
(CadC) or p5C-P/A (CadC-P/A), respectively, were cultivated microaerobically in KE minimal 
medium under non-inducing (pH 7.6 with or without 10 mM lysine, pH 5.8) and inducing conditions 
(pH 5.8 with 10 mM lysine). 
B) Western Blot with antibodies against CadC. 10 µl of cells adjusted to OD600 = 10 was 
loaded per lane. The Dotblot was quantified with ImageJ. Cells were cultivated as described in 
Fig. 23A.  
 
 
As expected, the amount of the CadC-P/A variant exceeded the wildtype CadC level under 
every condition. Additionally, levels of CadC were detected by Dotblot analysis using CadC-
specific antibodies for cells grown under inducing conditions (pH 5.8 with 10 mM lysine). 
Wildtype CadC contained 3 - 5 molecules per cell, whereas the CadC-P/A variant contained 
11 - 14 CadC molecules per cell, exceeding the number of wildtype CadC approximately 
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three times (Fig. 23B). Thus, EF-P mediated translation is crucial to maintain low CadC 
levels. 
3.6.3. The effect of different CadC copy numbers on cadBA expression 
To corroborate the correlation between the stimulus-dependent transcriptional activity and the 
copy number of CadC in more detail, wildtype CadC copy number was varied by expressing 
cadC from different plasmids. Therefore, cells of strain MG-CL-123 were transformed with 
plasmids pET16b-CadC, p5C and pBAD24-CadC, which allowed adjustment of low (3 - 5), 
medium (5 - 8) and high (23 - 28) CadC molecule numbers per cell, respectively. The 
different protein copy numbers were obtained by variations in promoter strength, RNA-
polymerase dependency and plasmid copy number (Antoine & Locht, 1992; Cronan, 2006; 
Guzman et al., 1995). Cells of strain MG-CR were used as wildtype control. Levels of CadC 
were detected from cells grown in KE minimal medium by Dotblot analysis using CadC-
specific antibodies and quantified with the software ImageJ. 
In CadC wildtype cells, the cadBA operon was only induced by both stimuli low pH and 
lysine. This is reflected by an increase of the CadC copy number of 1 - 3 molecules per cell at 
pH 7.6 to 3 - 4 molecules at pH 5.8 (Fig. 24A). This “CadC boost” can be mainly attributed to 
the derepression of cadC by H-NS at low pH leading to enhanced cadC transcript levels and 
thus to more CadC (Krin et al., 2010). In addition, lysine is needed for cadBA induction, thus 
one stimulus (low pH) is not sufficient for cadBA expression. The presence of lysine weakens 
the inhibition of CadC by the lysine permease LysP (Tetsch et al., 2008) and therefore, the 
cad operon is only expressed when two stimuli (exogenous lysine and low pH) are present. 
Cells expressing plasmid-encoded CadC at low protein level in strain MG-CL-123 harboring 
pET-16b-CadC showed only a slightly increased expression pattern in comparison to the 
wildtype (Fig. 24A). By contrast, an increase of CadC to a medium protein level (5 - 6 
molecules per cell at pH 7.6, 7 - 8 molecules per cell at pH 5.8) in cells harboring plasmid 
p5C caused significant higher cadBA expression in response to either low pH or available 
lysine. Finally, a high level of CadC (23 - 25 molecules per cell at pH 7.6, 25 - 28 molecules 
per cell at pH 5.8) in cells harboring pBAD24-CadC led to stimulus-independent full 
induction of cadBA expression. These results clearly indicate the importance of a tight control 
of the CadC copy numbers for regulated cadBA expression and acid stress response.  
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Figure 24: CadC amount is crucial for regulated stress response. 
A) Influence of CadC copy number on cadBA expression. Strains MG-CR (cadC wildtype, 
PcadBA-lacZ), MG-CL-123 (∆cadC, PcadBA-lacZ) and MG-CL-123 harboring plasmids pET16b-CadC 
(for low CadC amount), p5C (for medium CadC amount) and pBAD24-CadC (for high CadC amount) 
were grown under non-inducing (pH 7.6; pH 7.6 + 10 mM lysine; and pH 5.8) and inducing conditions 
(pH 5.8 + 10 mM lysine). Levels of CadC were detected by Dotblot analysis using CadC-specific 
antibodies and quantified with the software ImageJ. 
B) Comparison of CadC levels in cells grown under non- and inducing conditions. Cells of 
BW25113 wildtype, JW1225 (∆hns) and JW4107 (∆efp) harboring plasmid p5C were cultivated under 
non-inducing conditons (pH 7.6) in KE minimal medium and then shifted to inducing conditions 
(pH 5.8, 10 mM lysine) for 1 h. 150 µg membrane vesicles were loaded per lane. The Western Blot 
analysis was performed using CadC specific antibodies. Quantifications were made with the software 
ImageJ. 
C) cadC transcript levels in the BW25113 wildtype and the JW1225 (∆hns) mutant. Transcript 
levels were determined by qRT-PCR. Cells were cultivated as described in Fig. 24B.  
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The “CadC boost” at pH 5.8 could be also detected for cells grown in KE minimal medium by 
Western Blot analysis using membrane vesicles of BW25113 harboring plasmid p5C and 
CadC specific antibodies (Fig. 24B). For the Western Blot, cells of BW25113 wildtype and 
JW4107 (∆efp) harboring p5C were cultivated under non-inducing conditions (pH 7.6 without 
lysine) and were then shifted to lysine-rich low pH medium. Indeed, membrane vesicles of 
wildtype cells, which were shifted to inducing conditions, contained 1.74 times more CadC 
protein than those from cells grown under non-inducing conditions (Fig. 24B).  
Additionally, cells of strain JW1225 (∆hns) harboring plasmid p5C were cultivated like the 
wildtype above to confirm the correlation between the CadC amount and H-NS dependent 
regulation. As expected, ∆hns cells revealed 3.6 times higher CadC amounts under non- and 
under inducing conditions in comparison to the wildtype (pH 7.6). This result could be 
confirmed by qRT-PCR for cells grown in LB medium (Fig. 24C) standing in good 
accordance to the results of Krin et al. (Krin et al., 2010).  
3.7. Identification of additional EF-P dependent proteins  
The proteome of E. coli contains approximately 100 proteins with three or more prolines, 
including six proteins with four (EntS, YcgL, Cls, YdeI, MtlR, YodB), two with five (RzoR, 
YaaX) and one with eight consecutive prolines (AmiB) (Table A1). To test whether these 
proteins are also EF-P dependent, eight proteins were chosen, which have the proline cluster 
in the first half of their coding sequence. These proteins - AmiB, FlhC, Flk, HisD, NlpD, 
RzoR, TonB and UvrB - differ in function, cellular localization, proline number and location 
of the polyproline stretch (Table 6). Expression of the corresponding genes was set under 
control of the cadC promoter to ensure low and equal transcriptional levels, and genes were 
fused to lacZ in plasmid p3LC. In the case of rzoR, tonB, amiB and flk, the sequence encoding 
the signal peptide or the periplasmic domain, respectively, had to be removed since LacZ is 
only active in the cytoplasm. Strains BW25113 and JW4107 (∆efp) were transformed with the 
resulting plasmids. After cultivation in LB medium, cells were harvested at the exponential 
growth phase and the β-galactosidase activities were measured. Except of HisD-LacZ, all 
other hybrids were EF-P dependent and revealed lower β-galactosidase activities in the ∆efp 
mutant as in the wildtype (Fig. 25A).  
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Table 6: EF-P dependency of various polyproline-containing proteins in E. coli. Translational 
gene-lacZ fusions were placed under the control of the cadC promoter to ensure low and equal 
transcriptional levels. In case of amiB, flk, nlpD, rzoR and tonB, the sequence encoding the signal 
peptide or the transmembrane domain (flk) were removed since LacZ is only active in the cytoplasm. 
Positions of the corresponding first and last amino acids as well as of the proline stretches are marked 
by numbers. Full length and truncated sizes of the gene products tested in in vitro 
transcription/translation assays (Fig. 25) are marked below each gene. 
 
Protein 
Function Protein 
localization 
Proline 
numbera 
Schematic of the translational lacZ 
fusionsb 
AmiB 
N-acetylmuramoyl-
l-alanine amidase 
periplasm 8  
 
FlhC 
transcription 
activator of 
flagellar genes 
cytoplasm 3  
 
Flk 
predicted flagella 
assembly protein 
cytoplasmic 
membrane  
3  
 
HisD 
histidinol 
dehydrogenase 
cytoplasm 3 
 
NlpD 
predicted 
lipoprotein 
outer 
membrane 
3  
 
RzoR 
predicted 
lipoprotein 
outer 
membrane 
5 and 3  
 
TonB 
energy transducer cytoplasmic 
membrane 
3  
 
UvrB 
excision nuclease 
subunit B 
cytoplasm 3  
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Fig. 25: EF-P dependent proteins. 
A) The β-galactosidase activities of translation fusions of the polyproline-containing E. coli 
proteins AmiB, FlhC, Flk, NlpD, RzoR, TonB and UvrB with LacZ were determined in BW25113 
wildtype and JW4107 (∆efp).  
B) Autoradiographs of SDS-PAGE analysis of [35S]Met-labeled in vitro translation time 
courses of FlhC, Flk and RzoR performed in the absence and presence of modified EF-P. Control 
reactions with truncated FlhC1-53, Flk1-10 and RzoR1-18, with post-reaction RNase A treatment were 
performed. The position of full-length protein (FL), peptidyl-tRNA and free peptides are arrowed. 
This work was done by Dr. Agata Starosta (Gene Center, Munich). 
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To determine whether the proline clusters in these diverse proteins also cause translational 
stalling that can be alleviated by EF-P, in vitro translation assays were employed using flhC, 
flk and rzoR as templates (Fig. 25B). This work was done by Dr. Agata Starosta (Gene Center, 
Munich). The expected size of the full-length FlhC is 21.6 kDa and stalling at 51PPP53 would 
produce a 6 kDa nascent chain. Consistently, in the absence of EF-P, a band was observed at 
26 kDa (lanes 1-2). This band corresponded to the FlhC1-53 peptidyl-tRNA (lane 5), was 
sensitive to RNase A (lane 6) and became weaker in the presence of EF-P (lanes 3-4). In 
contrast to FlhC, the size of Flk is 36.7 kDa. It has a proline cluster, 8PPP10, very close to the 
NH2-terminus and stalling would produce a small 1 kDa nascent chain. Indeed, translation of 
Flk in the absence of EF-P led to the appearance of bands at ~21 kDa (lanes 7 - 8), which 
corresponded to the size of the truncated Flk1-10 peptidyl-tRNA (lane 11). These bands were 
sensitive to RNase A (lane 12) and became significantly weaker in the presence of EF-P 
(lanes 9 - 10). Finally, the translation of RzoR was monitored, which is a small 4.7 kDa 
protein with five consecutive prolines, 14PPPPP18. Stalling at this site would produce a 1.9 
kDa nascent chain that would be visible by a 21.9 kDa peptidyl-tRNA product. In the absence 
of EF-P, a strong band was observed at ~22 kDa (lanes 13 - 14), which corresponded to the 
RzoR1-18 peptidyl-tRNA (lane 17). The band was sensitive to RNase A (lane 18) and was not 
detected in the presence of EF-P (lane 15 - 16). 
3.9 Proline cluster and the “plus”  
In a next approach it was investigated if the proline stretch is sufficient for fully EF-P 
dependency, or if other factors – like the proline localization or other amino acids – could 
influence EF-P related ribosomal stalling. 
3.9.1 Importance of proline localization 
The locations of the proline clusters of the eight tested proline rich proteins were analyzed 
with respect to the predicted secondary structures via PSIPRED (Buchan et al., 2010). As 
shown in Fig. 26A, the proline clusters are located in unstructured regions varying in length 
and lead to EF-P dependency in a range from 60% (FlhC) to 90% (RzoR and TonB).  
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Figure 26: Secondary structures of regions containing proline clusters of proline-rich proteins 
(A) and CadC´-LacZ hybrids (3xPro) (B, see also Fig. 20B). Predictions were performed computer 
based using the program PSIPRED. EF-P dependency is given in %. 
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In CadC, which shows about 85% EF-P dependency (TL158, Fig. 16B), the proline cluster 
can be found in a long unstructured region consisting of more than 50 amino acids (Fig. 22B). 
In FlhC, revealing almost the lowest EF-P dependency of the tested proteins in vivo, the 
unstructured region consists of only 12 amino acids. The proline cluster is located two amino 
acids after an α-helix. Interestingly in the EF-P independent HisD, the proline cluster lays in 
an even shorter unstructured region, directly between an α-helix and a β-strand.  
Considering again Fig. 20B (3xPro), the introduction of three consecutive prolines at various 
positions within CadC resulted in EF-P dependency in every variant, but the strength varied 
also in this experiment with the proline positions (Fig. 26B). In TL-66-PPP, the proline 
cluster is located in a relatively short unstructured region leading to 60% EF-P dependency. 
This result is comparable to the data obtained with FlhC. In TL-30-PPP and TL-100-PPP, the 
unstructured region harboring the proline cluster is longer than in TL-66-PPP, and also the 
EF-P dependency is higher (85% and 80%, respectively) in these two variants. Strains 
transformed with plasmid TL-108-PPP revealed 75% EF-P dependency. In the case of Flk and 
TL-02-PPP, the proline cluster can be found at the protein NH2-terminus leading to strong EF-
P dependency (85% and 80%, respectively).  
Taken together, these results indicate that the secondary structure of the nascent polypeptide 
chain most likely plays an additional role in EF-P mediated translation elongation. Thus, the 
translation of proteins becomes preferentially EF-P dependent, when the proline cluster is 
located in a long unstructured region between two helices or if the cluster occurs directly after 
the start codon. 
3.9.2 Prolines in combination with other amino acids 
Next, it was tested if an exchange of the prolines against alanines in FlhC, which showed 60% 
EF-P dependency, could influence translation in the same way as in CadC. For that reason, 
three additional flhC-lacZ reporter fusions were constructed resulting in plasmids p3LC-FlhC-
APP, p3LC-FlhC-PAP and p3LC-FlhC-AAA. Plasmids were transformed into strains 
BW25113 and JW4107 (∆efp), cells were grown in LB medium and the β-galactosidase 
activities were measured. Comparable to the results obtained with CadC and the 
proline/alanine substitutes (Fig. 18), efp mutants harboring plasmid p3LC-FlhC-AAA with an 
exchange of all three prolines against alanines were less EF-P dependent as with wildtype 
FlhC and revealed 20% higher β-galactosidase activities (Fig. 27A). However, plasmid p3LC-
FlhC-PAP did not lead to enhanced activities in the absence of efp, which was observed in 
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∆efp cells harboring the CadC-PAP variant. Interestingly, plasmid p3LC-FlhC-APP led only 
to 10% of the wildtype activity. This raised the question, whether amino acids surrounding the 
proline cluster could also play a role in EF-P dependent translation. To investigate this aspect 
further, the amino acids upstream of the proline cluster of CadC, HisD and FlhD were 
observed in more detail. In CadC wildtype, two serines can be found next to the proline 
stretch (SSPPP). The EF-P independent HisD protein contains a cysteine and a serine next to 
the three prolines (CSPPP), and FlhC harbors a glycine and a serine (GSPPP). To test, if the 
HisD-CSPPP or the FlhD-GSPPP sequence could change the EF-P dependency in CadC, the 
sequences were exchanged in plasmid TL158, in which 158 amino acids of CadC are fused to 
the reporter LacZ. Cells of wildtype BW25113 and JW4107 (∆efp) were transformed with the 
resulting plasmids TL158-CSPPP, TL158-GSPPP and TL158 as control. After cultivation in 
LB medium, the cells were harvested at exponential growth phase and the β-galactosidase 
activities between efp+ and efp- cells were compared and given as ratio efp-/efp+. In 
accordance to the former results, cells harboring wildtype CadC in TL158 revealed a ratio of 
0.15. By contrast, plasmids TL158-GSPPP or TL158-CSPPP led to a ratio of 0.2 and 0.3, 
respectively (Fig. 27B), indicating that besides the secondary structure, amino acids upstream 
of the proline cluster can also lead to variations in the strength of EF-P dependency.  
 
Finally, it was investigated if EF-P also relieves stalling at additional proline rich sequences 
different to PPP. It was demonstrated before that the exchange of a proline against alanine in 
the CadC variants CadC-APP and CadC-PPA could weaken the EF-P dependency, but the 
variants still showed more than 60% reduced β-galactosidase activities in comparison to efp 
wildtype cells (Fig. 18B). Plasmid p3LC-FlhC-APP resulted in even lower β-galactosidase 
activities in the efp mutant as with wildtype FlhC (Fig. 27A). This raises the question, if an 
amino acid other than proline could cause EF-P dependent stalling, when it is embebbed in 
the context of two prolines. To this end, cadC’-lacZ reporter fusions were generated encoding 
truncated CadC1-30 followed by GPP, PGP or PPG, respectively, and the LacZ reporter (TL30-
GPP, TL30-PGP, TL30-PPG). Strains BW25113 and JW4107 (∆efp) were transformed with 
the resulting plasmids and with plasmids TL30 (no prolines) and TL30-PPP (with 3 prolines) 
as controls. After cultivation in LB medium, cells were harvested at exponential growth phase 
and β-galactosidase activities were measured. As shown before, strains harboring TL30-PPP 
showed a very high reduction of about 85% in β-galactosidase activity in the efp mutant 
compared to the wildtype (Fig. 27C). Remarkably, strains harboring TL-GPP and TL-PPG 
revealed EF-P dependency, but showed only a reduction of about 75% in the mutants standing 
3. Results 
 
80 
 
in good accordance with the results obtained with the CadC-APP and CadC-PPA variants 
mentioned before. Disruption of the proline stretch by a glycine in TL30-PGP led to about 
50% EF-P dependency. These results confirm that besides three consecutive prolines also 
other proline-rich sequences can lead to EF-P dependent translation. 
 
 
 
 
Figure 27: EF-P dependent translation of proteins containing proline-rich sequences.  
A) Proline/alanine substitutions in FlhC. β-Galactosidase activities of cells of wildtype 
BW25113 and JW4107 (∆efp) harboring p3LC-FlhC, p3LC-FlhC-APP, p3LC-FlhC-PAP and p3LC-
FlhC-AAA are indicated by a ratio efp-/efp+.  
B) Amino acid substitution upstream of the CadC proline cluster. β-Galactosidase activities of 
cells of wildtype BW25113 and JW4107 (∆efp) harboring p3LC-TL158 (CadC wildtype: SSPPP), 
p3LC-TL158-GSPPP and p3LC-TL158-CSPPP are indicated by a ratio efp-/efp+. 
C) Proline/glycine substitutions in CadC. β-Galactosidase activities of cells of wildtype 
BW25113 and JW4107 (∆efp) harboring CadC1-30 -LacZ (TL30) variants are indicated by a ratio  
efp-/efp+. 
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3.10 Differences in cadBA expression in KE and LB medium 
The ∆efp mutant revealed abolished CadA activity in KE (Fig. 6B) as well as in LB medium 
(Fig. 29A). Cells of strains MG-CR-yjeA and MG-CR-yjeK cultivated in KE medium also 
showed highly reduced cadBA expression (Fig. 10). However in low pH LB medium, the 
cadBA operon was still expressed in the mutants and showed 28% and even 81% of the 
wildtype expression in the ∆yjeK strain and in the ∆yjeA strain, respectively (Fig. 28A). In 
addition, also strain MG-CR revealed at least two times higher β-galactosidase activities in 
LB medium than in KE medium (data not shown). To investigate possible reasons for this 
discrepancy, following experiments were conducted:  
In Western Blot analysis, the CadC amounts were usually higher in cells grown in LB 
medium than in cells grown in KE medium (Fig. 28B). Therefore, it was investigated if cadC 
is transcribed more efficiently in LB medium than in KE medium. A higher cadC transcript 
amount could then result in higher cadC translation rate and to cadBA expression even in the 
absence of active EF-P. To further analyze this point, a qRT-PCR was performed testing cadC 
expression in LB medium and comparing the result with the cadC expression in KE medium. 
The cadC transcript level seems to be higher in LB medium than in KE medium, but the LB 
samples contained a very high standard deviation (Fig. 28C). Thus, cadC transcript levels 
probably vary only slightly in KE and in LB medium. However, these slight variations could 
be sufficient for higher cadC expression in complex medium, as only two more CadC 
molecules are enough for cadBA expression under inducing conditions in comparison to non-
inducing conditions (see Fig. 24A). 
Additionally, the hns and efp double mutant SU4 was constructed to investigate if an 
enhanced cadC transcript level can lead to an EF-P independent CadA phenotype. It was 
shown before that an hns mutant reveals enhanced cadC transcript levels and higher CadC 
amounts in comparison to the wildtype (Krin et al., 2010; Fig. 24B, C). Therefore, the double 
mutant, wildtype BW25113 and the ∆hns and ∆efp single mutants as positive and negative 
controls, respectively, were incubated in inducing KE medium (pH 5.8 with 10 mM lysine), 
and CadA activities were determined. As expected, the ∆efp strain revealed no CadA activity, 
whereas the ∆hns strain exhibited a 40% higher CadA activity than the wildtype, reflecting 
the derepression of both the cadC and cadBA promoter (Fig. 28D). Remarkably, the double 
mutant also showed 30% more CadA activity than the wildtype. Previous studies have 
revealed that a double mutation in hns and cadC leads to a CadA negative phenotype 
comparable to efp- cells (Küper & Jung, 2005). This indicates that the expression of the 
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cadBA operon is exclusively induced by CadC, even when H-NS as repressor of the cadBA 
operon is missing. Therefore, the high CadA activity in the ∆hns ∆efp double mutant led to 
the assumption that a high transcript level of a gene can mask EF-P dependent ribosomal 
stalling.  
 
 
 
Fig. 28: Differences in cadBA expression in LB and KE medium. 
A) β-Galactosidase activities of cells of MG-CR (PcadBA-lacZ), MG-CR-yjeA (PcadBA-lacZ 
∆yjeA) and MG-CR-yjeK (PcadBA-lacZ ∆yjeK) grown in LB medium.   
B) CadC amount in MG1655 wildtype cells grown in LB and KE medium. Western Blot 
analysis was done with CadC-specific antibodies. Quantifications were made by using the software 
ImageJ. 
C) cadC transcript levels in the BW25113 wildtype grown in KE minimal (pH 5.8, 10 mM 
lysine) or LB medium (pH 5.8). Transcript levels were determined by qRT-PCR.  
D) CadA phenotype of JW4106 (∆hns) mutant and SU4 (∆hns ∆efp). Cells were grown under 
inducing conditions in KE minimal medium (pH 5.8, 10 mM lysine). 
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It is well known that LB is rich in nutrients, thus cells can grow faster and harbor more 
ribosomes than in minimal medium (Tao et al., 1999). Therefore, it was tested if the amount 
of EF-P is also higher in LB than in KE medium resulting in higher CadC amounts in the 
complex medium. To test this, BW25113 wildtype cells were cultivated in LB and KE 
medium under inducing or non-inducing conditions to an OD600 of about 0.5. Subsequently, 
cells were harvested and adjusted to an OD600 of 10. 10 µl of each sample was loaded onto a 
12.5% SDS gel, and a Western Blot was performed using EF-P specific antibodies. Indeed, 
the amount of EF-P was two times higher in LB medium than in KE medium, whereas no 
difference between cells grown in pH 7.6 or pH 5.8 could be observed (Fig. 29A). Thus, it is 
possible that a higher level of EF-P together with a higher level of ribosomes in LB is 
responsible for cadC translation and thus cadBA expression even in the absence of one of the 
EF-P modifiers (see Fig. 28A).  
Interestingly, Keio strain JW4106 harboring a start to stop deletion of yjeK showed a partial 
rescue of the wildtype CadA activity even in KE minimal medium (Fig. 29B). As the start 
codon of yjeK can be found only 41 bp upstream of the translational start site of efp, strain 
JW4106 simultaneously harbors a shortened efp promoter. Thus, the CadA activity in this 
strain could be explained by a repressor binding site within the efp promoter region. A 
deletion of this site would then lead to enhanced expression of efp and to cadBA expression 
also in the yjeK mutant. As the modification of EF-P must be incomplete due to the lack of 
yjeK (Yanagisawa et al., 2010), the wildtype CadA activity can be restored by only 77%, but 
one can speculate that an enhanced amount of α-lysylated EF-P could be sufficient to turn on 
the Cad system. To this end, strains BW25113, JW4107 (∆efp), JW4106 (∆yjeK), SU1 
(∆yjeK643-1029) and JW1225 (∆hns) were cultivated microaerobically in KE medium under 
inducing conditions until the cells reached an OD600 of about 0.5. Subsequently, cells were 
harvested, loaded onto a SDS gel, and a Western Blot was performed using EF-P specific 
antibodies. Indeed, in Keio strain JW4106 (∆yjeK) the EF-P amount was 30% higher than in 
the wildtype (Fig. 29C). However, H-NS can be excluded as possible repressor, since an hns 
deletion did not result in enhanced EF-P levels. In addition, it was excluded that an enhanced 
amount of unmodified EF-P could lead to activation of the cadBA operon, since an induction 
of plasmid pQE70-Eco_efp K34A by IPTG could not complement the negative CadA 
phenotype in ∆efp cells (Fig. 29B).  
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Fig. 29: EF-P amounts in LB and KE medium. 
A) Western Blot analysis of cells grown in LB or KE medium using EF-P specific antibodies. 
Cells of BW25113 were first cultivated microaerobically in LB or KE medium under non-inducing 
conditions (pH 7.6) and were then shifted to inducing conditions (pH 5.8, with 10 mM lysine in KE) 
for 1 h. Quantifications were made by using the program ImageJ. 
B) CadA phenotype of BW25113 wildtype, JW4106 (∆yjeK, including efp promoter) and 
JW4107 (∆efp) harboring plasmid pQE70-ECO-efp K34A. Cells were grown in KE minimal medium 
under inducing conditions (pH 5.8, 10 mM lysine). Strain JW4106 harbors a start to stop deletion of 
yjeK, including the efp promoter. 
C) Western Blot analysis with EF-P specific antibodies. Cells of strain BW25113 wildtype 
(wt), SU1 (∆yjeK643-1029), JW4106 (∆yjeK, including efp promoter), and JW1225 (∆hns) were grown in 
KE minimal medium under inducing condtions (pH 5.8, 10 mM lysine). 10 µl of cells adjusted to 
OD600 = 10 were loaded per lane. Quantifications were made by using the program ImageJ. 
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3.11 Role of Hfq in the Cad system 
The Gad system (AR2) employs not only regulatory proteins like GadX and GadW, but also 
the small regulatory RNAs GadY and GcvB, participating in the very complex regulation of 
the stress system (Jin et al., 2009; Opdyke et al., 2004). The protein Hfq is known to interact 
with and to stabilize small RNAs. To examine, if small RNAs are occupied in the Cad system 
as well, an hfq mutant was used, which was described before (Muffler et al., 1996). The ∆hfq 
mutant, wildtype MG1655 and the mutant harboring plasmid pBAD24-Hfq-His6 were 
cultivated in KE medium (pH 5.8 with 10 mM lysine), harvested at their exponential growth 
phase and the CadA activities were determined. Interestingly, the hfq mutation led to a highly 
reduced CadA activity, which could be restored by complementation (Fig. 30A). When the 
strains were cultivated in LB medium, the ∆hfq mutant regained 60% of the wildtype CadA 
activity (Fig. 30A). 
In a parallel approach, hfq1-230 was deleted in strain MG-CR (MG1655 ∆lacZ ∆cadBA PcadBA-
lacZ), too. Since the start codon of hflx, encoding for a GTPase, is located only 75 bp 
downstream of the stop codon of hfq, only nucleotides 1-230 were exchanged by 
chloramphenicol. Thus, secondary effects could be excluded. Additionally, hflx1-750 was 
exchanged by a kanamycin resistance cassette in strain MG-CR. Afterwards, cells of strains 
MG-CR, MG-CL-12-hfq and MG-CL-12-hflx were cultivated under inducing conditions (KE 
medium, pH 5.8 with 10 mM lysine), and β-galactosidase activities were measured. Again, 
the hfq mutation had a strong effect on cadBA expression (Fig. 30B). However, ∆hflx cells 
revealed wildtype-like β-galactosidase activities, excluding Hflx to play a role in the Cad 
system. 
Next, it was explored if Hfq is crucial for cadC expression. To this end, MG1655 wildtype 
cells and ∆hfq cells were cultivated under inducing conditions in KE minimal medium. After 
preparation of the membrane vesicles of these cells, 150 µg of the total protein amount were 
loaded onto a SDS gel and a Western Blot was performed using specific CadC antibodies. 
Indeed, no CadC could be detected in the mutant (Fig. 30C). 
Guisbert et al. previously showed by microarray analysis that Hfq plays a role for EF-P 
expression (Guisbert et al., 2007). To verify that the EF-P amount is altered in a ∆hfq 
background, 40 ml of cells of wildtype MG1655 and the ∆hfq mutant were incubated in 
inducing KE medium (pH 5.8 with 10 mM lysine). After harvesting, 10 µl of cells (OD600 = 
10) of each sample were loaded onto a SDS gel, and a Western Blot was performed using 
specific antibodies against EF-P. However, no difference could be observed in the EF-P 
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amounts of the wildtype and the ∆hfq mutant (Fig. 30D), excluding any direct effect of Hfq 
on efp expression. 
 
 
 
Figure 30: Hfq is involved in cadBA expression.  
A) CadA phenotype of the ∆hfq mutant in KE minimal and LB medium. Cells were grown 
under inducing condtions (pH 5.8 and 10 mM lysine in KE medium). 
B) cadBA expression in the ∆hfq mutant and ∆hflx mutant. Cells were grown in KE minimal 
medium under inducing conditions (pH 5.8, 10 mM lysine). 
C) Western Blot analysis of CadC in the wildtype and the ∆hfq mutant using CadC specific 
antibodies. 
D) Western Blot analysis of EF-P in the wildtype and the ∆hfq mutant using EF-P specific 
antibodies. 
 
 
As mentioned above, the ∆hfq mutant regained 60% of the wildtype CadA activity, when 
cultivated in LB medium (Fig. 30A). This raises the question, if Hfq is needed for expression 
of the EF-P modifiers YjeA and YjeK. yjeA and yjeK mutants showed a similar cadBA 
expression pattern in KE medium and in LB medium comparable to the hfq mutant: No 
cadBA expression could be observed in KE medium under non-inducing conditions, but 80% 
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(∆yjeA), 30% (∆yjeK) or 60% (∆hfq) expression of the wildtype in LB medium under non-
inducing conditions (Fig. 28A, 30A). Therefore, cells of MG1655 and the ∆hfq mutant were 
transformed with plasmids pBAD24-yjeA and pBAD24-yjeK, respectively.  
 
 
 
Figure 31: Regulation of modified EF-P.  
A) Effect of hfq mutation on yjeA and B) yjeK expression. Cells were grown in KE medium 
under non- (pH 7.6) and inducing conditions (pH 5.8, 10 mM lysine). Western Blot analysis were 
prformed using Penta-His anti-Mouse antibodies against His6-YjeA and His6-YjeK. 10 µl of cells 
adjusted to OD600 = 10 were loaded per lane. Quantifications were made by using the program ImageJ. 
C) Western Blot analysis of CadC using a Penta-His anti-Mouse antibody. Cells of MG1655 
∆cadC harboring pET16b-CadC were cultivated in LB under non-inducing conditions (pH 7.6) and 
were then shifted to inducing conditions (pH 5.8, 10 mM lysine) for 1 h. 150 µg of membrane vesicles 
were loaded per lane. Quantifications were made by using the program ImageJ. 
 
 
Cells were first cultivated in KE medium under non-inducing conditions (pH 7.6) and then, at 
an OD600 of ≈ 0.5, shifted to inducing conditions (KE medium, pH 5.8 with 10 mM lysine, no 
shaking) for 1 h. 10 µl of cells adjusted to an OD600 of 10 were loaded onto a SDS gel. The 
Western blot was performed by using specific antibodies against the His-tag. Strikingly, both 
YjeA and YjeK protein levels were highly reduced in the ∆hfq mutant (Fig. 31A, B), 
indicating an effect on yjeA and yjeK expression by Hfq. Additionally, YjeA and YjeK levels 
were nearly twice as much for cells grown for 1 h under inducing conditions as for cells 
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grown only under non-inducing conditions (Fig. 31A, B). To further investigate, if 
consistently not only cadC transcription, but also translation is enhanced under stress 
conditions leading to the CadC “boost” at pH 5.8, strain MG1655 ∆cadC was transformed 
with plasmid pET16b-CadC. As cadC was set under the control of the T7 promoter in 
pET16b, transcriptional regulation could be excluded. Cells were cultivated aerobically in KE 
or LB medium, pH 7.6, and were subsequently shifted for 1 h to inducing conditions. After 
preparation of the membrane vesicles, 100 µg of the total protein amount were loaded onto a 
SDS gel, and a Western blot analysis was employed using specific CadC antibodies. Indeed, 
the CadC amount was slightly enhanced, so that cells exposed to acidic stress in KE as well as 
in LB medium showed 1.3 times higher CadC levels (Fig. 31C, for KE data no shown).  
Given that higher amounts of YjeK and YjeA lead to enhanced EF-P modification and thus to 
enhanced synthesis of EF-P dependent proteins, these results could provide the first hint that 
the modification of EF-P is stress dependently regulated.  
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4. Discussion 
4.1. EF-P and its role in translation 
EF-P is highly conserved in all kingdoms of life and present in all bacteria. Despite its 
universal conservation, the biological function of EF-P has remained enigmatic so far. It has 
been highly discussed for years, if EF-P and its eukaryotic orthologue eIF5A act as initiation 
or elongation factors. In this study, the ability of EF-P to influence first peptide bond 
synthesis was further characterized in more detail.  
In contrast to the in vitro data, it turned out that an exchange of amino acid two (following the 
initiator methionine) in LacZ did not lead to an EF-P dependent increase or reduction of 
protein synthesis in vivo (section 3.4.1), excluding a general role of EF-P in translation 
initiation. However, protein synthesis varied greatly in the efp mutant and as well in the 
wildtype dependent on the second amino acid, showing high expression rates with 
phenylalanine and low expression rates with glycine at amino acid position two. The 
ribosomal petidyltransferase does not condense all aminoacyl-tRNAs equally (Rychlik et al., 
1970; Symons et al., 1978), and it has been reported before that not only the amino acid itself, 
but also its codon is critical for protein expression rates (Bivona et al., 2010; Looman et al., 
1987). Thus, translation initiation is a crucial rate limiting step in translation (Preiss & 
Hentze, 2003). This effect was also observed, when cadC was cloned into vector pBBR-
MCS5 with variable codons at position two: When cadC contained the codon for a glycine 
after the start codon, the sequence AUG-GGU resulted in about 10 times higher CadC 
amounts than AUG-GGG (Marie-Charlotte Lenoir, unpublished). This so-called codon bias is 
based on the fact that some codons are more often used than others (Konigsberg & Godson, 
1983; Robinson et al., 1984; Sharp & Li, 1987). Codon bias leads to faster and higher 
expression rates for mRNAs containing major codons (like GGU), and to reduced expression 
of mRNAs containing minor codons (like GGG) (Brockmann et al., 2007; Sorensen et al., 
1989). Given that a high protein amount is often desired, for example for protein purification 
or increased detection of fluorescence signals (Bivona et al., 2010; Haas et al., 1996), it is 
very useful to know that protein amounts can be optimized with regard to the second codon of 
the gene sequence. However, it can be excluded that EF-P acts as ribosomal helper protein for 
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less frequent codons, as the ribosomal stalling in efp mutants happens codon independently at 
proline stretches (Fig. 20A). 
Previous studies supported a role for eIF5A in translation elongation, as ribosome profiles of 
eIF5A-depleted yeast cells did not show reduced polysome sizes or an increase in the 80S 
peak, which would be characteristic for an impaired translation initiation (Kang & Hershey, 
1994; Saini et al., 2009). In addition, modified eIF5A was identified to interact with 
elongation factors eEF1A and eEF2 and with the 80S ribosome (Jao & Chen, 2006; Zanelli et 
al., 2006). However, this study revealed that EF-P is not important for translation of lacZ, 
cadA, cadB or poxB, thereby ruling out a general role of EF-P in translation. Accordingly, 
former reports suggested that EF-P and eIF5A are only needed for a small subset of mRNAs 
(Kang & Hershey, 1994; Navarre et al., 2010; Yanagisawa et al., 2010). It has been also 
considered that EF-P and eIF5A work in a field different to translation, like mRNA transport 
and mRNA decay (Bevec et al., 1996; Hofmann et al., 2001; Zuk & Jacobson, 1998). 
Although additional functions for EF-P or eIF5A cannot be excluded, the crystal structure of 
EF-P bound to the ribosome (Blaha et al., 2009), the L-shaped structure of EF-P resembling 
the characteristic design of tRNAs (Hanawa-Suetsugu et al., 2004), and the results obtained in 
this study claim a dominant role for EF-P in translating a small subset of proline-rich proteins.  
4.2. Ribosomal stalling at a cluster of three prolines and additional stalling 
sequences 
In CadC, a cluster of three consecutive prolines can be found in a long linker region between 
the DNA-binding domain and the transmembrane domain (Fig. 17). Proline is unique in that it 
is not an amino acid, but an imino acid (N-alkylamino acid), leading to very slow dipeptide 
formation accommodating the ribosomal A-site (Pavlov et al., 2009). The secondary α-amino 
group of proline is an inefficient acceptor during peptide-bond formation (Fig. 32) (Muto & 
Ito, 2008; Pavlov et al., 2009). Thus, translation of proteins containing three consecutive 
prolines resulted in ribosome stalling in vivo and in vitro in the absence of EF-P (Fig. 17, 
Fig. 21). The stalled ribosome is recognized by EF-P, which probably binds in a manner such 
that the lysinylated-lysine 34 extends into the peptidyltransferase center (PTC) of the 
ribosome and stimulates peptide-bond formation between the prolyl-tRNAPro substrates 
(Fig. 32). 
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Fig. 32: EF-P alleviates ribosomal stalling at poly-proline stretches.  
A, B) Binding of a third consecutive Pro-tRNA to a translating ribosome results in 
translational stalling. 
C) The 3xPro-stalled ribosome is recognized by EF-P, which binds to the ribosome and 
stimulates peptide-bond formation between the A- and P-site proline substrates (arrowed). Thus, the 
elongation arrest is alleviated and translation can continue. 
 
 
Interestingly, the crystal structure of EF-P bound to the 70S ribosome revealed that EF-P is 
located between the ribosomal P- and E-site (Blaha et al., 2009), standing in good accordance 
with the proposed model above (Fig. 32C). Furthermore, EF-P interacts with the ribosomal L1 
protein, which builds the highly mobile L1 stalk of the 50S subunit with three 23S rRNA 
helices (Blaha et al., 2009). The L1/EF-P interaction leads to the transfer of the stalk into the 
E-site (Blaha et al., 2009), thereby playing a role for the translocation of tRNAs from the P- 
to the E-site and the release of empty tRNAs from the E-site (Trabuco et al., 2010). Another 
reason for stalling alleviation could be a conformational change of the ribosomal PTC or the 
right positioning of the Pro-Pro-Pro peptide chain triggered by EF-P.  
For ribosomal stalling, the nascent peptide chain also seems to be important. Some nascent 
peptides, like SecM or TnaC, regulate their own translation rate via a special stalling motif 
(Tanner et al., 2009). As the nascent peptide chain has to transit the aqueous exit tunnel of the 
50S subunit (Nissen et al., 2000), before it is released to the cytoplasm, various events can 
occur to trigger ribosomal stalling. For example, residues of the ribosomal tunnel and the 
nascent chain can interact, leading to conformational changes in the nascent chain and/or in 
the ribosome (Woolhead et al., 2006). In addition, the conformation of the peptidyl t-RNA 
can be altered resulting in abolished translocation (Woolhead et al., 2006). In the case of 
SecM, the ribosome stalls at a 17 amino acid long sequence containing residues which are 
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crucial for the stalling process: FXXXXWIXXXXGIRAGP166 (Nakatogawa & Ito, 2002). The 
stalling can be released, when the signal peptide of SecM is “pulled” out of the ribosomal 
tunnel by components of the Sec apparatus (Butkus et al., 2003). By contrast, translational 
stalling is not abolished under conditions with insufficient secretion. The stalling then results 
in changes of the secondary structure of the mRNA and in expression of the downstream gene 
secA (Nakatogawa & Ito, 2001), which encodes for a preprotein translocase subunit (Cabelli 
et al., 1988). Similarly to the SecM stalling motif, also TnaC, the leader peptide of the 
tryptophanase operon (Konan & Yanofsky, 1997), contains a C-terminal sequence crucial for 
stalling: WXXXDXXXXXXXPstop (Gong & Yanofsky, 2002). In the absence of tryptophan, 
the ribosome stalls leading to an antiterminator stem loop on the mRNA and to expression of 
the downstream genes including tryptophan producing enzymes. In the presence of tryptophan 
however, the stalling is abolished and a terminator stem loop is built. As a consequence, 
downstream genes are not expressed (Buchan & Stansfield, 2007; Yanofsky & Horn, 1994). 
The stalling motifs of SecM and TnaC both contain a C-terminal proline, which is very 
crucial for the translational arrest (Tanner et al., 2009). Furthermore, an Asp, Glu or Pro 
upstream of the Pro-Stop of protein YbeL leads to enhanced SsrA-tagging (Hayes et al., 
2002). SsrA is also known as transfer-messenger RNA (tmRNA) and it can recognize and 
relief stalled ribosomes by a special mechanism, in which the stalled aminoacyl-tRNA at the 
A-site is replaced by an Ala from the aminoacylated tmRNA. The tmRNA then acts as 
template for a short peptide tag. The hybrid protein is released from the ribosome and 
afterwards degraded by cellular proteases (Keiler et al., 1996; Tu et al., 1995). This tagging 
method was also used by Tanner et al. to identify additional stalling peptides (Tanner et al., 
2009). Interestingly, isolated peptides contained the consecutive amino acids PPP, PPG and 
APP, respectively. The same amino acid clusters were identified to cause stalling in cadC 
(PPP, PPG) and flhC (APP) in the absence of EF-P in this study (Fig. 27A, C). Consistent 
with the stalling caused by GPP in cadC (Fig. 27C), Muto et al. could show that a glycine 
tRNAGly occupying the ribosomal P-site and a prolyl-tRNAPro occupying the ribosomal A-site 
disrupt the peptidyltransferase reaction (Muto & Ito, 2008). Accordingly, Doerfel et al. 
confirmed an EF-P mediated release of ribosomal stalling at PPG sequences (Doerfel et al., 
2013). Taken together, it is obvious that EF-P recognizes specific clusters of three amino 
acids, mostly harboring at least two prolines. The strongest stalling effect was observed with 
three consecutive prolines in this study. For future studies it will be important to examine all 
possible EF-P related stalling sequences in more detail.  
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Besides the consecutive prolines, other residues of the nascent chain were identified to 
interact with ribosomal residues leading to a conformational change of the peptide in the exit 
tunnel, and – together with the proline at the A-site – to ribosomal stalling (Woolhead et al., 
2006). The essential amino acids of the nascent peptide chain possess preferably large side 
chains, as tryptophan or phenylalanine, and lay 11 to 15 amino acids upstream of the stalling 
point (Woolhead et al., 2006). Interestingly, E. coli CadC contains a tryptophan 14 amino 
acids upstream of Pro120. By contrast, Vibrio CadC lacks not only the prolines, but also the 
tryptophan (Fig. 22A).  
All these investigations stand in good accordance with section 3.9 of this study, in which 
stalling parameter in addition to the prolines were examined in more detail. It was shown that 
the effect of an efp mutation is more severe, when the prolines are located in a long 
unstructured region (Fig. 26). Comprising the facts described above, it can be speculated, why 
a helix upstream of the stalling region could reduce ribosome stalling. One possible reason is 
that the long unstructured region, being flexible, simplifies interaction with the ribosomal 
tunnel, leads to conformational changes of the nascent chain in the tunnel and/or the ribosome 
and thus increases ribosomal stalling. Accordingly, a shorter unstructured region followed by 
a helix or a β-strand - as it is the case in HisD, which is EF-P independent – could lead to 
more rigidity of the peptide and thus to less interaction with the ribosome resulting in reduced 
ribosomal stalling.  
As mentioned above, the accommodation step (binding of the aminoayl t-RNA to the A-site) 
and the peptidyl transfer are very slow, when a proline is incorporated in the nascent 
polypeptide chain (Pavlov et al., 2009). Consequently, three consecutive prolines lead to even 
higher ribosomal stalling, which requires the help of an auxiliary protein like EF-P to continue 
translation. The interaction of EF-P with ribosomal components like the L1 stalk could then 
result in conformational changes of the ribosome, the nascent peptide chain or the peptidyl-
tRNAs, which is important to continue translation elongation. Without EF-P, only a short 
peptide is built, before the ribosomal complex is disassembled (see Fig. 21 and 25). Thus, the 
protein concentration drops to a minimum, as it was experienced in the case of CadC. 
Additionally, not only the amino acid itself, but also codon bias plays a significant role for 
ribosomal stalling (Hayes et al., 2002; Konigsberg & Godson, 1983). The proline codon CCC 
is rarely used in the E. coli genome, thus also its corresponding t-RNA is diminished in the 
cell leading to even slower proline incorporation as obtained with the other three codons 
(Pavlov et al., 2009). Interestingly, cadC contains three consecutive prolines with the codon 
CCU, which is the second rarest codon for proline in the E. coli genome, whereas the EF-P 
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independent hisD contains three CCG prolines – a codon, which can be found quite frequently 
in the genome (Sharp & Li, 1987). However, also the EF-P dependent NlpD protein contains 
three prolines with the CCG codon. Therefore, it is very likely that the codon bias contributes 
to ribosomal stalling with some RNAs, but not with others depending on additional stalling 
factors. 
 
In conclusion, three consecutive prolines can induce ribosomal stalling, which is alleviated by 
EF-P. In addition, other stalling sequences can be identified, like APP, PPG and GPP, but 
three consecutive prolines have the strongest effect. Additionally, also the proline preceeding 
amino acids can be essential for ribosomal stalling, as the ribosomal tunnel can interact with 
residues of the nascent polypeptides. Furthermore, the codon bias can contribute to the rate 
determing step of accommodation of the aminoacyl t-RNA to the A-site. Accordingly, 
different stalling motifs can lead to distinct stalling events and thus to different translation 
rates of proteins (Ito et al., 2010). 
4.3. The CadC/LysP balance model 
It has been discussed previously that EF-P as well as eIF5A help to synthesize only certain 
proteins (Bartig et al., 1992; Roy et al., 2011). This raises the question, why cadC is one of 
the specific targets of EF-P. Further studies revealed that the amount of CadC is important for 
regulated expression of the cadBA operon (Küper & Jung, 2005). Having demonstrated that 
modified EF-P is crucial for CadC translation, the importance of this new control mechanism 
for the regulation of the Cad-module was investigated in more detail. The EF-P independent 
CadC-PPPIP/AAAIS variant resulted in about three times more CadC molecules as wildtype 
CadC leading to partial cadBA expression even in the absence of stimulation (Fig. 23A, B). 
Accordingly, expression of plasmid-encoded CadC at different levels corroborated the strong 
correlation between the increased CadC copy number and a stimulus-independent response 
(Fig. 24A). As depicted in Fig. 2, activation of CadC is dependent on its co-sensor LysP. 
Overproduction of LysP prevents cadBA expression under all conditions (Neely & Olson, 
1996) indicating that the copy number of LysP is also crucial for a stimulus-dependent 
response.  
Together with the new data on CadC levels, a balance model can be proposed for the Cad-
system (Fig. 33): In wildtype cells the CadC/LysP ratio is balanced (Fig. 33A, middle panel). 
In response to the two stimuli, low pH and lysine, the balance is shifted in favor of activated 
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CadC leading to cadBA expression (Fig. 33A, left panel). Under non-inducing conditions, 
expression of cadC is lower than under inducing conditions (Krin et al., 2010).  
 
 
 
Fig. 33: The CadC/LysP balance model.  
A) In the wildtype, the balance can shift in favor of CadC under inducing conditions (left 
panel) and in favor of LysP under non-inducing conditions (neutral pH medium without lysine, right 
panel). The CadC/LysP ratio is balanced (middle panel). 
B) An efp deletion leads to the shift in favor of LysP (left panel). The EF-P independent 
variant CadC PPPIP/AAAIS leads to the shift in favor of CadC (middle panel).  
 
 
Simultaneously, lysP expression is enhanced due to the lack of lysine repression (Ruiz et al., 
2011), thus leading to a shift of the balance in favor of LysP and to abolished cadBA 
expression (Fig. 33A, right panel). In cells lacking EF-P, the CadC/LysP ratio is imbalanced 
to disfavor CadC and therefore cadBA expression is significantly reduced (Fig. 33B, left 
panel). In cells harboring the EF-P independent variant CadC-PPPIP/AAAIS, the CadC/LysP 
ratio is also imbalanced but in favor of CadC, resulting in a partial stimulus-independent 
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cadBA expression (Fig. 33B, middle panel). Therefore, the translational control of CadC by 
active EF-P represents a novel mechanism to tightly fine-tune the protein copy number.  
Interestingly, Vibrio lacks not only the CadC inhibitor LysP, but also the proline cluster 
(section 3.6.1). As these bacteria do not have to deal with the CadC/LysP ratio, they also do 
not need the proline cluster for EF-P mediated copy number control. 
 
Taking the Northern Blot results of Neeley et al. into account (Neely & Olson, 1996), the 
CadC/LysP balance model can help to explain the varying stress response times of the cad 
operon obtained by three different start conditions: 
Firstly, when E. coli cells (∆cadA) were grown in neutral pH minimal medium with lysine, 
before they were shifted to inducing conditions (pH 5.8 with 10 mM lysine), cadB mRNA 
was detected 4 min after the shift (Neely & Olson, 1996). lysP expression is repressed by 
lysine (Neely & Olson, 1996; Ruiz et al., 2011). Thus in lysine containing medium, the level 
of LysP is lower than in medium without lysine. Additionally, in neutral pH medium cadC is 
expressed, but to a lower extent than in low pH medium (Dell et al., 1994; Krin et al., 2010). 
Furthermore, lysine is transported into the cell by LysP resulting in reduced CadC inhibition 
(Tetsch et al., 2008). When cells are shifted to acidic medium with lysine, expression of cadC 
is enhanced, but not the expression of lysP. CadC can form dimers as its levels are increased 
due to the low pH and thus transfer the stress signal to the cadBA operon (Eichinger et al., 
2011; Haneburger et al., 2011; Tetsch et al., 2011).  
Secondly, the same response time was obtained, when cells were first grown in low pH 
medium without lysine (Neely & Olson, 1996). In low pH medium without lysine, the LysP 
level is increased in comparison to medium with lysine, because its expression lacks lysine 
repression. Furthermore, CadC levels are higher due to the low pH. Thus, both levels of LysP 
and CadC are increased in pH 5.8 medium, but the CadC/LysP ratio is comparable to that in 
the pH 7.6 medium containing lysine. Consequently, this leads to the same short response 
time of cadB expression. 
Finally, when cells were first grown in neutral pH medium without lysine, it took 15 min until 
cadB expression could be detected (Neely & Olson, 1996). This raises the question, why two 
stimuli (lysine and low pH) lead to nearly four times slower stress response than one stimulus 
(lysine or low pH). In neutral medium without lysine, LysP levels are high, as no lysine 
repression occurs. By contrast, CadC levels are lower than under acidic conditions, thus all 
CadC molecules are inhibited by LysP, an excess of free LysP is still available and the 
balance is shifted in favor of LysP (Fig. 33A, right panel). Thus, the CadC/LysP ratio differs 
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from the ratio described above. Therefore, more CadC molecules must be built for sufficient 
cadBA expression after the shift to overcome higher LysP levels. Consequently, a two stimuli 
induction takes more time than induction by only one stimulus.  
 
Another interesting aspect is the de novo synthesis suggested by Neely et al. (Neely & Olson, 
1996). Following this line, EF-P could be important for the new synthesis of an active form of 
CadC under inducing conditions resulting in the expression of the cadBA operon. This leads 
to the question, whether EF-P itself is regulated under specific stress conditions. In general, 
regulation of gene expression is achieved by several different ways, including regulation of 
transcription via various transcription activators, repressors and sigma factors (Browning & 
Busby, 2004; Mata et al., 2005). The concentration of proteins depends also on mRNA 
stability, the translation rate and protein degradation rate (Mata et al., 2005). Amongst others, 
translation is affected by ribosomal stalling, secondary mRNA structures, the codon bias and 
the number of available ribosomes, tRNAs and translation factors (Brockmann et al., 2007; 
Konigsberg & Godson, 1983; Kozak, 2005; Mata et al., 2005). One EF-P molecule per 10 
ribosomes exists in the cell (An et al., 1980), which stands in good accordance to the number 
of other translation factors (Cole et al., 1987). However, the number of active EF-P could be 
much lower as the protein has to be posttranslational modified by the two enzymes YjeK and 
YjeA, which have rather low enzymatic activities (Behshad et al., 2006; Brevet et al., 1995). 
Therefore it is possible, that under specific stress conditions the modification of EF-P 
increases resulting in higher translation rates for the EF-P target mRNAs. Only few reports 
exist about translation factors, which are modified and activated under certain stress 
conditions (Blais et al., 2004; Giuliodori et al., 2007; Milon et al., 2006; Spriggs et al., 2010). 
This study revealed that the amounts of YjeA and YjeK are doubled, when cells were grown 
microaerobically in medium with low pH and lysine (Fig. 31A, B). In addition to that, also the 
translation of cadC was slightly increased under inducing conditions (Fig. 31C). Thus, a stress 
dependent modification of EF-P is very likely. However, whether this effect is due to the 
switch from neutral to acidic medium or from oxygenated medium to medium with low 
oxygen needs to be further investigated.  
Furthermore, this study indicates that the amounts of CadC, YjeA and YjeK, but not of EF-P, 
are decreased in hfq mutants. Hfq acts as RNA binding chaperone, stabilizes small non-coding 
RNAs (sRNA) and facilates mRNA/sRNA interactions, thereby causing stabilization or 
degradation of mRNAs (Valentin-Hansen et al., 2004; Zhang et al., 2003). This result leads to 
speculations, if the mRNAs of yjeA and yjeK are controlled by small regulatory RNAs. 
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Interestingly, computational analysis predicted an yet unknown small non-coding RNA in the 
genomic region of yjeA (Rivas et al., 2001). However, if this small RNA really influences the 
stability of the yjeA mRNA, or if additional proteins are involved causing the effects of the 
hfq mutant, needs still to be uncovered in future experiments.  
4.4. EF-P and its importance in plant and mammalian diseases 
The deletion of efp or its orthologues leads to several different phenotypes. Having 
demonstrated that EF-P alleviates translational stalling at polyproline-stretches in E. coli, it is 
now possible to address some of the proteins, which could be responsible for the resulting 
effects in efp, yjeK and yjeA mutants. 
Peng et al.. determined the phenotype of a deletion mutant (∆chvH) in Agrobacterium 
tumefaciens (Peng et al., 2001). chvH encodes for a homologue to E. coli efp and clusters with 
poxA (yjeA) and kamA (homologue to yjeK) in the genome. The chvH deletion leads to 
avirulence and other pleiotropic effects, which can be complemented by E. coli EF-P (Peng et 
al., 2001). A. tumefaciens is very particular as it is able to transfer bacterial DNA into the 
plant host, followed by integration of the DNA into the plant genome and formation of crown 
galls (Bevan & Chilton, 1982). The tumor-inducing plasmid Ti harbors the VirA/VirG two-
component system, which is responsible for the expression of additional vir genes (Leroux et 
al., 1987; Ronson et al., 1987; Winans et al., 1986). Comparable to CadC, VirG and VirA are 
only expressed to significant levels, when cells respond to environmental stress conditions 
like low pH (Peng et al., 2001; Winans et al., 1988). Interestingly, protein amounts of VirA, 
VirG and other tested Vir proteins are reduced in the chvH mutant (Peng et al., 2001). VirA 
contains the amino acid sequence PPG, which was previously shown to cause ribosomal 
stalling (Tanner et al, 2009; Doerfel et al, 2013; this study). Therefore it can be speculated, 
whether the reduced protein level of the hisidine kinase VirA leads to the observed impaired 
production of the Vir proteins in the chvH mutant. In addition, also VirB9 (PPQP), VirB10 
(PPS, PPA, PPP, PPT), VirB11 (PPT, PPQ), VirE2 (PPP, PPI) and VirD2 (PPD, PSPP) 
contain a cluster of at least two prolines, indicating that also these amino acid sequences could 
contribute to ribosomal stalling and to decreased protein levels in the chvH mutant. 
Furthermore, the deletion of chvH reveals an increased production of a so far uncharacterized 
protein (Peng et al., 2001). As the transcriptional regulator VirB, which is phosphorylated by 
VirA, shows a highly reduced protein amount in the chvH mutant (Peng et al, 2001), the 
unknown protein perhaps acts as repressor of VirB. Taken together, it seems very likely that 
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ChvH fine-tunes the levels of vir regulon components for adequate stress response, which is 
comparable to the Cad system. 
In the U.S., approximately 9.4 million people contract foodborne diseases each year, resulting 
in over 1,300 deaths, of which 11% derive from Salmonella enterica (Mead et al., 1999; 
Scallan et al., 2011). These bacteria are able to overcome the host immune system and to 
multiply in varieties of mammalian cells while residing in so-called Salmonella-containing 
vacuoles (SCV) (Bakowski et al., 2008; Prost et al., 2007). Via horizontal gene transfer, 
S. enterica acquired several pathogenicity islands, which are essential for host invasion and 
survival in the new intracellular environment (Haraga et al., 2008). Crucial for Salmonella 
virulence are two type III secretion systems, which are encoded on the pathogenicity islands 1 
and 2 (SP-1 and SP-2) (Hansen-Wester & Hensel, 2001). Consistent with the chvH deletion in 
A. tumefaciens, deletions of yjeK or yjeA lead to attenuation in virulence and altered gene 
expression in S. enterica, including genes found on SPI-1 (Navarre et al., 2010). The 
discovery of the role of EF-P in translation now opens up the possibility to determine 
proteins, which protein levels are very likely affected in these mutants. Several important 
virulence proteins contain polyproline-stretches, such as the type III secretion ATPase SsaN 
and the secretion system enhancer protein SseF, both of which are located on SPI-2. 
Moreover, EnvZ and PhoR, which regulate the transcription of SPI-1 and SPI-2 (Ellermeier & 
Slauch, 2008; Garmendia et al., 2003), also contain polyproline-stretches. Furthermore, Zou 
et al. found out that the overexpression of the poorly characterized porin KdgM is the reason 
for the susceptibility to antibiotics, hypoosmotic stress and several detergents in efp mutants 
observed by Navarre et al. (Navarre et al., 2010; Zou et al., 2012). In the plant pathogen 
Erwinia chrysanthemi, KdgM is important for the transport of long oligogalacturonides 
derived from pectines (Blot et al., 2002). Interestingly, kdgM expression is repressed by 
OmpR, a transcriptional activator that needs to be phosphorylated by the histidine kinase 
EnvZ for activity (Cai & Inouye, 2002; Condemine & Ghazi, 2007; Egger & Inouye, 1997). 
As mentioned above, EnvZ contains three consecutive prolines making it a promising target 
for EF-P. 
Genomic analyses reveal an abundance of polyproline-stretches not only in bacteria, but also 
in archaea and eukaryotes. For example, ~1,000 (13%) yeast proteins contain at least three 
consecutive proline residues, whereas over 6,000 (20%) polyproline-containing proteins are 
present in humans. eIF5A has been shown to be involved in several human diseases. For 
example, Ruhl et al. described an interaction between eIF5A and the viral protein Rev, which 
is needed for HIV-1 mRNA transport out of the nucleus into the cytoplasm (Ruhl et al., 
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1993). Thus it was discussed, if eIF5A also plays a role in mRNA transport. However, Rev 
contains a cluster of three consecutive prolines, thereby leading to the suggestion that eIF5A 
is rather important for the proper translation of Rev than for mRNA transport.  
Furthermore, high levels of eIF5A could be detected in cancer cells making it an appropriate 
target as tumor marker (Balabanov et al., 2007; Lee et al., 2010; Preukschas et al., 2012). 
High amounts of mutated p53 can be found in malign cells as well. Normally, the 
transcription regulator p53 leads to cell cycle arrest under genotoxic stress (Pellegata et al., 
1996). During this arrest, the cells have time to repair the DNA or to provoke apoptosis. 
Unregulated overproduction of p53 however leads to reduced cell cycle arrest, thus cells are 
able to divide themselves uncontrolled leading to the formation of tumors. Interestingly, p53 
is a very proline rich protein containing a cluster of three consecutive prolines, but also 
several clusters of two prolines including the sequence PPG. eIF5A seems to mediate the 
translation of p53, thus contributing to a high level of mutated p53 in tumor cells.  
Taken together, it could be demonstrated that EF-P and eIF5A play a major role for plant and 
mammalian diseases. Blocking of eIF5A/EF-P or of hypusination/lysinylation via 
pharmacological substrates will be of great importance for further studies in respect to find 
new antibiotics and therapies against bacterial infections, HIV and cancer (Balabanov et al., 
2007; Doerfel et al., 2013; Hauber et al., 2005; Lee et al., 2010). 
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5. Summary 
Enterobacteria have evolved several strategies to survive the acidic environment of the 
gastrointestinal tract. One of the acid stress resistance systems is the Cad system in 
Escherichia coli, which is induced by low pH and in the presence of external lysine. It 
consists of CadA, which catalyzes the decarboxylation of lysine to cadaverine, the 
lysine/cadaverine antiporter CadB and the pH sensing transcriptional regulator CadC. 
Moreover, the lysine permease LysP inhibits the induction of cadBA expression when lysine 
is absent, and the small histon-like molecule H-NS acts as repressor for both cadBA and cadC 
transcription. Additionally, a random mutagenesis approach revealed that a deletion in yjeK 
leads to highly reduced cadaverine production. YjeK acts as 2,3-lysine aminomutase (LAM) 
while catalyzing the isomerization of (S)-α-lysine to (R)-β-lysine. The truncated lysyl-tRNA 
synthetase YjeA uses (R)-β-lysine as substrate to post-translationally modify and to activate 
the translation elongation factor EF-P at a conserved lysine residue (K34). EF-P and its 
ortholog eukaryotic initiation factor 5A (eIF5A) have been investigated for more than thirty 
years, but their roles in translation remained enigmatic.  
In this work the role of active EF-P in the Cad system was investigated in more detail. 
Reduced cadBA expression in ∆yjeA, ∆yjeK642-1029 and ∆efp mutants was linked to impaired 
CadC translation. As the translation of cadA and cadB was EF-P independent, a general role 
of EF-P in translation could be excluded.  
The identification of CadC as first direct target for EF-P in E. coli allowed further 
investigations on the role of EF-P in translation. Determining the β-galactosidase activities of 
CadC´-LacZ translational fusions of increasing CadC length in efp- and efp+ cells revealed 
that EF-P is required for translation of the sequence found between codon 108 and 158 in 
cadC. This region comprises a cluster of three consecutive prolines (Pro120-Pro121-Pro122). 
Substitution of these prolines by alanines diminished EF-P dependency. Remarkably, cells 
harboring the CadC-PPPIP/AAAIS variant revealed cadBA expression even under non-
inducing conditions. Thus, EF-P tightly controls the CadC copy number, which is crucial for 
stress dependent regulation of the Cad system.  
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In order to investigate the work mechanism of EF-P in more detail, EF-P independent 
CadC´-LacZ hybrids were employed to artificially introduce prolines. Three consecutive 
prolines were sufficient for EF-P dependency, regardless of the codon or the context. The 
proline-rich proteins AmiB, FlhC, Flk, NlpD, RzoR, TonB and UvrB also showed EF-P 
dependent expression. Thus, the recognition of three consecutive prolines by EF-P is a general 
mechanism and not limited to CadC. Dr. Agata Starosta of the group of Dr. Daniel Wilson 
(Gene Center, LMU Munich) confirmed ribosomal stalling at polyproline-stretches in samples 
lacking EF-P with in vitro translation assays.  
Finally it was investigated, if EF-P expression and modification could be stress-
dependently regulated. In this work first hints are given that the efp promoter contains a 
repressor site, and that expression of yjeA and yjeK is dependent on the pH of the medium and 
the presence of the small RNA binding protein Hfq. This leads to the suggestion that small 
regulatory RNAs are also involved in regulation of the EF-P modification enzymes. 
In conclusion, the results obtained in this work reveal a new regulatory mechanism by 
EF-P dependent translation. 100-1000´s of polyproline rich proteins exist in bacteria, archaea 
and eukaryotes. Therefore, EF-P and its orthologs aIF5A and eIF5A most likely play an 
important role in the adjustment of copy numbers of proteins with different functions in all 
kingdoms of life. 
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6. Zusammenfassung 
Enterobakterien haben eine Reihe von Strategien entwickelt, um saure Bedingungen im 
Gastrointestinaltrakt überleben zu können. Ein Resistenzsystem gegen Säurestress ist das Cad 
System von Escherichia coli, das durch niedrigen pH und extern vorhandenes Lysin induziert 
wird. Es setzt sich aus der Decarboxylase CadA, welche die Decarboxylierung von Lysin zu 
Cadaverin katalysiert, dem Lysin/Cadaverin Antiporter CadB und dem 
Transkriptionsregulator CadC zusammen. Bei Lysinmangel verhindert die Lysin-Permease 
LysP die Expression des cadBA Operons, während das kleine Nukleoid-assoziierte Protein H-
NS die Transkription sowohl von cadBA als auch von cadC unterdrückt. Anhand einer 
ungerichteten Mutagenese-Studie konnte aufgedeckt werden, dass eine Deletion von yjeK zu 
einer stark reduzierten Cadaverinproduktion führt. yjeK kodiert für eine 2,3-Lysin-
Aminomutase (LAM), welche die Isomerisation von (S)-α-Lysin zu (R)-β-Lysin katalysiert. 
Die verkürzte lysyl-tRNA Synthetase YjeA benutzt das entstandene (R)-β-Lysin, um den 
Translations-Elongationsfaktor EF-P posttranslational an einem konservierten Lysinrest (K34) 
zu modifizieren. Schon seit über dreißig Jahren gibt es Untersuchungen zu EF-P und seinem 
eukaryotischen Ortholog eIF5A, aber die genaue Funktion der beiden Proteine in Bezug auf 
die Translation konnte bisher nicht entschlüsselt werden.  
In dieser Arbeit wurde die Rolle von modifiziertem und somit aktivem EF-P innerhalb 
des Cad Systems genauer untersucht. Die stark verminderte cadBA Expression in ∆yjeA, 
∆yjeK642-1029 und ∆efp Mutanten konnte auf eine reduzierte CadC Translation zurückgeführt 
werden. Da Experimente zeigen konnten, dass die Translation von cadA und cadB EF-P 
unabhängig ist, konnte eine allgemeine Rolle von EF-P in der Translation ausgeschlossen 
werden. 
Die Identifikation von CadC als erstes direktes Zielobjekt von EF-P in E. coli erlaubte 
weitere Untersuchungen in Hinsicht auf die Funktion von EF-P. β-Galactosidase Tests mit 
CadC´-LacZ Fusionen unterschiedlicher CadC Länge in efp- und efp+ Zellen ergaben, dass 
EF-P für die Translation einer Sequenz benötigt wird, die sich in cadC zwischen Codon 108 
und 158 befindet. Innerhalb dieser Sequenz findet man eine Gruppe von drei 
aufeinanderfolgenden Prolinen (Pro120-Pro121-Pro122). Der Austausch der Prolingruppe 
gegen Alanine führte in den Test-Zellen sogar unter nicht-induzierenden Bedingungen zu 
hoher cadBA Expression. Folglich scheint die Kopienzahl von CadC durch EF-P streng 
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reguliert zu werden, was für eine Stress-abhängige Regulation des Cad Systems unerlässlich 
ist.  
Um den Wirkungsmechanismus von EF-P besser zu verstehen, wurden EF-P 
unabhängige CadC´-LacZ Hybride verwendet, in die artifiziell eine unterschiedliche Anzahl 
an Prolinen eingebaut wurde. Drei Proline reichten aus, um die Translation der Konstrukte 
EF-P abhängig zu machen. Dabei spielte das Prolincodon oder der Kontext der Proline im 
Protein keine Rolle. Außerdem war die Expression der prolinreichen Proteine AmiB, FlhC, 
Flk, NlpD, RzoR, TonB und UvrB ebenfalls von EF-P abhängig. Das Erkennen von drei 
aufeinanderfolgende Prolinen durch EF-P ist folglich ein genereller Mechanismus und nicht 
auf CadC begrenzt. Dr. Agata Starosta aus der Gruppe von Dr. Daniel Wilson (Gene Center, 
LMU München) bestätigte das Stocken der Ribosomen an polyprolinreichen Sequenzen, das 
durch das Fehlen von EF-P ausgelöst wird, über in vitro Translationsexperimente.  
Abschließend wurde untersucht, ob die Expression und Modifikation von EF-P Stress-
abhängig reguliert wird. In dieser Arbeit gibt es erste Hinweise darauf, dass die Transkription 
von efp über einen Repressor reguliert wird. Außerdem scheint die Expression von YjeA und 
YjeK vom pH-Wert des Mediums und der Anwesenheit des kleinen RNA-bindenden Proteins 
Hfq abhängig zu sein. Somit könnten auch kleine regulatorische RNAs bei der Modifikation 
von EF-P eine Rolle spielen.  
Die Ergebnisse dieser Arbeit enthüllen einen neuen Regulationsmechanismus durch 
EF-P - abhängige Translation. Hunderte bis Tausende polyprolinreiche Proteine existieren in 
Bakterien, Archaeen und Eukaryoten. Deshalb scheinen EF-P und seine Orthologe aIF5A und 
eIF5A in allen drei Reichen des Lebens eine wichtige Rolle in der Anpassung der Kopienzahl 
von Proteinen mit unterschiedlicher Funktion zu spielen.  
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Appendix 
A1: Exchange of lysine residues against alanines or arginines in CadC 
 
 
 
Figure A1: Exchange of lysines against alanines (A) or arginines (B) in CadC.  
Single mutations were achieved by two step PCR using plasmid pET16b-CadC (Küper & Jung, 2005). 
Cells of strain MG-CL-123 were transformed with the resulting plasmids and were grown 
microaerobically in KE medium under inducing conditions (pH 5.8 with 10 mM lysine). To confirm 
CadC membrane integration, 10 µl of whole cells (OD600 ≈ 10) (A) or 25 µg of membrane vesicles (B) 
were loaded onto a SDS gel. Western Blots were performed using CadC specific antibodies.  
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Various bacterial proteins are targets for post-translational modifications such as acetylation, 
pupylation, glycosylation or phosphorylation (Abu-Qarn et al., 2008; Garnak & Reeves, 1979; 
Pearce et al., 2008; van Noort et al., 2012; Wang et al., 2010; Yu et al., 2008). These are 
important for protein stability and activity and often occur at lysine residues (van Noort et al., 
2012; Wang et al., 2010; Zhao et al., 2010). It was speculated, if active CadC could contain 
such a modified lysine residue as well. Therefore, lysine residues of the cytoplasmic domain 
of CadC were exchanged against alanines or arginines. Interestingly, lysine 95 led to fully 
abolished cadBA expression (A1). However, future studies have to reveal if this residue is 
really a candidate for post-translational modification of CadC, or if it is just very crucial for 
stereospecific interaction of CadC with the cadBA promoter DNA.  
 
 
A2: β-Galactosidase activities in strain MG-CL-1 (cadA::lacZ) and the search for a 
promoter upstream of cadA 
 
Fig. A2 (A) shows the β-galactosidase activities measured in strains MG-CL-1 (cadA::lacZ), 
MG-CL-1-yjeA and MG-CL-1-yjeK. The result was the same as obtained with strain MG-CR 
(cadBA::lacZ). However, β-galactosidase activities in MG-CL-1 cells grown under inducing 
conditions were usually twice as high as the ones measured in MG-CR cells (see Fig. 9).  
 
To investigate, if cadA is regulated by a promoter additional to PcadBA, several “PcadA”-lacZ 
fusions were constructed. Therefore, 79 bp, 100 bp, 200 bp, 300 bp, 400 bp, 500 bp, 600 bp, 
700 bp or 800 bp of the sequence upstream of nucleotide +1 of cadA were cloned into vector 
pBBR1-MCS3-LacZ. Cells of strain BW25113 (wildtype) were transformed with the resulting 
plasmids. No significant β-galactosidase activities could be measured with any of the “PcadA”-
lacZ constructs (Fig. A2, B), indicating that cadA is not under control of a second promoter.  
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Figure A2:  A) β-Galactosidase activities in cells harboring a cadA::lacZ mutation. Strains MG-
CL-1 (MG1655 ∆lacZ cadA::lacZ), MG-CL-1-yjeA (∆yjeA) and MG-CL-1-yjeK (∆yjeK) were grown 
microaerobically in KE medium under inducing (pH 5.8 with 10 mM lysine) and non-inducing 
(pH 5.8) conditions. 
B) “PcadA”-lacZ fusions. Cells of BW25113 harboring various pBBR1-MCS3-PcadA-
LacZ plasmids were cultivated microaerobically in LB medium (pH 5.8). The length (bp) of the 
sequence found upstream of the transcriptional start site of cadA is depicted as a number (79, 100, 200 
and so forth). 
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A3: E. coli proteins containing polyproline stretches 
 
Table A1: Polyproline-rich proteins in E. coli. 
Gene GI Protein 
aceK g1790446 Isocitrate dehydrogenase kinase/phosphatase 
adrA g1786584 Diguanylate cyclase for cellulose regulation 
adrB g87081980 predicted membrane-anchored cyclic-di-GMP phosphodiesterase  
agp g1787237 glucose-1-phosphatase/inositol phosphatase 
amiB g1790611 N-acetylmuramoyl-l-alanine amidase II 
bcsB g1789952 regulator of cellulose synthase, cyclic di-GMP binding 
cadC g1790576 DNA-binding transcriptional activator 
clsA g1787502 cardiolipin synthase 1 
clsB g1787007 cardiolipin synthase 2 
clsC g87081826 cardiolipin synthase 3, active in stationary phase 
creC g1790861 sensory histidine kinase in two-component regulatory system with CreB or 
PhoB, regulator of the CreBC regulon 
cyoB g1786634 cytochrome o ubiquinol oxidase subunit I 
dppF g1789962 dipeptide transporter 
entF g1786801 enterobactin synthase multienzyme complex component, ATP-dependent 
entS g1786806 enterobactin exporter, iron-regulated 
envZ g1789808 sensory histidine kinase in two-component regulatory system with OmpR 
eutL g1788780 predicted carboxysome structural protein with predicted role in ethanolamine 
utilization 
flhC g1788201 DNA-binding transcriptional dual regulator with FlhD 
flk g1788661 predicted flagella assembly protein 
focB g1788837 predicted formate transporter 
ftsK g1787117 DNA translocase at septal ring sorting daughter chromsomes 
gfcC g1787220 conserved protein 
ggt g1789856 gamma-glutamyltranspeptidase 
glpR g1789829 DNA-binding transcriptional repressor 
gltB g1789605 glutamate synthase, large subunit 
gntX g87082263 protein required for the utilization of DNA as a carbon source 
gor g1789915 glutathione oxidoreductase 
gpr g1789375 L-glyceraldehyde 3-phosphate reductase 
hcaD g1788892 phenylpropionate dioxygenase, ferredoxin reductase subunit 
hisD g1788331 bifunctional histidinal dehydrogenase/ histidinol dehydrogenase 
hofM g87082257 protein required for the utilization of DNA as a carbon source, pilus assembly 
protein homolog 
holB g1787341 DNA polymerase III, delta prime subunit 
hyaF g1787211 proteininvolved in nickelincorporationinto hydrogenase-1 proteins 
hyfR g87082117 DNA-binding transcriptional activator, formate sensing 
insZ' g1787491 pseudogene, transposase homolog 
katE g48994891 catalase HPII, heme d-containing 
lepA g1788922 back-translocating elongation factor EF4, GTPase 
ligT g87081692 2'-5' RNA ligase 
lsrC g1787793 autoinducer 2 import system permease protein 
malG g1790464 maltose transporter subunit 
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mepA g1788668 murein DD-endopeptidase 
mrcA g87082258 fused penicillin-binding protein 1a: mureintransglycosylase/ 
mureintranspeptidase 
mtlR g1790029 mannitol operon repressor 
nhaR g1786202 DNA-binding transcriptional activator 
nlpC g1788001 predicted peptidase, C40 clan, lipoprotein 
nlpD g1789099 activator of AmiC murein hydrolase activity, lipoprotein 
nudC g48994995 NADH pyrophosphatase 
nuoC g1788622 NADH:ubiquinone oxidoreductase, fused CD subunit 
paoB g1786479 PaoABC aldehyde oxidoreductase, FAD-containing subunit 
patA g87082205 putrescine:2-oxoglutaric acid aminotransferase, PLP-dependent 
patD g1787715 gamma-aminobutyraldehyde dehydrogenase 
pfkB g1788017 6-phosphofructokinase II 
phoB g1786599 DNA-binding response regulator in two-component regulatory system with 
PhoR (or CreC) 
phoR g1786600 sensory histidine kinase in two-component regulatory system with PhoB 
pka g1788938 protein lysine acetyltransferase 
ppc g1790393 phosphoenolpyruvate carboxylase 
pstA g1790163 phosphate transporter subunit 
pstS g2367271 periplasmic phosphate binding protein, high-affinity 
recB g1789183 exonuclease V (RecBCD complex), beta subunit 
recG g2367254 ATP-dependent DNA helicase 
rnb g1787542 ribonuclease II 
rsmA g1786236 16S rRNA m(6)A1518, m(6)A1519 dimethyltransferase, SAM-dependent 
rutD g1787244 putative aminoacrylate hydrolase, reactive intermediate detoxification 
rzoD g87081757 DLP12 prophage; predicted lipoprotein 
rzoR g87081890 Racprophage; predicted lipoprotein 
sdaC g1789160 predicted serine transporter 
slyX g1789747 protein required for phi X174 lysis 
tamA g1790666 translocation and assembly module for autotransporter export, outer 
membrane subunit 
tauC g1786564 taurine transporter subunit 
tonB g1787505 membrane spanning protein in TonB-ExbB-ExbD transport complex 
uvrB g1786996 excinulease of nucleotide excision repair, DNA damage recognition 
valS g1790708 valyl-tRNA synthetase 
yaaX g1786186 predicted protein 
yacH g1786308 predicted protein 
yaeI g87081695 phosphodiesterase with model substrate bis-pNPP 
yafZ g87081705 CP4-6 prophage; conserved protein 
yceI g1787295 secreted protein 
ycgG g87081845 predicted membrane-anchored cyclic-di-GMP phosphodiesterase 
ycgL g1787427 conserved protein 
ycgR g1787443 flagellar velocity braking protein, c-di-GMP-regulated 
ydcO g87081909 inner membrane protein, predicted transporter, function unknown 
ydeI g1787817 conserved protein 
ydiK g1787979 inner membrane protein, UPF0118 family 
yeeJ g87082015 probable adhesin 
yegI g1788385 conserved protein 
yeiG g1788477 S-formylglutathione hydrolase 
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yfbK g1788606 conserved protein 
yfcO g87082086 predicted protein 
yfcR g1788676 predicted fimbrial-like adhesin protein 
yfdK g1788696 CPS-53 (KpLE1) prophage; conserved protein 
yfjQ g1788987 CP4-57 prophage; predictedprotein 
yhbW g1789551 predicted enzyme 
yhfW g1789781 predicted mutase 
yidI g1790111 inner membrane protein 
yifB g1790201 predicted bifunctional enzyme and transcriptional regulator 
yifL g87082333 predicted lipoprotein 
yjbG g1790460 conserved protein 
yjdA g1790548 mutational suppressor of yhjH motility mutation, function unknown; related 
to dynamin GTPase 
yodB g87082013 cytochrome b561 homolog 
ypdI g2367134 predicted lipoprotein involved in colanic acid biosynthesis 
ytfE g1790654 iron-sulfur cluster repair protein RIC 
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